<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON FEBRUARY 25, 1994
REGISTRATION NO. 33-
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
------------------------
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
4525 HARDING ROAD
NASHVILLE, TENNESSEE 37205
(615) 383-4444
(ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE, OF
REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)
<TABLE>
<S> <C>
DELAWARE 62-1234332
(STATE OR OTHER JURISDICTION OF (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NUMBER)
</TABLE>
------------------------
PHILIP D. WHEELER, ESQ.
SENIOR VICE PRESIDENT, GENERAL COUNSEL AND SECRETARY
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
4525 HARDING ROAD
NASHVILLE, TENNESSEE 37205
(615) 383-4444
(NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE,
OF AGENT FOR SERVICE)
COPIES TO:
<TABLE>
<S> <C>
MORTON A. PIERCE, ESQ. WINTHROP B. CONRAD, ESQ.
DEWEY BALLANTINE DAVIS POLK & WARDWELL
1301 AVENUE OF THE AMERICAS 450 LEXINGTON AVENUE
NEW YORK, NY 10019 NEW YORK, NY 10017
(212) 259-8000 (212) 450-4000
</TABLE>
------------------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: As soon as
practicable after the effective date of this Registration Statement.
If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. / /
If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. / /
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
- ---------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------
PROPOSED
PROPOSED MAXIMUM
AMOUNT MAXIMUM AGGREGATE AMOUNT OF
TITLE OF EACH CLASS OF TO BE OFFERING PRICE OFFERING REGISTRATION
SECURITIES TO BE REGISTERED REGISTERED PER UNIT(1) PRICE(1) FEE
- ---------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
% Subordinated Notes............... $200,000,000 100% $200,000,000 $68,966
- ---------------------------------------------------------------------------------------------------
- ---------------------------------------------------------------------------------------------------
</TABLE>
(1) Estimated solely for the purpose of determining the registration fee.
------------------------
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF
THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A),
MAY DETERMINE.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE> 2
***************************************************************************
* *
* INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A *
* REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED *
* WITH THE SECURITIES AND EXCHANGE COMMISSION. THESE SECURITIES MAY NOT *
* BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE *
* REGISTRATION STATEMENT BECOMES EFFECTIVE. THIS PROSPECTUS SHALL NOT *
* CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY *
* NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY JURISDICTION *
* IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO *
* REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH *
* JURISDICTION. *
* *
***************************************************************************
SUBJECT TO COMPLETION, DATED FEBRUARY 25, 1994
PROSPECTUS
, 1994
$200,000,000
HEALTHTRUST INC.
The Hospital Company
% SUBORDINATED NOTES DUE 2004
------------------------
The % Subordinated Notes due 2004 (the "Securities") are being
offered by Healthtrust, Inc. - The Hospital Company. Interest on the Securities
will be payable semi-annually on and of each year, commencing
, 1994. The Securities are redeemable at the option of the Company, in
whole or in part, at any time on or after , 1999 at the redemption prices
set forth herein, together with accrued and unpaid interest. Upon a Change of
Control Triggering Event (as defined herein) and the satisfaction of certain
conditions regarding Senior Indebtedness, each holder of the Securities may
require the Company to repurchase such Securities at 100% of the principal
amount thereof, together with accrued and unpaid interest, if any. See
"Description of the Securities."
Concurrently with the offering of the Securities, the Company is publicly
offering 5,200,000 shares of its common stock. This offering and the common
stock offering are being made as part of the financing of the Company's
acquisition of EPIC Holdings, Inc. and certain related transactions. This
offering and the common stock offering are contingent upon the consummation of
the acquisition. See "The Acquisition and the Financing Plan."
The Securities will be subordinated in right of payment to all existing and
future Senior Indebtedness (as defined herein) of the Company and effectively
subordinated in right of payment to all existing and future liabilities of the
Company's subsidiaries. The Securities will be pari passu in right of payment to
the Company's 10 3/4% Subordinated Notes due 2002 and 8 3/4% Subordinated
Debentures due 2005. After giving effect to the offering of the Securities, the
Acquisition and the other transactions contemplated by the Financing Plan, all
as described herein, as though they had occurred on November 30, 1993, the
amount of Senior Indebtedness and obligations of the Company's subsidiaries
(excluding intercompany indebtedness) effectively ranking senior to the
Securities would have been approximately $726.3 million, assuming 100% of the
Specified EPIC Debt Securities (as defined herein) is purchased in the Tender
Offers (as defined herein). As of November 30, 1993, there were $500 million
aggregate principal amount of 10 3/4% Subordinated Notes due 2002 and $300
million aggregate principal amount of 8 3/4% Subordinated Debentures due 2005 of
the Company outstanding.
FOR INFORMATION CONCERNING CERTAIN FACTORS THAT SHOULD BE CONSIDERED BY
PROSPECTIVE INVESTORS, SEE "INVESTMENT CONSIDERATIONS."
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR
HAS THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE
SECURITIES COMMISSION PASSED UPON THE ACCURACY OR
ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION
TO THE CONTRARY IS A CRIMINAL OFFENSE.
<TABLE>
- -----------------------------------------------------------------------------------------------
PRICE TO UNDERWRITING PROCEEDS TO
PUBLIC(1) DISCOUNT(2) COMPANY(3)
- -----------------------------------------------------------------------------------------------
<S> <C> <C> <C>
PER SECURITY............................. % % %
TOTAL.................................... $ $ $
- -----------------------------------------------------------------------------------------------
</TABLE>
(1) Plus accrued interest, if any, from the date of issuance.
(2) The Company has agreed to indemnify the Underwriters against certain
liabilities, including liabilities under the Securities Act of 1933. See
"Underwriting."
(3) Before deducting expenses of the offering payable by the Company estimated
at $ .
The Securities are offered by the several Underwriters, subject to prior
sale, when, as and if delivered to and accepted by the Underwriters and subject
to various prior conditions, including its right to reject orders in whole or in
part. It is expected that delivery of the Securities will be made in New York,
New York on or about , 1994.
DONALDSON, LUFKIN & JENRETTE MERRILL LYNCH & CO.
SECURITIES CORPORATION
<PAGE> 3
[MAP OF HOSPITALS]
IN CONNECTION WITH THIS OFFERING, THE UNDERWRITERS MAY OVER-ALLOT OR EFFECT
TRANSACTIONS WHICH STABILIZE OR MAINTAIN THE MARKET PRICES OF THE SECURITIES AT
LEVELS ABOVE THOSE WHICH MIGHT OTHERWISE PREVAIL IN THE OPEN MARKET. SUCH
TRANSACTIONS MAY BE EFFECTED IN THE OPEN MARKET OR OTHERWISE. SUCH STABILIZING,
IF COMMENCED, MAY BE DISCONTINUED AT ANY TIME.
2
<PAGE> 4
THE COMPANY
Healthtrust, Inc. - The Hospital Company (together with its subsidiaries,
"Healthtrust" or the "Company") is one of the largest providers of health care
services in the United States, delivering a full range of inpatient, outpatient
and other health care services principally through its affiliated hospitals. At
February 1, 1994, the Company owned or leased through its subsidiaries or joint
ventures 81 acute care hospitals (the "affiliated hospitals") and is an
investor, through joint ventures, in four other acute care hospitals. The
Company's affiliated hospitals are located in rural, suburban and urban
communities in 21 southern and western states. Approximately 40% of
Healthtrust's affiliated hospitals are the sole providers of general acute care
hospital services in their communities, and an additional 20% are one of two
general acute care hospitals in their communities. The Company's affiliated
hospitals generally provide a full range of inpatient and outpatient health care
services, including medical/surgical, diagnostic, obstetric, pediatric and
emergency services. Many of the Company's affiliated hospitals also offer
certain specialty programs and services, including occupational medicine
programs, home health care services, skilled nursing services, physical therapy
programs, rehabilitation services, alcohol and drug dependency programs and
selected mental health services.
The Company has experienced consistent growth since it began operations
through the acquisition of a group of hospitals and related assets (the
"Formation") from Hospital Corporation of America ("HCA") in September 1987. The
81 affiliated hospitals presently operated by the Company generated
approximately $2.4 billion of net operating revenue for the fiscal year ended
August 31, 1993, compared with approximately $1.8 billion of net operating
revenue for the fiscal year ended August 31, 1989 generated by the 94 hospitals
then operated by the Company. In addition, for the same periods, the Company's
net operating revenue less hospital service costs ("EBITDA") increased from
$339.2 million to $506.0 million and EBITDA as a percentage of net operating
revenue increased from 19.2% to 21.1%.
The Company's principal objective is to be a significant and growing
provider of low cost, high quality health care services in the markets in which
it operates. Although the means of achieving this objective will vary depending
upon the local market and the relative position of the Company's affiliated
hospitals and other health care businesses in that market, the strategies
employed generally include (i) expanding market share through improvements in
quality and reductions in cost for existing services and through the provision
of new or expanded services to meet underserved needs, (ii) participating in
quality health care delivery networks through affiliations, joint ventures,
partnerships and other arrangements with physicians, other hospitals and
providers of other health care related services, (iii) continuously improving
operating and financial performance, and (iv) developing the resources needed by
management to operate more effectively in the changing health care environment.
In addition, the Company has pursued and will continue to pursue other
opportunities to grow through the acquisition, construction or development of
hospital facilities or other health care related businesses that are or can be
positioned competitively in their markets consistent with the Company's
objectives. The Company recently entered into a letter of intent to acquire
Nashville Memorial Hospital in Madison, Tennessee and executed a definitive
agreement to purchase Holy Cross Hospital of Salt Lake City, Utah, Holy
Cross-Jordan Valley Hospital in Jordan Valley, Utah and St. Benedict's Hospital
in Odgen, Utah.
Consistent with the Company's strategy, Healthtrust entered into an
agreement on January 9, 1994 to acquire EPIC Holdings, Inc. (together with its
subsidiaries, "EPIC") (the "Acquisition"). EPIC is a health care services
provider that owns and operates 34 general acute care hospitals providing
inpatient, outpatient and other specialty services in 10 southern, southwestern
and western states. Approximately 29% of EPIC's hospitals are the sole providers
of general acute care hospital services in their communities, and an additional
27% of EPIC's hospitals are one of two general acute care hospitals in their
communities. Following the Acquisition, Healthtrust will be the second largest
hospital management company in the United States, operating 115 hospitals in 22
states. Of these 115 hospitals, approximately 37% are the sole providers of
general acute care hospital services in their communities and an additional 22%
are one of two such providers in their communities. Total combined net operating
revenue and combined EBITDA for Healthtrust and EPIC for their 1993 fiscal years
were approximately $3.4 billion and $651.4 million, respectively.
3
<PAGE> 5
The Company believes that the Acquisition will enhance the Company's
presence in the geographic areas it presently serves and provide access to new
markets. In addition, the Acquisition will allow the Company to expand its
health care delivery capabilities in such areas as home health care,
geropsychiatric care, rehabilitation services and physical therapy services,
thereby enhancing the Company's development of integrated health care delivery
networks designed to provide a full range of health care services to managed
care plans, self-insured employers and certain government payors. Healthtrust
also expects to realize operating cost savings of approximately $50 million
during the fiscal year ending August 31, 1995 resulting from increased economies
of scale and improved operating efficiencies following the Acquisition. After
giving effect to these savings, the Acquisition is expected to add $0.10 to
$0.12 per share to the Company's earnings during fiscal year 1995. See
"Investment Considerations -- Acquisition-Related Considerations," "The
Acquisition and the Financing Plan" and the Unaudited Pro Forma Condensed
Combined Financial Statements of the Company included elsewhere in this
Prospectus.
4
<PAGE> 6
THE OFFERING
SECURITIES OFFERED......... $200,000,000 principal amount of % Subordinated
Notes due 2004 of the Company (the "Offering").
MATURITY DATE.............. , 2004.
INTEREST PAYMENT DATES..... and commencing
, 1994.
OPTIONAL REDEMPTION........ The Securities are redeemable by the Company, in
whole or in part, at any time on or after
, 1999 at the redemption prices set
forth herein, together with accrued and unpaid
interest.
CHANGE OF CONTROL.......... Upon the occurrence of both a Change of Control (as
defined herein) and a Rating Decline (as defined
herein) (a "Change of Control Triggering Event")
(including a Change of Control Triggering Event
involving a transaction led or approved by
Company management or in connection with a
recapitalization of the Company) and the
satisfaction of certain conditions regarding
Senior Indebtedness, each holder of Securities
may require the Company to repurchase the
Securities at a purchase price equal to 100% of
the principal amount thereof together with
accrued and unpaid interest thereon to the date
of repurchase. See "Description of the
Securities -- Certain Definitions" and
" -- Certain Covenants of the Company."
RANKING.................... The Securities are subordinated to all Senior
Indebtedness (as defined herein) of the Company
and effectively subordinated to all existing and
future liabilities of the Company's subsidiaries.
The Securities will be pari passu in right of
payment to the Company's 10 3/4% Subordinated
Notes due May 1, 2002 (the "10 3/4% Notes") and
8 3/4% Subordinated Debentures due March 15, 2005
(the "8 3/4% Debentures"). As of November 30,
1993, the amount of Senior Indebtedness and
obligations of the Company's subsidiaries
(excluding intercompany indebtedness) that
effectively ranked senior to the Securities was
approximately $183.9 million. After giving effect
to the Offering, the Acquisition and the other
transactions contemplated by the Financing Plan
as though they had occurred on November 30, 1993,
the amount of Senior Indebtedness and obligations
of the Company's subsidiaries (excluding
intercompany indebtedness) that effectively
ranked senior to the Securities would have been
approximately $726.3 million, assuming 100% of
the Specified EPIC Debt Securities (as
hereinafter defined) is purchased in the Tender
Offers. See "The Acquisition and the Financing
Plan" and "Description of the Securities --
Subordination."
RESTRICTIVE COVENANTS...... The Indenture limits, among other things, (i) the
incurrence of indebtedness by the Company and its
subsidiaries, including the incurrence of
indebtedness by the Company that is subordinate
in right of payment to the Securities, (ii)
dividends and distributions on and repurchases of
the Company's capital stock and certain other
restricted payments and investments by the
Company and its subsidiaries and (iii) the
Company's ability to engage in certain mergers,
consolidations or sales of all or substantially
all of its assets. All of these limitations are
subject to a number of important qualifications.
See "Description of the Securities -- Certain
Covenants of the Company."
USE OF PROCEEDS............ The proceeds of the Offering, together with the
proceeds of the Common Stock Offering, borrowings
under the 1994 Credit Agreement and cash on hand,
will be used to finance the Acquisition, the
Tender Offers and the Debt Redemption (all as
hereinafter defined). See "Use of Proceeds."
5
<PAGE> 7
INVESTMENT CONSIDERATIONS
Prospective investors should consider carefully, in addition to the other
information contained in this Prospectus, the following factors before
purchasing the Securities offered hereby.
SUBSTANTIAL INDEBTEDNESS
Following the consummation of the Acquisition and the Financing Plan, the
Company will continue to have substantial indebtedness and, as a result,
significant debt service obligations. As of November 30, 1993, the Company's
ratio of long-term debt (including current maturities) to stockholders' equity
was 1.4 to 1. After giving effect to the Offering, the Acquisition and the other
transactions contemplated by the Financing Plan, at November 30, 1993, the ratio
of the Company's long-term debt (including current maturities) to stockholders'
equity would have been 2.1 to 1, assuming 100% of each issue of Specified EPIC
Debt Securities is purchased in the Tender Offers. See "Capitalization" and the
Unaudited Pro Forma Condensed Combined Financial Statements of the Company
included elsewhere in this Prospectus.
The degree to which the Company is leveraged could have important
consequences to holders of the Securities, including the following: (i) the
Company's ability to obtain additional financing in the future for working
capital, capital expenditures, acquisitions, general corporate purposes or other
purposes may be impaired; (ii) a substantial portion of the Company's cash flow
from operations must be dedicated to the payment of principal and interest on
its indebtedness, thereby reducing the funds available to the Company for its
operations; (iii) certain of the Company's borrowings are and will continue to
be at variable rates of interest, which causes the Company to be vulnerable to
increases in interest rates; and (iv) such indebtedness contains numerous
financial and other restrictive covenants, including those restricting the
incurrence of indebtedness, the creation or existence of liens, the declaration
or payment of dividends, certain investments, the acquisition of securities of
the Company, and certain extraordinary corporate transactions. Failure by the
Company to comply with such covenants may result in an event of default which,
if not cured or waived, could have a material adverse effect on the Company.
The Company's ability to make scheduled payments or to refinance its
obligations with respect to its indebtedness depends on its financial and
operating performance, which, in turn, is subject to prevailing economic
conditions and to financial, business and other factors beyond its control.
Although the Company's cash flow from its operations has been sufficient to meet
its debt service obligations in the past, there can be no assurance that the
Company's operating results will continue to be sufficient for payment of the
Company's indebtedness.
SUBORDINATION; EFFECT OF ENCUMBRANCES
The Securities will be subordinated to all Senior Indebtedness of the
Company and will rank pari passu with the 10 3/4% Notes and the 8 3/4%
Debentures. The Securities also will be effectively subordinated to all existing
and future liabilities of the Company's subsidiaries. As of November 30, 1993,
the amount of Senior Indebtedness and obligations of the Company's subsidiaries
(excluding intercompany indebtedness) that effectively ranked senior to the
Securities was approximately $183.9 million. After giving effect to the
Acquisition and the transactions contemplated by the Financing Plan, the amount
of Senior Indebtedness and obligations of the Company's subsidiaries (excluding
intercompany indebtedness) that effectively ranked senior to the Securities
would have been approximately $726.3 million, assuming 100% of each issue of
Specified EPIC Debt Securities is purchased in the Tender Offers. See "The
Acquisition and the Financing Plan."
The Company may not pay the principal of, premium, if any, or interest on,
the Securities or repurchase, redeem or otherwise retire the Securities if any
Senior Indebtedness is not paid when due or any other default on Senior
Indebtedness occurs and the maturity of such Senior Indebtedness is accelerated
in accordance with its terms unless, in either case, the default has been cured
or waived, any such acceleration has been rescinded or such Senior Indebtedness
has been paid in full. In addition, if any default exists with respect to
certain Senior Indebtedness and certain other conditions are satisfied, the
Company may not make any payments on the Securities for a designated period of
time. Upon any payment or distribution of assets of the Company
6
<PAGE> 8
upon liquidation, dissolution, reorganization or any similar proceeding, the
holders of Senior Indebtedness will be entitled to receive payment in full
before the holders of the Securities are entitled to receive any payment. See
"Description of the Securities."
The Company has granted the lenders under its existing bank credit facility
a senior security interest in the capital stock of the Company's subsidiaries
and instruments evidencing indebtedness owed to the Company by its subsidiaries
and anticipates that it will grant the lenders under the 1994 Credit Agreement a
senior security interest in the capital stock of the Company's subsidiaries. At
November 30, 1993, there was approximately $167.0 million outstanding under the
Company's existing bank credit facility. Upon consummation of the Acquisition
and Financing Plan, the Company anticipates that there will be approximately
$671.4 million outstanding under the 1994 Credit Agreement, assuming 100% of
each issue of Specified EPIC Debt Securities is purchased in the Tender Offers.
The Securities will be unsecured. If the Company becomes insolvent or is
liquidated, or if its indebtedness is accelerated, the lenders under its
existing credit facility or the 1994 Credit Agreement, as the case may be, will
be entitled to payment in full from the proceeds of their security prior to any
payment to the holders of Securities. In such event, it is possible that there
would be no assets remaining from which claims of the holders of Securities
could be satisfied or, if any assets remain, such assets may be insufficient to
satisfy fully such claims. See "The Acquisition and the Financing Plan."
SUBSIDIARY OPERATIONS
Since substantially all of the Company's operations are conducted, and
substantially all of the Company's assets are owned, by its subsidiaries, the
Securities will effectively be subordinated to all existing and future
liabilities of the Company's subsidiaries, including the subsidiaries'
guarantees of indebtedness incurred under its bank credit facility. In addition,
following the consummation of the Acquisition, EPIC and its subsidiaries will be
subsidiaries of the Company, and any indebtedness existing or incurred in the
future at the EPIC level, including any Specified EPIC Debt Securities that are
not purchased in the Tender Offers and any EPIC indebtedness that remains
outstanding if the Debt Redemption does not occur, also will be effectively
senior to the Securities. Any right of the Company to participate in any
distribution of the assets of any of the Company's subsidiaries upon the
liquidation, reorganization or insolvency of such subsidiary (and the consequent
right of the holders of the Securities to participate in those assets) will be
subject to the claims of the creditors (including trade creditors) and preferred
stockholders, if any, of such subsidiary, except to the extent the Company has a
claim against such subsidiary as a creditor of such subsidiary. The Company has
expressly subordinated certain of its claims against its subsidiaries to the
subsidiaries' guarantees of indebtedness incurred under its existing bank credit
facility, and anticipates that it will similarly subordinate certain of its
claims against its subsidiaries to the subsidiaries' guarantees of indebtedness
incurred under the 1994 Credit Agreement. In addition, in the event that claims
of the Company as a creditor of a subsidiary are recognized, such claims would
be subordinate to any security interest in the assets of such subsidiary and any
indebtedness of such subsidiary senior to that held by the Company. A majority
of the hospitals presently owned and operated by EPIC are subject to mortgages
granted in connection with the issuance of the EPIC Mortgage Notes.
Additionally, the capital stock of EPIC Properties has been pledged as
collateral for the EPIC Mortgage Notes and the capital stock of certain
subsidiaries of EPIC has been pledged as collateral for certain of the EPIC
indebtedness to be redeemed pursuant to the Debt Redemption (the "EPIC
Redeemable Debt"). Following the consummation of the Acquisition, the claims of
holders of any EPIC Mortgage Notes that are not purchased in the Tender Offers
and the claims of holders of any EPIC Redeemable Debt not redeemed in the Debt
Redemption will be senior with respect to such security interests to the claims
of the Company as a creditor of the applicable EPIC subsidiaries. See
"Description of EPIC." However, the ability of a subsidiary to incur
indebtedness is limited by certain of the restrictive covenants set forth in the
Company's existing bank credit facility and in the indentures relating to
certain of the Company's other long-term indebtedness, and the Company
anticipates that similar restrictions will be included in the 1994 Credit
Agreement and the indenture governing the indebtedness to be issued in the
Offering.
In addition, the Company's ability to make required principal and interest
payments with respect to the Company's indebtedness, including the Securities,
depends on the earnings of its subsidiaries and on its ability to receive funds
from such subsidiaries through dividends or other payments. Since the Securities
are
7
<PAGE> 9
obligations of the Company only, the Company's subsidiaries are not obligated or
required to pay any amounts due pursuant to the Securities or to make funds
available therefor in the form of dividends or advances to the Company.
Additionally, if the Tender Offers (including the related consent solicitations)
and the Debt Redemption are not consummated, the indentures governing the
Specified EPIC Debt Securities and the EPIC Redeemable Debt that remain
outstanding will contain provisions that restrict EPIC's ability to make
payments to the Company in the form of dividends or otherwise.
HEALTH CARE REFORM
On November 20, 1993, President Clinton submitted proposed comprehensive
health care reform legislation ("Administration's Proposal") to Congress. A
central component of the Administration's Proposal is the restructuring of
health insurance markets through the use of "managed competition." Under the
Administration's Proposal, states would be required to establish regional
purchasing cooperatives, known as "regional alliances," that would be the
exclusive source of coverage for individuals and employers with less than 5,000
employees. All employers would be required to make coverage available to their
employees and contribute 80% of the premium, and all individuals would be
required to enroll in an approved health plan. Regional alliances would contract
with health plans that demonstrate an ability to provide consumers with a full
range of benefits, including hospital services, and the provision of such
benefits would be mandated by the federal government. The federal government
would provide subsidies to low income individuals and certain small businesses
to help pay for the cost of coverage. These subsidies and other costs of the
Administration's Proposal would be funded in significant part by reductions in
payments by the Medicare and Medicaid programs to providers, including
hospitals. The Administration's Proposal would also place stringent limits on
the annual growth in health plan premiums. Other comprehensive reform proposals
have been or are expected to be introduced in Congress. These other proposals
contain or are expected to contain coverage guarantees, benefit standards,
financing and cost control mechanisms which are different than the
Administration's Proposal. The Company is unable to predict what, if any,
reforms will be adopted, or when any such reforms will be implemented. No
assurance can be given that such reforms will not have a material adverse impact
on the Company's revenues or earnings.
REIMBURSEMENT AND REGULATION
The Company derives a substantial portion of its revenue from Medicare and
Medicaid programs. Such programs are highly regulated and subject to frequent
and in certain cases substantial changes. Significant changes in Medicare and
Medicaid reimbursement programs have resulted in reduced levels of reimbursement
for a substantial portion of hospital procedures and costs. Changes in other
existing reimbursement programs are scheduled or anticipated in the future which
changes are likely to result in further reductions in reimbursement levels. In
addition, the Company's revenue could be affected by any implementation of
federal government sequestration under the Balanced Budget and Emergency Deficit
Control Act of 1985, as amended.
The health care industry is subject to extensive federal, state and local
regulation relating to licensure, conduct of operations, addition of facilities
and services and cost containment. Over the past several years, federal and
state initiatives have been undertaken to evaluate the impact that financial
arrangements between health care providers and physicians may have on Medicare
and state health care programs. As a result of such initiatives, the U.S.
Department of Health and Human Services ("HHS") issued final regulations
outlining certain "safe harbor" practices which, although potentially capable of
inducing prohibited referrals of business, would not be subject to enforcement
action under the Social Security Act of 1935, as amended (the "Social Security
Act"). In addition, certain provisions of Section 1877 of the Social Security
Act, commonly known as the "Stark Bill," have recently been amended to
significantly broaden the scope of prohibited physician self-referrals
thereunder. Certain of the Company's current financial arrangements with
physicians do not qualify for the safe harbor exemptions and, as a result, risk
scrutiny by HHS and may be subject to enforcement action. Additionally, the
Company believes that certain of EPIC's financial arrangements with physicians
do not qualify for the safe harbor exemptions. The Company's participation in
and development of joint ventures and other financial arrangements with
physicians could be adversely affected by the recent HHS
8
<PAGE> 10
regulations and Stark Bill amendments. The Company is unable to predict the
future course of federal, state and local regulation or legislation, including
Medicare and Medicaid statutes and regulations. Further changes in the
regulatory framework could have an adverse impact on the Company.
DEPENDENCE ON PHYSICIANS AND OTHER KEY PERSONNEL
Since physicians generally control the majority of hospital admissions, the
success of the Company, in part, is dependent upon the number and quality of
physicians on its hospitals' medical staffs. The Company's operations also are
dependent on the efforts, ability and experience of its key corporate and
hospital management teams. The loss of some or all of these key personnel or an
inability to attract and retain sufficient numbers of qualified physicians could
adversely affect the Company's hospitals.
COMPETITION
The health care business is highly competitive and subject to excess
capacity. Competition among hospitals and other health care providers for
patients has intensified in recent years. During this period, hospital occupancy
rates in the United States have declined as a result of cost containment
pressures, changing technology, changes in regulations and reimbursement,
changes in practice patterns from inpatient to outpatient treatment, an
increasing supply of physicians and other factors. In many geographic areas in
which the Company operates, there are other hospitals or facilities that provide
inpatient or outpatient services comparable to those offered by the Company's
hospitals. Certain of these hospitals have greater financial resources than the
Company's hospitals and offer a wider range of services than the Company's
hospitals. Even in communities in which the Company's hospitals are the sole
providers of general acute care hospital services, the Company may face
competition from local providers of outpatient services and hospitals and other
health care providers in nearby communities. The competitive position of the
Company's hospitals also has been, and in all likelihood will continue to be,
affected by the increased initiatives undertaken during the past several years
by federal and state governments and other major purchasers of health care,
including insurance companies and employers, to revise payment methodologies and
monitor health care expenditures in order to contain health care costs. Due in
part to these initiatives, managed care organizations such as health maintenance
organizations ("HMOs") and preferred provider organizations ("PPOs"), which
offer prepaid and discounted medical services packages, represent an increasing
segment of health care payors, tending to reduce the historical rate of growth
of hospital revenue. In addition, hospitals owned by governmental agencies or
other tax-exempt entities benefit from endowments, charitable contributions and
tax-exempt financing, which advantages are not enjoyed by the Company's
hospitals.
LEGAL PROCEEDINGS
Certain of the Company's Utah hospitals, along with other Utah hospitals,
were the subject of a federal grand jury investigation of possible criminal
violations of the federal antitrust laws in connection with nursing compensation
practices. The Company has been informed by the Antitrust Division of U.S.
Department of Justice that the Government does not intend to pursue criminal
charges against the Company but may pursue civil proceedings in connection with
the actions of its Utah facilities. Although the Company attempts to structure
its compensation practices to comply with federal and state law, the Company
cannot predict with certainty the outcome of this ongoing civil investigation.
PROFESSIONAL LIABILITY
As is typical in the health care industry, the Company is subject to claims
and legal actions by patients and others in the ordinary course of business. The
Company generally self-insures against substantially all of its professional and
general liabilities and maintains an unfunded reserve for liability risks. While
the Company's cash flow has been adequate to provide for liability claims in the
past, there can be no assurance that the Company's cash flow will continue to be
adequate. If payments with respect to self-insured liabilities increase in the
future, the results of operations of the Company could be adversely affected.
9
<PAGE> 11
PRINCIPAL STOCKHOLDER
As of December 31, 1993, the trustee (the "Plan Trustee") of the Company's
401(k) Retirement Program (the "Plan") held approximately 31% of the outstanding
common stock, par value $.001 per share, of the Company (the "Common Stock").
After giving effect to the Common Stock Offering, as of December 31, 1993, the
Plan Trustee would have held approximately 28% of the outstanding Common Stock.
Shares of Common Stock held by the Plan Trustee are held in the accounts of
participants in the Plan. Such participants are able to direct the Plan Trustee
to vote the shares allocated to their accounts, except when the Plan Trustee
believes its fiduciary duties obligate it to override such directions. As a
principal stockholder, the Plan Trustee may have the ability to influence the
policies and affairs of the Company to a greater extent than other stockholders.
LACK OF PUBLIC MARKET FOR SECURITIES
There is no public market for the Securities and the Company may or may not
list the Securities on a securities exchange. The Company has been advised by
Donaldson, Lufkin & Jenrette Securities Corporation ("DLJ") and Merrill Lynch,
Pierce, Fenner & Smith Incorporated ("Merrill Lynch") (collectively, the
"Underwriters") that they presently intend to make a market in the Securities
after the consummation of the Offering, although they are under no obligation to
do so and may discontinue any market making at any time. No assurance can be
given as to the liquidity of the trading market for the Securities or that an
active trading market for the Securities will develop. If an active public
market does not develop, the market price and liquidity of the Securities may be
adversely affected.
FORMATION-RELATED CONSIDERATIONS
In connection with the Formation of Healthtrust in 1987, HCA agreed to
indemnify the Company against tax claims, professional liability claims and
claims covered by standard public liability insurance relating to the acquired
assets, in each case relating to periods prior to the Formation. In the past HCA
has satisfied its obligation to indemnify the Company for all such claims, and
the Company has no reason to believe that HCA would not continue to do so.
However, if HCA should fail to meet its indemnification obligations, the Company
would be responsible for the satisfaction of any such claims in the future,
which claims, if substantial, could have a material adverse effect on the
Company.
With respect to certain taxable periods ending on or prior to the Formation
in September 1987, the Company and certain of its subsidiaries filed federal
income tax returns on a consolidated basis with HCA and, as a result, under
federal income tax law, the Company and such subsidiaries are severally liable
with HCA for the federal income taxes of HCA's consolidated group for such
periods. However, in connection with the Formation, HCA agreed that it would be
responsible for the payment of all taxes, assessments, interest and penalties
imposed by any taxing authority for any periods prior to and including the date
of the Formation. HCA has disclosed that following a recent examination of HCA's
federal income tax returns for tax years 1981 through 1990, the Internal Revenue
Service has proposed certain adjustments to such returns, and HCA has received
notices of deficiencies for certain years, which it is contesting through
litigation. Should HCA be unable to sustain its position on disputed matters,
additional taxes would approximate $383 million, plus accrued interest of
approximately $640 million as of December 31, 1993, for taxable periods in which
the Company and certain of its subsidiaries were members of HCA's consolidated
group. If the additional taxes that have been asserted by the Internal Revenue
Service were finally determined to be due and HCA were unable to, or for any
other reason did not, pay such taxes or related interest, the Company could be
responsible for such payment, which payment could have a material adverse effect
on the Company.
ERISA MATTERS
In connection with the Formation in 1987, the Company's Employee Stock
Ownership Plan (the "ESOP") purchased approximately 50.9 million shares of
Common Stock for $810 million. The purchase price was based on the determination
of the committee administering the ESOP (the "ESOP Committee") as to the fair
market value of such shares at that time. Based on such determination, and
subject to limitations
10
<PAGE> 12
contained in the Internal Revenue Code of 1986, as amended (the "Code"), the
Company has claimed income tax deductions for contributions to the ESOP for the
years to which such contributions relate. Contributions to the ESOP were used by
the ESOP to pay interest and principal on the loans owed to the Company. These
payments were in turn used by the Company to pay interest and principal on the
ESOP term loans under the Company's previous bank credit agreement and certain
other indebtedness related to the ESOP. As a result, the Company was effectively
able to obtain a deduction for principal, as well as interest payments, on
ESOP-related borrowings. If the ESOP Committee's determination of fair market
value was incorrect, the Company's contribution to the ESOP might not be fully
deductible, which could have a material adverse effect on the Company.
It was intended that qualified holders of the ESOP term loans and the other
indebtedness incurred in connection with the ESOP be entitled to exclude from
taxable income 50% of the interest received on such indebtedness. In addition,
the loans to the ESOP and the purchase of Common Stock by the ESOP were intended
to qualify for exemption from the "prohibited transaction" rules under the Code
and the Employee Retirement Income Security Act of 1974, as amended ("ERISA"),
which rules generally prohibit sale and loan transactions between an employer
and a qualified retirement plan. The 50% interest exclusion and the prohibited
transaction exemption were available only if the plan was designed to invest
primarily in "employer securities." It is likely that if Healthtrust and HCA
were deemed to have been members of the same "controlled group of corporations"
for purposes of the relevant section in the Code or ERISA, the stock of HCA, and
not Healthtrust's Common Stock, would have been "employer securities" for these
purposes. Healthtrust and HCA concluded that they were not in the same
"controlled group of corporations" (as defined in Section 409(1) of the Code).
If, notwithstanding such conclusion, HCA's common stock were deemed to have been
"employer securities" for such purposes, there could be severe adverse
consequences to Healthtrust, including violation of the prohibited transaction
rules discussed above (which could subject Healthtrust or other disqualified
persons with respect to the ESOP to an excise tax and could require that certain
corrective action be taken) and retroactive increases in the rate of interest
payable on certain of the Company's previously outstanding ESOP-related
indebtedness as a result of the loss of the 50% interest exclusion. In addition,
the 50% interest exclusion and the prohibited transaction exemption were
available only if the price paid by the ESOP reflected the fair market value of
the employer securities as determined in good faith by the plan fiduciaries.
Accordingly, if the ESOP Committee's determination of fair market value was
incorrect, the 50% interest exclusion might not have been fully available and
the Company or other disqualified persons may have committed prohibited
transactions, either of which events could have a material adverse effect on the
Company. See Note 6 to "Capitalization."
ACQUISITION-RELATED CONSIDERATIONS
The purchase of EPIC common stock by the EPIC Employee Stock Ownership Plan
(the "EPIC ESOP") in connection with EPIC's acquisition (the "EPIC Formation")
of its facilities from American Medical International, Inc. ("AMI") in 1988 was
structured in a manner similar to the purchase of Common Stock by the ESOP in
connection with the Formation of Healthtrust and was intended to (i) qualify for
exemption from the "prohibited transaction" rules of the Code and ERISA, (ii)
permit EPIC to deduct for federal income tax purposes its contributions to the
EPIC ESOP used to pay principal and interest on loans made by EPIC to the EPIC
ESOP and (iii) permit qualified holders of indebtedness incurred in connection
with the EPIC ESOP to benefit from the 50% interest exclusion provision referred
to in "-- ERISA Matters" above. Exemption from the prohibited transaction rules
and the availability of the ESOP-related benefits described above depends on (i)
the amount the EPIC ESOP paid for EPIC common stock not having exceeded the fair
market value of that EPIC common stock, (ii) the EPIC common stock being
"employer securities" and (iii) compliance with the other relevant provisions of
the Code and ERISA. If (i) the EPIC ESOP paid an amount in excess of fair market
value for the EPIC common stock, (ii) the EPIC common stock were to fail to
qualify as "employer securities" or (iii) the EPIC ESOP were to fail to comply
with the other relevant provisions of the Code or ERISA, such events could
result in material adverse consequences to EPIC similar to those described with
respect to the Company under "-- ERISA Matters" above, which could have a
material adverse effect on the Company following consummation of the
Acquisition. See "The Acquisition and the Financing Plan" and Note 6 to
"Capitalization." In addition, although the Company
11
<PAGE> 13
believes that the actions which the parties intend to take with respect to the
EPIC ESOP pursuant to the ESOP Agreement (as hereinafter defined) should not
give rise to any adverse tax or other consequences to EPIC or the Company, if
the Internal Revenue Service or the Department of Labor were to successfully
challenge certain aspects of such actions, the Company or EPIC could be subject
to certain taxes or penalties, which could have a material adverse effect on the
Company following consummation of the Acquisition. See "The Acquisition and the
Financing Plan."
In connection with the EPIC Formation, AMI agreed to indemnify EPIC against
certain losses, including the loss of certain expected tax benefits. If AMI is
unable to or otherwise does not satisfy such indemnification obligations, EPIC
could be responsible for such losses, which could adversely affect the Company
following the Acquisition.
The Company will use the proceeds of the Offering to fund a portion of the
Acquisition. While the Company believes that it can improve the profitability of
the operations acquired from EPIC, there can be no assurance that this will be
the case. In addition, there can be no assurance that the Company will be able
to realize expected operating and economic efficiencies following the
Acquisition or that the Acquisition will not adversely affect the Company's
results of operations or financial condition. See the Unaudited Pro Forma
Condensed Combined Financial Statements of the Company included elsewhere in
this Prospectus.
12
<PAGE> 14
THE ACQUISITION AND THE FINANCING PLAN
On January 9, 1994, Healthtrust, Odyssey Acquisition Corp., a wholly-owned
subsidiary of Healthtrust ("Odyssey") and EPIC entered into a merger agreement
pursuant to which Odyssey will merge into EPIC and EPIC will become a
wholly-owned subsidiary of Healthtrust. Upon consummation of the Acquisition,
the holders of EPIC common stock (and securities exercisable therefor) will
become entitled to receive $7.00 per share in cash from Healthtrust. It is
anticipated that the Company will purchase approximately 39.7 million shares of
EPIC common stock (and securities exercisable therefor) at the closing of the
Acquisition, for an aggregate purchase price of approximately $278 million,
comprised of the following securities: (i) approximately 17.6 million shares of
EPIC common stock allocated or allocable to EPIC ESOP participants, (ii)
approximately 15.9 million other shares of outstanding EPIC common stock and
(iii) outstanding stock appreciation rights, warrants and options exercisable
for approximately 6.2 million shares of EPIC common stock. The consummation of
the Acquisition is subject to certain conditions, including, among others, the
approval of the stockholders of EPIC, certain regulatory approvals and the
consent solicitation in connection with the Specified EPIC Debt Securities
described below. The approval of the Acquisition requires the affirmative vote
of the holders of a majority of the outstanding shares of EPIC common stock
entitled to vote thereon. Subject to certain conditions, each of AMI and the
EPIC ESOP Trustee has agreed to vote the shares of EPIC common stock over which
it exercises voting power (in the aggregate approximately 52% of the EPIC common
stock outstanding on January 8, 1994) in favor of the Acquisition.
In connection with the Acquisition, the Company entered into an agreement
(the "ESOP Agreement") with EPIC, EPIC Healthcare Group, Inc. ("EPIC Group"),
U.S. Trust Company of California, N.A., the trustee of the trust established
under the EPIC ESOP (the "EPIC ESOP Trustee") and the EPIC Committee
administering the EPIC ESOP. Pursuant to the ESOP Agreement, all shares of EPIC
common stock held by the EPIC ESOP Trustee and not allocated or allocable to
EPIC ESOP participants as of the closing of the Acquisition (approximately 6.7
million shares) will be returned to EPIC in full satisfaction of certain loans
granted by EPIC to the EPIC ESOP Trustee, and contributions to the EPIC ESOP
will be terminated. Subject to certain Code limitations, the parties to the ESOP
Agreement have agreed that there will be approximately 17.6 million shares of
EPIC common stock allocated or allocable to EPIC ESOP participants as of the
closing of the Acquisition. Following the Acquisition, the EPIC ESOP
participants who continue to be employed by the Company will be entitled to
participate in the Plan or in a similar plan to be established by the Company
(the Plan or such other plan, the "Healthtrust Plan"). Subject to Code
limitations, EPIC ESOP participants who participate in the Healthtrust Plan will
be allocated additional shares of EPIC common stock in an amount equivalent to
the 4% profit sharing contribution (described below) to which EPIC ESOP
participants would have been entitled had they participated in the Plan from
March 1, 1994 through the Acquisition closing date. In addition, the Company has
agreed to provide certain minimum retirement benefits in accordance with the
terms of the Plan and subject to Code limitations, including (i) a profit
sharing contribution by the Company on behalf of EPIC ESOP participants who
participate in the Healthtrust Plan of 4% of compensation from the Acquisition
closing date through December 31, 1994 and (ii) a matching contribution by the
Company of 100% for each EPIC ESOP participant who participates in the
Healthtrust Plan, up to a maximum of 3% of compensation, for the period from the
Acquisition closing date through December 31, 1998. In the event that fewer
shares are so allocated or allocable to EPIC ESOP participants as of the closing
or the full amount of contributions to the Healthtrust Plan are not permitted to
be made due to Code limitations, additional contributions will be made in the
future in lieu of any shares not so allocated or allocable and any contributions
not so permitted to be made. The obligations of the parties under the ESOP
Agreement are conditioned upon, among other things, the consummation of the
Acquisition. The foregoing does not purport to be a complete description of the
ESOP Agreement and reference is hereby made to the ESOP Agreement, which is
filed as an exhibit to the Registration Statement of which this Prospectus is a
part.
In connection with the Acquisition and the related merger agreement, it is
anticipated that certain EPIC subsidiaries will offer to purchase up to 100% of
the following outstanding debt securities of EPIC (collectively, the "Specified
EPIC Debt Securities") at the following purchase prices: (i) $250 million
aggregate principal amount (representing an aggregate accreted value of
approximately $170.6 million) of 12% Senior Deferred Coupon Notes due 2002 of
EPIC Holdings, Inc. (the "EPIC 12% Notes") for 112% of
13
<PAGE> 15
accreted value (expected to be approximately $178.8 million at the time of
purchase), (ii) $160 million aggregate principal amount of 10 7/8% Senior
Subordinated Notes due 2003 of EPIC Group (the "EPIC 10 7/8% Notes") for 116% of
principal amount, (iii) $100 million aggregate principal amount (representing an
aggregate accreted value of approximately $99.6 million) of 11 3/8% Class B-1
First Priority Mortgage Notes due 2001 of EPIC Properties (the "EPIC Class 1
Mortgage Notes") for 118 3/4% of principal amount, (iv) $83.5 million aggregate
principal amount (representing an aggregate accreted value of approximately
$83.1 million) of 11 1/2% Class B-2 First Priority Mortgage Notes due 2001 of
EPIC Properties (the "EPIC Class 2 Mortgage Notes") for 121 1/8% of principal
amount and (v) $15 million aggregate principal amount of Floating Rate Class B-3
First Priority Mortgage Notes due 1998 (with an interest rate of 6 3/8% at
February 1, 1994) of EPIC Properties (the "EPIC Class 3 Mortgage Notes" and,
together with the EPIC Class 1 Mortgage Notes and EPIC Class 2 Mortgage Notes,
the "EPIC Mortgage Notes") for 103 1/8% of principal amount. In connection
therewith, the consent of the holders of the Specified EPIC Debt Securities will
be solicited to eliminate or modify substantially all of the restrictive
covenants and certain event of default provisions relating to any Specified EPIC
Debt Securities which remain outstanding after the offers to purchase are
completed. Consent payments of $20 per $1,000 of principal amount will be made
with respect to the Specified EPIC Debt Securities for which consents have been
validly delivered (and not revoked) prior to the acceptance thereof. The offers
to purchase the Specified EPIC Debt Securities and the related solicitations of
consents are hereinafter referred to as the "Tender Offers." The obligation to
make the consent payments is subject to certain conditions, including the
acceptance for purchase and payment of the applicable issue of Specified EPIC
Debt Securities in the Tender Offers. The consummation of the Tender Offers is
conditioned upon, among other things, (i) the consummation of the Acquisition,
(ii) receipt of validly delivered and unrevoked consents from holders of a
majority in aggregate principal amount of each of the EPIC 12% Notes, EPIC
10 7/8% Notes and EPIC Mortgage Notes and (iii) there having been validly
tendered and not withdrawn at least a majority in aggregate principal amount of
each of the EPIC 12% Notes, EPIC 10 7/8% Notes and EPIC Mortgage Notes.
Following the consummation of the Acquisition, it is anticipated that the
following outstanding indebtedness of EPIC Group will be redeemed in accordance
with the optional redemption provisions thereof (the "Debt Redemption"): (i)
approximately $74.8 million aggregate principal amount (representing an
aggregate accreted value of approximately $72.2 million) of 11 7/8% Senior ESOP
Notes due 1998, (ii) approximately $96.4 million aggregate principal amount
(representing an aggregate accreted value of approximately $31.5 million) of
Zero Coupon Notes due 2001 (with an effective interest rate of 14.8% at November
30, 1993) and (iii) approximately $30.1 million aggregate principal amount
(representing an aggregate accreted value of approximately $19.7 million) of 11%
Junior Subordinated Pay-In-Kind Notes due 2003.
The Acquisition, the Tender Offers and the Debt Redemption will be financed
through the following:
(i) the Offering;
(ii) the public offering by the Company of 5,200,000 shares of Common
Stock (the "Common Stock Offering");
(iii) the refinancing of the Company's existing bank credit facility
with a new bank credit facility (the "1994 Credit Agreement"), which will
provide for aggregate commitments of up to $1.2 billion; and
(iv) cash on hand.
The Tender Offers, the Debt Redemption, the Offering, the Common Stock
Offering and the 1994 Credit Facility are hereinafter referred to as the
"Financing Plan." The Offering is expected to occur contemporaneously with the
Acquisition and the other transactions contemplated by the Financing Plan and is
conditioned upon the consummation of the Acquisition.
The following table sets forth the sources of funds to be used to effect
the Acquisition, the Tender Offers and the Debt Redemption, assuming (i) $200
million aggregate principal amount of Securities are sold by the Company in the
Offering at a public offering price of 100% of principal amount, (ii) 5,200,000
shares of Common Stock are sold by the Company in the Common Stock Offering at a
public offering price of $28.625
14
<PAGE> 16
per share (the average of the high and low prices for the Common Stock reported
on the NYSE for February 18, 1994), (iii) approximately 39,687,000 shares of
EPIC common stock (and securities exercisable therefor) are purchased pursuant
to the Acquisition and (iv) 100% of each issue of the Specified EPIC Debt
Securities is purchased in the Tender Offers.
ACQUISITION AND FINANCING PLAN
(DOLLARS IN MILLIONS)
<TABLE>
<S> <C>
SOURCES OF FUNDS
Cash on hand................................................... $ 215.8
1994 Credit Agreement.......................................... 671.4
The Common Stock Offering...................................... 148.9
The Offering................................................... 200.0
--------
Total................................................ $1,236.1
--------
--------
USE OF FUNDS
Purchase of EPIC equity in Acquisition......................... $ 277.8
Tender Offers(1)............................................... 632.7
Debt Redemption................................................ 138.2
Refinancing of existing bank credit facility................... 167.0
Estimated Fees and Expenses(2)................................. 20.4
--------
Total................................................ $1,236.1
--------
--------
</TABLE>
- ---------------
(1) Represents (a) the principal amount of the EPIC 10 7/8% Notes and the EPIC
Class 3 Mortgage Notes, (b) the accreted value as of November 30, 1993 of
the EPIC 12% Notes, EPIC Class 1 Mortgage Notes and EPIC Class 2 Mortgage
Notes and (c) $104.4 million of aggregate premiums and consent payments.
(2) Includes underwriting discounts and commissions, bank fees and legal and
accounting expenses.
USE OF PROCEEDS
The net proceeds to the Company from the sale of the Securities in the
Offering are estimated to be approximately $ million. The Company intends to
use the net proceeds of the Offering, together with the net proceeds of the
Common Stock Offering, borrowings under the 1994 Credit Agreement and cash on
hand, to effect the Acquisition, the Tender Offers and the Debt Redemption. See
"The Acquisition and the Financing Plan."
15
<PAGE> 17
CAPITALIZATION
The following table sets forth the capitalization of the Company as of
November 30, 1993, and as adjusted to reflect the Acquisition, the Offering, the
Common Stock Offering and the other transactions contemplated by the Financing
Plan. This table should be read in conjunction with "The Acquisition and the
Financing Plan," the Unaudited Pro Forma Condensed Combined Financial Statements
of the Company and the historical financial statements of the Company and EPIC
and the notes thereto included or incorporated by reference in this Prospectus.
<TABLE>
<CAPTION>
AS OF NOVEMBER 30, 1993
------------------------------------------------
ACTUAL
-----------------------
HEALTHTRUST EPIC COMBINED AS ADJUSTED
------------ ------- ---------------------
(DOLLARS IN MILLIONS)
<S> <C> <C> <C>
LONG-TERM DEBT:
Bank Indebtedness.................................................... $ 167.0 $ -- $ 671.4
10 3/4% Subordinated Notes due 2002.................................. 500.0 -- 500.0
8 3/4% Subordinated Debentures due 2005.............................. 300.0 -- 300.0
Securities offered hereby............................................ -- -- 200.0
Specified EPIC Debt Securities....................................... -- 528.3 --(1)
EPIC Redeemable Debt................................................. -- 123.4 --
EPIC Group 15% Senior Subordinated Notes(2).......................... -- 40.3 --
Other Debt........................................................... 16.9 38.0 54.9
------------ ------- --------
Less Current Portion............................................. (35.6) (47.0) (42.3)
------------ ------- --------
Total Long-Term Debt......................................... 948.3 683.0 1,684.0
STOCKHOLDERS' EQUITY:
Common Stock, $.001 par value: 400,000,000 shares authorized,
81,130,136 shares issued and outstanding(3)........................ 0.1 -- 0.1
EPIC common stock, $.01 par value: 100,000,000 shares authorized,
40,167,753 shares issued and outstanding(4)........................ -- 0.4 --
Common Stock Offering(5)............................................. -- -- 142.9
Additional paid-in capital(6)........................................ 827.4 245.8 827.4
Deferred compensation................................................ (0.9) (137.4) (0.9)
Retained deficit..................................................... (130.8) (188.8) (130.8)
------------ ------- --------
Total Stockholders' Equity................................... 695.8 (80.0) 838.7
------------ ------- --------
Total Capitalization......................................... $1,644.1 $ 603.0 $ 2,522.7
------------ ------- --------
------------ ------- --------
</TABLE>
- ---------------
(1) Assumes 100% of each issue of Specified EPIC Debt Securities is purchased in
the Tender Offers.
(2) EPIC has delivered redemption notices with respect to such indebtedness and
will redeem such indebtedness in February 1994.
(3) Excludes (i) 7,798,170 shares of Common Stock reserved for issuance under
the Company's stock plans and upon exercise of options granted under the
Company's stock option plans; and (ii) 3,409,219 shares of Common Stock
reserved for issuance upon the exercise of warrants to purchase Common Stock
("Warrants"). Also excludes approximately 1,000,000 shares of Common Stock
to be issued and contributed by the Company to the Plan on or about May 15,
1994.
(4) As of January 8, 1994. Excludes 6,227,165 shares reserved for issuance upon
exercise of certain options, stock appreciation rights and warrants.
(5) Excludes 3,409,219 shares of Common Stock issuable upon the exercise of
Warrants, of which shares will be sold in the Common Stock Offering
by the holders thereof.
(6) Additional paid-in capital with respect to the Company equals the total
amount of (i) the net proceeds of the Company's initial public offering of
Common Stock, (ii) the net proceeds of the sales of Common Stock to the
ESOP, (iii) the estimated value of shares of Common Stock awarded under the
Company's stock plans, (iv) the estimated aggregate fair market value of
Warrants that were issued to HCA and certain other investors in connection
with the Formation and the financing thereof and (v) the estimated aggregate
fair market value of the Company's preferred stock surrendered by HCA upon
exercise of Warrants to receive Common Stock, minus (vi) dividends paid and
accrued and accretion of discount on preferred stock. In connection with the
Formation, the Company issued Warrants exercisable for an aggregate of
36,874,551 shares of Common Stock (33,460,240 shares for HCA and 3,414,311
shares of certain other investors). The Company initially recorded its
Warrants at an aggregate fair value of $117.0 million, or $3.18 per Warrant,
as determined by an independent investment banking firm subsequent to the
Formation. HCA recorded the fair value of its investment in the Warrants at
$37.0 million or $1.11 per Warrant, based upon a valuation range determined
by another investment banking firm. These respective values were based upon
a number of assumptions and projections as to financial results, including
estimates by the investment banking firms of the discounted present value of
a share of Common Stock at September 17, 1987 ($3.38 in the case of the
Warrant value recorded by the Company and a range of $.66 to $1.59 in the
case of the Warrant value recorded by HCA). Each such estimate was based
upon, among other things, certain different assumptions in the valuation of
the Warrants as to the investment objectives of a purchaser of such Warrants
(and, accordingly, an annual yield assumption for discounting to the date of
the Formation the estimated value of a share of Common Stock at a future
date) and the number of shares of Common Stock subject to the Warrants.
After further review, the Company decreased the amount recorded for Warrants
to $52.0 million, or $1.41 per Warrant. In addition, EPIC has received
determinations of the fair value of the EPIC common stock from independent
financial advisors that valued such stock at prices lower than the amount
paid therefor by the EPIC ESOP in connection with the EPIC Formation.
16
<PAGE> 18
SELECTED HISTORICAL FINANCIAL INFORMATION
The following tables set forth selected historical financial information
for (i) the Company for each of the years in the five-year period ended August
31, 1993 and for the three months ended November 30, 1993 and 1992; and (ii)
EPIC for each of the years in the five-year period ended September 30, 1993 and
for the three months ended December 31, 1993 and 1992. The selected financial
information for the Company and EPIC for each of the years in the five-year
periods ended August 31, 1993 and September 30, 1993, respectively, are derived
from the consolidated financial statements of the Company and EPIC, each of
which have been audited by Ernst & Young, independent auditors. The selected
financial information for the Company and EPIC for the three months ended
November 30, 1993 and 1992 and December 31, 1993 and 1992, respectively, are
derived from unaudited condensed consolidated financial statements of the
Company and EPIC and reflect all adjustments (consisting of normal recurring
adjustments) that, in the opinion of management, are necessary for a fair
presentation of such information. Operating results for the three months ended
November 30, 1993 and December 31, 1993 are not necessarily indicative of the
results that may be expected for the Company's fiscal year ending August 31,
1994.
All information contained in the following tables should be read in
conjunction with "Management's Discussion and Analysis of Financial Condition
and Results of Operations" and with the consolidated financial statements and
related notes of the Company and EPIC included or incorporated by reference
herein.
17
<PAGE> 19
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
<TABLE>
<CAPTION>
THREE MONTHS
ENDED
NOVEMBER 30, YEAR ENDED AUGUST 31,
---------------- --------------------------------------------------------
1993 1992 1993 1992 1991 1990 1989
------ ------ -------- -------- -------- -------- --------
(UNAUDITED) (DOLLARS IN MILLIONS, EXCEPT PER SHARE DATA)
<S> <C> <C> <C> <C> <C> <C> <C>
STATEMENT OF OPERATIONS DATA:
Net operating revenue............................ $622.1 $591.8 $2,394.6 $2,265.3 $2,025.7 $1,856.9 $1,769.1
Hospital service costs........................... 494.3 464.0 1,888.6 1,796.0 1,615.8 1,488.2 1,429.9
------ ------ -------- -------- -------- -------- --------
127.8 127.8 506.0 469.3 409.9 368.7 339.2
Depreciation and amortization.................... 34.6 33.1 132.7 127.5 120.8 119.2 121.5
Interest expense................................. 21.6 25.6 99.8 119.6 152.6 161.1 189.8
ESOP/pension expense............................. 9.9 11.6 39.0 38.7 97.0 100.7 138.6
Deferred compensation expense.................... 0.3 0.9 4.3 8.1 18.7 31.1 27.2
Other (income) expense, net...................... (5.5) (3.2) (7.6) (4.6) (14.5) 23.1 14.8
------ ------ -------- -------- -------- -------- --------
Income (loss) before minority interests, taxes
and extraordinary charges.................... 66.9 59.8 237.8 180.0 35.3 (66.5) (152.7)
Minority interests............................... 1.4 3.3 11.9 15.3 13.3 8.6 1.7
Income tax expense (benefit)..................... 26.6 23.2 90.7 71.4 15.4 (21.9) (53.1)
Extraordinary charges (net of taxes)(1).......... -- -- 13.6 136.4 -- 5.8 --
------ ------ -------- -------- -------- -------- --------
Net income (loss).............................. 38.9 33.3 121.6 (43.1) 6.6 (59.0) (101.3)
Redeemable preferred stock dividends............. -- -- -- 24.6 76.3 65.7 58.6
------ ------ -------- -------- -------- -------- --------
Net income (loss) to common stockholders....... $ 38.9 $ 33.3 $ 121.6 $ (67.7) $ (69.7) $ (124.7) $ (159.9)
------ ------ -------- -------- -------- -------- --------
------ ------ -------- -------- -------- -------- --------
EARNINGS (LOSS) PER SHARE:
Before extraordinary charges..................... $ 0.46 $ 0.40 $ 1.62 $ 0.90 $ (1.15) $ (2.03) $ (2.78)
Extraordinary charges............................ -- -- 0.16 1.78 -- 0.10 --
------ ------ -------- -------- -------- -------- --------
Net income (loss) per common share............... $ 0.46 $ 0.40 $ 1.46 $ (0.88) $ (1.15) $ (2.13) $ (2.78)
------ ------ -------- -------- -------- -------- --------
------ ------ -------- -------- -------- -------- --------
Ratio of earnings to fixed charges(2)............ 3.3x 2.8x 2.8x 2.2x 1.1x (3) (3)
</TABLE>
<TABLE>
<CAPTION> AS OF
NOVEMBER 30, AS OF AUGUST 31,
------------ --------------------------------------------------------
1993 1993 1992 1991 1990 1989
------------ -------- -------- -------- -------- --------
(UNAUDITED) (DOLLARS IN MILLIONS)
<S> <C> <C> <C> <C> <C> <C>
BALANCE SHEET DATA:
Cash and short-term investments.................... $ 167.4 $ 151.3 $ 172.6 $ 302.6 $ 230.7 $ 12.2
Working capital.................................... 305.6 219.1 245.3 390.2 309.8 72.9
Total assets....................................... 2,489.0 2,536.7 2,379.7 2,445.4 2,293.8 2,210.6
Long-term debt..................................... 948.3 948.6 1,033.9 1,150.0 1,155.6 1,151.3
Redeemable preferred stock......................... -- -- -- 575.9 499.6 433.9
Stockholders' equity............................... 695.8 655.7 530.8 88.0 42.1 34.9
</TABLE>
<TABLE>
<CAPTION>
THREE MONTHS
ENDED
NOVEMBER 30, YEAR ENDED AUGUST 31,
----------------- --------------------------------------------------
1993 1992 1993 1992 1991 1990 1989
------ ------ ------ ------ ------ ------ ------
(UNAUDITED) (DOLLARS IN MILLIONS)
<S> <C> <C> <C> <C> <C> <C> <C>
OTHER DATA:
EBITDA(4)......................................... $127.8 $127.8 $506.0 $469.3 $409.9 $368.7 $339.2
EBITDA margin(5).................................. 20.5% 21.6% 21.1% 20.7% 20.2% 19.9% 19.2%
Capital expenditures.............................. $ 34.3 $ 39.0 $321.4 $178.1 $170.3 $120.8 $ 98.4
Ratio of EBITDA to interest expense............... 5.9x 5.0x 5.1x 3.9x 2.7x 2.3x 1.8x
</TABLE>
- ---------------
(1) Extraordinary after-tax charges relate to the early extinguishment of debt.
(2) The ratio of earnings to fixed charges was computed by dividing (i) income
from continuing operations before fixed charges and income taxes by (ii)
fixed charges, which consist of interest charges (interest expense plus
interest charged to construction) and the portion of rent expense which is
deemed to be equivalent to interest expense.
(3) The Company's earnings were inadequate to cover fixed charges for the years
ended August 31, 1990 and 1989 by $75.5 million and $154.5 million,
respectively.
(4) EBITDA represents net operating revenue less hospital service costs.
(5) EBITDA margin represents the ratio of EBITDA to net operating revenue.
18
<PAGE> 20
EPIC HOLDINGS, INC.
<TABLE>
<CAPTION>
THREE MONTHS
ENDED
DECEMBER 31, YEAR ENDED SEPTEMBER 30,
------------------- ---------------------------------------------------------
1993 1992 1993 1992 1991 1990 1989
------- ------- --------- ------- ------- ------- -------
(UNAUDITED) (DOLLARS IN MILLIONS, EXCEPT PER SHARE DATA)
<S> <C> <C> <C> <C> <C> <C> <C>
STATEMENT OF OPERATIONS DATA:
Net operating revenue.................... $ 272.5 $ 244.4 $ 1,019.1 $ 941.3 $ 802.7 $ 742.4 $ 613.2
Hospital service costs................... 236.2 215.1 873.7 809.9 683.3 631.7 520.1
------- ------- --------- ------- ------- ------- -------
36.3 29.3 145.4 131.4 119.4 110.7 93.1
Depreciation and amortization............ 13.1 13.8 57.9 53.0 49.3 47.5 44.4
Interest expense......................... 23.8 22.0 89.9 79.8 68.3 69.2 76.2
ESOP expense............................. 5.7 5.2 20.7 20.7 23.1 15.4 16.9
Deferred compensation expense............ 0.7 (0.5) 3.8 11.8 8.1 5.8 15.6
Other income, net........................ (0.8) (0.6) (7.2) (2.8) (4.9) (5.1) (8.2)
------- ------- --------- ------- ------- ------- -------
Loss before minority interests, taxes
and extraordinary charges............ (6.2) (10.6) (19.7) (31.1) (24.5) (22.1) (51.8)
Minority interests....................... 1.7 0.6 3.5 2.0 2.1 1.8 0.1
Income tax expense (benefit)............. 0.4 0.2 2.0 (9.3) (7.6) (6.6) (17.0)
Extraordinary charges (net of
taxes)(1).............................. 0.6 21.9 1.3 2.6 -- --
------- ------- --------- ------- ------- ------- -------
Net loss............................... (8.3) (12.0) (47.1) (25.1) (21.6) (17.3) (34.9)
Redeemable preferred stock dividends..... -- -- -- 11.1 22.8 19.0 18.1
------- ------- --------- ------- ------- ------- -------
Net loss to common stockholders........ $ (8.3) $ (12.0) $ (47.1) $ (36.2) $ (44.4) $ (36.3) $ (53.0)
------- ------- --------- ------- ------- ------- -------
------- ------- --------- ------- ------- ------- -------
LOSS PER SHARE:
Before extraordinary charges............. $ (0.21) $ (0.28) $ (0.63) $ (1.07) $ (1.71) $ (1.48) $ (2.16)
Extraordinary charges.................... -- 0.01 0.55 0.04 0.11 -- --
------- ------- --------- ------- ------- ------- -------
Net loss per common share................ $ (0.21) $ (0.29) $ (1.18) $ (1.11) $ (1.82) $ (1.48) $ (2.16)
------- ------- --------- ------- ------- ------- -------
------- ------- --------- ------- ------- ------- -------
</TABLE>
<TABLE>
<CAPTION> AS OF
DECEMBER 31, AS OF SEPTEMBER 30,
------------ -------------------------------------------------------
1993 1993 1992 1991 1990 1989
------------ ------- ------- ------- ------- -------
(UNAUDITED) (DOLLARS IN MILLIONS)
<S> <C> <C> <C> <C> <C> <C>
BALANCE SHEET DATA:
Cash and short-term investments................. $ 89.3 $ 112.5 $ 53.8 $ 84.6 $ 69.1 $ 71.3
Working capital................................. 37.6 35.1 41.3 53.7 8.3 2.8
Total assets.................................... 898.5 875.0 780.8 763.4 758.0 743.2
Long-term debt.................................. 685.2 679.6 619.4 478.3 462.5 481.4
Redeemable preferred stock...................... -- -- -- 186.0 163.2 144.2
Stockholders' deficit........................... (82.9) (85.3) (58.4) (101.7) (79.9) (58.9)
</TABLE>
<TABLE>
<CAPTION>
THREE MONTHS
ENDED
DECEMBER 31, YEAR ENDED SEPTEMBER 30,
----------------- ------------------------------------------------------
1993 1992 1993 1992 1991 1990 1989
------ ------ ------- ------- ------- ------- ------
(UNAUDITED) (DOLLARS IN MILLIONS)
<S> <C> <C> <C> <C> <C> <C> <C>
OTHER DATA:
EBITDA(2)..................................... $ 36.3 $ 29.3 $ 145.4 $ 131.4 $ 119.4 $ 110.7 $ 93.1
EBITDA margin(3).............................. 13.3% 12.0% 14.3% 14.0% 14.9% 14.9% 15.2%
Capital expenditures.......................... $ 24.4 $ 11.5 $ 115.3 $ 60.1 $ 25.6 $ 40.2 $ 19.4
Ratio of EBITDA to interest expense........... 1.5x 1.3x 1.6x 1.6x 1.7x 1.6x 1.2x
</TABLE>
- ---------------
(1) Extraordinary after-tax charges relate to the early extinguishment of debt.
(2) EBITDA represents net operating revenue less hospital service costs.
(3) EBITDA margin represents the ratio of EBITDA to net operating revenue.
19
<PAGE> 21
SELECTED PRO FORMA FINANCIAL INFORMATION
The following selected pro forma financial information is derived from the
Unaudited Pro Forma Condensed Combined Financial Statements included elsewhere
in this Prospectus and is based upon the consolidated financial statements of
each of the Company and EPIC, adjusted to give effect to the Acquisition and the
Financing Plan. The selected pro forma statement of operations data for the year
ended August 31, 1993 and the three months ended November 30, 1993 gives effect
to the Acquisition and the Financing Plan as if they had occurred on September
1, 1992. The pro forma balance sheet data as of November 30, 1993 gives effect
to the Acquisition and the Financing Plan as if they had occurred on November
30, 1993.
All information contained in the following tables should be read in
conjunction with "The Acquisition and the Financing Plan," "Capitalization,"
"Management's Discussion and Analysis of Financial Condition and Results of
Operations," the Unaudited Pro Forma Condensed Combined Financial Statements of
the Company and the consolidated financial statements and related notes of the
Company and EPIC included or incorporated by reference herein.
<TABLE>
<CAPTION>
PRO FORMA
----------------------------
THREE MONTHS
ENDED YEAR ENDED
NOVEMBER 30, AUGUST 31,
1993 1993
------------ -----------
(UNAUDITED)
(DOLLARS IN MILLIONS EXCEPT
PER SHARE DATA)
<S> <C> <C>
STATEMENT OF OPERATIONS DATA:
Net operating revenue...................................................... $894.6 $ 3,413.7
Hospital service costs..................................................... 730.5 2,762.3
------------ -----------
164.1 651.4
Depreciation and amortization.............................................. 50.7 202.7
Interest expense........................................................... 35.2 151.2
ESOP/pension expense....................................................... 15.5 59.7
Deferred compensation expense.............................................. 0.3 4.3
Other income, net.......................................................... (3.1) (6.8)
------------ -----------
Income before minority interests, taxes and extraordinary charges.......... 65.5 240.3
Minority interests......................................................... 3.1 15.4
Income tax expense......................................................... 26.3 95.4
------------ -----------
Net income before extraordinary charges.................................... $ 36.1 $ 129.5
------------ -----------
------------ -----------
Earnings per share before extraordinary charges............................ $ 0.40 $ 1.46
------------ -----------
------------ -----------
Pro forma ratio of earnings to fixed charges(3)............................ 2.4x 2.2x
</TABLE>
<TABLE>
<CAPTION>
AS OF
NOVEMBER 30,
1993
---------------------
(UNAUDITED)
(DOLLARS IN MILLIONS)
<S> <C> <C>
BALANCE SHEET DATA:
Cash and short-term investments.......................................... $ 20.0
Working capital.......................................................... 104.6
Total assets............................................................. 3,645.7
Long-term debt........................................................... 1,684.0
Stockholders' equity..................................................... 838.7
</TABLE>
<TABLE>
<CAPTION>
THREE MONTHS
ENDED NOVEMBER YEAR ENDED
30, AUGUST 31,
1993 1993
----------------- ---------------
<S> <C> <C>
OTHER DATA:
EBITDA(1).............................................................. $ 164.1 $ 651.4
EBITDA margin(2)....................................................... 18.3% 19.1%
Capital expenditures................................................... $ 58.7 $ 436.7
Ratio of EBITDA to interest expense.................................... 4.7x 4.3x
</TABLE>
- ---------------
(1) EBITDA represents net operating revenue less hospital service costs.
(2) EBITDA margin represents the ratio of EBITDA to net operating revenue.
(3) The ratio of earnings to fixed charges was computed by dividing (i) income
from continuing operations before fixed charges and income taxes by (ii)
fixed charges, which consist of interest charges (interest expense plus
interest charged to construction) and the portion of rent expense which is
deemed to be equivalent to interest expense.
20
<PAGE> 22
SELECTED OPERATING STATISTICS
The following tables set forth certain operating statistics for the
hospitals operated by the Company and EPIC for each of the periods indicated.
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
<TABLE>
<CAPTION>
YEAR ENDED AUGUST 31,
----------------------------------------
1993 1992 1991
---------- ---------- ----------
(DOLLARS IN MILLIONS)
<S> <C> <C> <C>
HISTORICAL OPERATING DATA:
Number of hospitals.................................... 81 81 85
Bed capacity(1)........................................ 11,233 11,374 11,607
Gross revenue:(2)
Inpatient............................................ $ 2,594.2 $ 2,439.3 $ 2,148.6
Outpatient........................................... $ 1,181.6 $ 1,021.9 $ 814.2
Net operating revenue(3)............................... $ 2,394.6 $ 2,265.3 $ 2,025.7
Patient days........................................... 1,541,536 1,616,340 1,658,061
Adjusted patient days(4)............................... 2,243,677 2,293,453 2,286,357
Average length of stay (days).......................... 5.4 5.5 5.7
Admissions............................................. 284,606 291,599 293,344
Adjusted admissions(5)................................. 414,239 413,755 404,502
Occupancy rate(6)...................................... 40.5% 40.2% 40.4%
EBITDA margin(7)....................................... 21.1% 20.7% 20.2%
</TABLE>
EPIC HOLDINGS, INC.
<TABLE>
<CAPTION>
YEAR ENDED SEPTEMBER 30,
----------------------------------
1993 1992 1991
-------- -------- --------
(DOLLARS IN MILLIONS)
<S> <C> <C> <C>
HISTORICAL OPERATING DATA:
Number of hospitals........................................ 34 35 34
Bed capacity(1)............................................ 4,444 4,332 4,296
Net operating revenue:(3)
Acute inpatient net revenue.............................. $ 469.2 $ 489.1 $ 454.4
Outpatient net revenue................................... 317.2 282.1 234.7
Other net revenue(8)..................................... 232.7 170.1 113.6
-------- -------- --------
Net operating revenue...................................... $1,019.1 $ 941.3 $ 802.7
Patient days............................................... 589,283 641,373 643,210
Adjusted patient days(4)................................... 943,355 940,046 906,640
Average length of stay (days).............................. 5.8 6.0 6.0
Admissions................................................. 101,487 106,990 106,534
Adjusted admissions(5)..................................... 162,466 156,813 150,134
Occupancy rate(6).......................................... 39% 40% 41%
EBITDA margin(7)........................................... 14.3% 14.0% 14.9%
</TABLE>
- ---------------
(1) Average number of licensed beds during the period. "Licensed beds" are those
beds for which a facility has been granted approval to operate from the
appropriate state licensing agency.
(2) Gross revenue represents the hospitals' standard charges for services
performed prior to any contractual adjustments and/or policy discounts.
(3) Net operating revenue represents gross revenue less any contractual
adjustments and/or policy discounts.
(4) Represents actual patient days adjusted to include outpatient and emergency
room services by multiplying actual patient days by the sum of inpatient
revenue and outpatient revenue and dividing the result by inpatient revenue.
(5) Represents actual admissions adjusted to include outpatient and emergency
room services by multiplying actual admissions by the sum of inpatient
revenue and outpatient revenue and dividing the result by inpatient revenue.
(6) Based on the number of licensed beds in service.
(7) EBITDA margin for each period presented refers to the result obtained by
dividing (i) net operating revenue less hospital service costs by (ii) net
operating revenue.
(8) Other net revenue includes revenue from skilled nursing, rehabilitation and
geropsychiatric units, home health visits and management contract fees.
21
<PAGE> 23
DESCRIPTION OF EPIC
EPIC is a health care services provider that owns and operates acute care
hospitals and related health care businesses. EPIC owns and operates 34 general
acute care hospitals with a total of 4,444 licensed beds, and has approximately
11,200 full time equivalent employees. EPIC's hospitals offer inpatient,
outpatient and other specialty services and are situated primarily in suburban
locations and cities in 10 southern, southwestern and western states.
Twenty-seven of EPIC's hospitals are located in Texas, California, Oklahoma or
Louisiana. EPIC also owns or manages (i) associated medical office buildings, as
well as related health care businesses, (ii) two long-term care facilities,
(iii) certain vacant developed and undeveloped properties and (iv) a 238,000
square foot office facility in Dallas, Texas which serves as its administrative
support center. EPIC is also constructing a 125-bed acute care facility in
Mandeville, Louisiana which is expected to be completed in June 1994. As of
December 6, 1993, the EPIC ESOP, which was established to increase incentives to
EPIC employees and to finance the EPIC Formation, owned approximately 60.8% (53%
on a fully-diluted basis) of the EPIC common stock outstanding. Pursuant to the
ESOP Agreement and in connection with the Acquisition, contributions to the EPIC
ESOP will be terminated.
EPIC, through a group of its subsidiaries, is developing other health care
businesses which provide outpatient and health care management services. As of
November 30, 1993, these EPIC subsidiaries, among other things, provided home
health and rehabilitation services, managed eight non-EPIC owned hospitals,
managed four EPIC-owned outpatient surgery centers, owned and managed two
diagnostic imaging centers, owned one patient transport company, managed 56
geropsychiatric and skilled nursing units (46 of which are at non-EPIC
hospitals) and six partial day hospital programs, owned one long-term care
hospital and managed another long-term care hospital. These businesses generated
approximately $232.7 million of net operating revenue for the fiscal year ended
September 30, 1993.
PROPERTIES
The following table sets forth certain information relating to each of the
hospitals operated by the Company at November 1, 1993 and by EPIC at September
30, 1993, grouped by state. Hospitals operated by EPIC appear in italicized
type. Unless otherwise noted below, all hospitals are wholly-owned by
subsidiaries of the Company or EPIC.
<TABLE>
<CAPTION>
NUMBER OF
STATE NAME LOCATION LICENSED BEDS
- ---------------- ------------------------------------------ ------------------- -------------
<S> <C> <C> <C>
Alabama Andalusia Hospital Andalusia 77
Crestwood Hospital Huntsville 120
Selma Medical Center Selma 214
Arizona El Dorado Hospital & Medical Center Tucson 166
Northwest Hospital Tucson 150
Arkansas DeQueen Regional Medical Center DeQueen 122
*Medical Park Hospital Hope 91
California Chino Community Hospital Chino 118
Palm Drive Hospital Sebastopol 56
*Healdsburg General Hospital Healdsburg 49
*Mission Bay Memorial Hospital San Diego 150
*Visalia Community Hospital Visalia 52
Westside Hospital(1) Los Angeles 87
</TABLE>
22
<PAGE> 24
<TABLE>
<CAPTION>
NUMBER OF
STATE NAME LOCATION LICENSED BEDS
- ---------------- ------------------------------------------ ------------------- -------------
<S> <C> <C> <C>
Florida North Okaloosa Medical Center Crestview 110
Palm Beach Regional Hospital Lake Worth 200
East Pointe Hospital Lehigh Acres 88
Palms West Hospital Loxahatchee 117
Santa Rosa Medical Center(2) Milton 129
Plantation General Hospital(3) Plantation 264
Edward White Hospital St. Petersburg 167
South Bay Hospital Sun City Center 112
*Clearwater Community Hospital(4) Clearwater 133
*Lake City Medical Center Lake City 75
Georgia Doctors Hospital(5) Columbus 248
Lanier Park Regional Hospital Gainesville 124
*Barrow Medical Center Winder 60
Idaho West Valley Medical Center Caldwell 150
Eastern Idaho Regional Medical Center Idaho Falls 286
Indiana Terre Haute Regional Hospital Terre Haute 284
Kentucky Scott General Hospital Georgetown 75
Spring View Hospital Lebanon 113
PineLake Medical Center Mayfield 116
Meadowview Regional Hospital Maysville 111
Bourbon General Hospital Paris 60
Logan Memorial Hospital Russellville 100
Louisiana Medical Center of Baton Rouge Baton Rouge 225
Medical Center of SW Louisiana Lafayette 166
Women's and Children's Hospital(6) Lafayette 93
Lakeside Hospital Metairie 186
Dauterive Hospital New Iberia 113
Doctor's Hospital of Opelousas(7)(8) Opelousas 133
*Highland Park Hospital Covington 104
*Riverview Medical Center Gonzales 104
Mississippi Vicksburg Medical Center Vicksburg 144
*Garden Park Community Hospital(9) Gulfport 120
Missouri Springfield Community Hospital Springfield 200
North Carolina Davis Community Hospital Statesville 149
The Brunswick Hospital(10) Supply 60
Heritage Hospital Tarboro 127
Oklahoma Edmond Regional Medical Center Edmond 139
Wagoner Community Hospital(11) Wagoner 100
*Claremore Hospital Claremore 89
*Doctor's Medical Center Tulsa 211
*Southwestern Medical Center Lawton 108
Oregon McMinnville Community Hospital McMinnville 80
Douglas Community Hospital Roseburg 118
South Carolina Marlboro Park Hospital Bennettsville 111
Chesterfield General Hospital Cheraw 72
Colleton Regional Hospital Walterboro 131
Doctor's Memorial Hospital(8)(12) Spartanburg 108
</TABLE>
23
<PAGE> 25
<TABLE>
<CAPTION>
NUMBER OF
STATE NAME LOCATION LICENSED BEDS
- ---------------- ------------------------------------------ ------------------- -------------
<S> <C> <C> <C>
Tennessee Smith County Memorial Hospital Carthage 66
Sycamore Shoals Hospital Elizabethton 100
Trinity Hospital Erin 40
Hendersonville Hospital(13) Hendersonville 120
Johnson City Specialty Hospital(14) Johnson City 39
North Side Hospital(15) Johnson City 154
Crockett Hospital Lawrenceburg 106
Livingston Regional Hospital Livingston 106
River Park Hospital(16) McMinnville 89
South Pittsburg Municipal Hospital(17) South Pittsburg 107
Southern Tennessee Medical Center(18) Winchester 212
Stones River Hospital Woodbury 85
Texas Northeast Community Hospital Bedford 200
Valley Regional Medical Center Brownsville 158
Brownwood Regional Hospital(19) Brownwood 218
Doctors Hospital(20) Conroe 135
Medical Center Hospital Conroe 182
El Campo Memorial Hospital El Campo 41
Gilmer Medical Center Gilmer 46
Sun Belt Regional Medical Center(21) Houston 273
Midway Park Medical Center Lancaster 90
Longview Regional Hospital Longview 80
Woodland Heights Medical Center Lufkin 117
Coronado Hospital Pampa 115
Bayshore Medical Center Pasadena 469
Detar Hospital Victoria 303
Gulf Coast Medical Center Wharton 161
*Alice Physicians & Surgeons Hospital Alice 131
*Alvin Community Hospital Alvin 86
*Coastal Bend Hospital Aransas Pass 75
*Denton Regional Medical Center Denton 297
Doctor's Hospital of Laredo(22) Laredo 91
*Fort Bend Community Hospital Missouri City 80
*Katy Medical Center Katy 103
Mainland Regional Healthcare System(23) Texas City 430
Medical Arts Hospital(8) Dallas 72
Medical Arts Hospital(8) Texarkana 110
*Medical Plaza Hospital Sherman 164
North Texas Medical Center McKinney 270
*Parkway Hospital Houston 262
*Riverside Hospital Corpus Christi 89
*Round Rock Community Hospital Round Rock 75
Terrell Community Hospital(23) Terrell 101
*Westbury Hospital Houston 134
Utah Lakeview Hospital Bountiful 128
Brigham City Community Hospital Brigham City 50
Mountain View Hospital Payson 118
Castleview Hospital Price 88
Ashley Valley Medical Center Vernal 39
Pioneer Valley Hospital West Valley City 139
</TABLE>
24
<PAGE> 26
<TABLE>
<CAPTION>
NUMBER OF
STATE NAME LOCATION LICENSED BEDS
- ---------------- ------------------------------------------ ------------------- -------------
<S> <C> <C> <C>
Virginia Northern Virginia Doctors Hospital Arlington 267
Montgomery Regional Hospital Blacksburg 146
Pulaski Community Hospital Pulaski 153
Washington Capital Medical Center Olympia 110
Wyoming Riverton Memorial Hospital Riverton 70
</TABLE>
- ------------------------
* The land, building, and improvements are owned by EPIC Properties, are
subject to the Mortgages (as hereinafter defined), and are leased to EPIC
Master Leasing, Inc. ("Master Leasing") pursuant to a lease.
(1) Owned by a limited partnership of which 28.7% of the interest is held by
non-EPIC limited partners. The limited partnership has leased the hospital
to a joint venture of which approximately 23.7% is held by non-EPIC
minority owners.
(2) Lease expires in 2005, unless landlord exercises option to purchase
facility for book value in 1995.
(3) Operated by a partnership of which the Company is the general partner
owning 53% and certain physicians are limited partners owning 47%.
(4) Operated by a limited partnership of which approximately 18.0% of the
interest is held by non-EPIC limited partners.
(5) Owned by the Company as a tenancy in common with physicians having a
minority interest of 40.5%.
(6) Ground lease expires in 2011; there are two ten-year optional renewal
terms.
(7) Operated by a limited partnership of which approximately 23.0% of the
interest is held by non-EPIC limited partners.
(8) The facility is leased from a third party other than EPIC Properties.
(9) Operated by a limited partnership in which investors other than EPIC
receive the first $2 million earned by the partnership after payment of the
lease payments due to EPIC ($3 million per year, increasing by 15% per
year), and EPIC is entitled to 60% of all additional earnings.
(10) Lease expires in 1994.
(11) Lease expires in 2007.
(12) Operated by a limited partnership of which approximately 15% of the
interest is held by non-EPIC limited partners.
(13) Owned by a partnership of which the Company is the general partner owning
83% and certain physicians are limited partners owning 17%.
(14) Owned by a partnership of which the Company is the general partner owning
87% and certain physicians are limited partners owning 13%.
(15) Owned by the Company as a tenancy in common with physicians having a
minority interest of 30.25%.
(16) Owned by a partnership of which the Company is the general partner owning
78% and certain physicians are limited partners owning 22%.
(17) Managed by the Company for profits and losses attributable thereto with an
option to buy for $50,000 and the provision for full payment of all
outstanding indebtedness issued in connection with the construction of the
hospital. The Company's management contract for this facility expires in
1999.
(18) Includes a leased (lease expires in 2020) hospital campus located in
Sewanee, Tennessee with 50 licensed beds.
(19) Lease expires in 2000; there are two optional renewal terms of ten years
each.
(20) Initial term of lease expires in 2006; there are three optional renewal
terms of ten years each. The Company has an option to buy this facility for
an amount determined in accordance with a specified formula.
(21) Includes a hospital campus located at Channelview, Texas with 96 licensed
beds.
(22) Operated by a limited partnership of which approximately 22.125% of the
interest is held by non-EPIC limited partners.
(23) The hospital consists of two facilities, one of which is leased from a
third party.
The Company is engaged from time to time in discussions relating to
proposed sales of certain of its hospitals and of minority interests in, or
joint ventures with medical staff physicians or others with respect to, certain
other facilities. However, except as noted in the table above, as of November 1,
1993, no definitive arrangements with respect to any sales or joint ventures had
been agreed upon by the Company.
The Company also owns (i) a 50% interest in a general partnership with
Orlando Regional Medical Center, Inc., which partnership owns South Seminole
Community Hospital (126 beds) in Longwood, Florida; (ii) a 50% interest in a
general partnership with Presbyterian Hospital of Charlotte, which partnership
owns Orthopaedic Hospital of Charlotte (166 beds) in Charlotte, North Carolina;
and (iii) a 25% interest in a general partnership with AMI, which partnership
owns Encino Hospital (188 beds) in Encino, California and Tarzana Medical Center
(177 beds) in Tarzana, California. The Company has also formed a joint venture
with Austin Diagnostic Clinic, P.A. for the purpose of constructing and
operating an integrated healthcare facility in Austin, Texas. This facility,
currently under construction, will consist of a 180-bed hospital, a diagnostic
and treatment center and a medical office building. Following completion of
construction the Company will manage the hospital. In addition, the Company,
through its subsidiaries or joint venture
25
<PAGE> 27
arrangements, owns, leases or manages approximately 120 medical office buildings
with physicians' office space and various parcels of undeveloped land,
substantially all of which are adjacent to its hospitals. The Company also
occupies approximately 65,000 square feet of corporate office space in
Nashville, Tennessee.
Twenty-four of the 34 EPIC hospitals are owned by EPIC Properties, a
wholly-owned subsidiary of EPIC, and are subject to mortgages (the "Mortgages")
granted in connection with the issuance of the EPIC Mortgage Notes. EPIC
Properties leases these 24 hospitals to Master Leasing, a wholly-owned
subsidiary of EPIC. With respect to these 24 hospitals, EPIC has agreed to
indemnify EPIC Properties, the trustee under the indenture governing the EPIC
Mortgage Notes (the "Mortgage Notes Trustee"), all holders of the EPIC Mortgage
Notes and each of their respective subsidiaries, directors, officers, agents,
successors and assigns from liabilities relating to the presence of hazardous
wastes, any medical or infectious wastes, or substances in the soil or ground
water of any real property on which such hospitals are located in concentrations
that the applicable federal or state environmental agency would require remedial
action to correct (the "Environmental Indemnity"). Pursuant to the Environmental
Indemnity, EPIC is obligated to remediate or to cause to be remediated any
spill, leak, disposal, discharge or release of certain materials on or beneath
any property occurring during the period that the EPIC Mortgage Notes remain
outstanding. EPIC Properties has collaterally assigned the Environmental
Indemnity to the Mortgage Notes Trustee.
26
<PAGE> 28
DESCRIPTION OF THE SECURITIES
The Securities will be issued under an Indenture dated as of March 30, 1993
(the "Indenture") between the Company and The First National Bank of Boston as
trustee (the "Trustee"). The Indenture is filed as an exhibit to the
Registration Statement of which this Prospectus is a part. The Indenture is
subject to and is governed by the Trust Indenture Act of 1939, as amended. The
following statements relating to the Securities and the Indenture are summaries
and do not purport to be complete. Such summaries may make use of certain terms
defined in the Indenture and are qualified in their entirety by express
reference to the Indenture. In addition, certain defined terms are set forth
below under " -- Certain Definitions." Section references used in this
Prospectus refer to the sections of the Indenture.
GENERAL
The Securities will be limited to $200,000,000 aggregate principal amount
and will mature on , 2004. The Securities will be unsecured
subordinated obligations of the Company. The Securities will bear interest from
, 1994 or from the most recent interest payment date to which
interest has been paid at the rate set forth on the cover page hereof. Interest
will be payable semi-annually on and of each year commencing
, 1994 to the persons in whose names the Securities (or any
predecessor Securities) are registered at the close of business on the
or next preceding such interest payment date.
The Securities will be issued only in registered form without coupons, in
denominations of $1,000 and integral multiples thereof. Principal of and
premium, if any, and interest on the Securities will be payable, and the
Securities will be exchangeable and transferable, at the office or agency of the
Company in the City of New York (which initially will be BancBoston Trust
Company, New York, New York); provided, however, that at the option of the
Company, interest may be paid by check mailed to the person entitled thereto as
shown on the Security Register. No service charge will be made for any
registration of transfer or exchange of Securities, except for any tax or other
governmental charge that may be imposed in connection therewith.
OPTIONAL REDEMPTION
The Securities are redeemable at any time on or after , 1999, at
the option of the Company, in whole or in part, upon not less than 30 nor more
than 60 days' prior notice at the following redemption prices (expressed as
percentages of the principal amount), if redeemed during the 12-month period
beginning of the years indicated:
<TABLE>
<CAPTION>
YEAR REDEMPTION PRICE
------------------------------------------------------------------ ----------------
<S> <C>
1999.............................................................. %
2000.............................................................. %
2001.............................................................. %
</TABLE>
and thereafter at 100% of the principal amount, in each case together with
accrued and unpaid interest to the redemption date (subject to the right of
holders of record on relevant record dates to receive interest due on an
interest payment date). If fewer than all of the Securities are to be redeemed,
the Trustee shall select the Securities or portions thereof to be redeemed by a
method the Trustee considers fair and appropriate. There will be no mandatory
sinking fund payments for the Securities.
SUBORDINATION
The indebtedness represented by the Securities and the payment of the
Subordinated Obligations are subordinated in right of payment to the prior
payment in full in cash or cash equivalents of all Senior Indebtedness. (Section
13.01) The Securities will rank pari passu with the 10 3/4% Notes and the 8 3/4%
Debentures. The Securities are also effectively subordinated to all existing and
future indebtedness of the Company's subsidiaries.
No payment or distribution of any assets of the Company of any kind or
character will be made on account of Subordinated Obligations or on account of
the purchase, redemption or other acquisition of, the
27
<PAGE> 29
Securities upon the occurrence of any default in the payment of any Senior
Indebtedness beyond any applicable grace period, unless and until such default
is cured or waived or ceases to exist or such Senior Indebtedness is discharged.
(Section 13.03)
During the continuance of any non-payment event of default with respect to
any Designated Senior Indebtedness pursuant to which the maturity thereof may be
accelerated, no payment or distribution of any assets of the Company of any kind
or character may be made by the Company on account of Subordinated Obligations
or on account of the purchase, redemption or other acquisition of, the
Securities for the period specified below (the "Payment Blockage Period"). The
Payment Blockage Period shall commence upon the receipt of notice by the Company
or the Trustee from the agent for the Banks or other representative of a holder
of Designated Senior Indebtedness and shall end on the earlier of (i) 179 days
thereafter, (ii) the date on which such event is cured, waived or ceased to
exist or on which such Designated Senior Indebtedness is discharged or (iii)
such Payment Blockage Period shall have been terminated by notice to the Company
or the Trustee from the agent for the Banks or other representative of holders
of the Designated Senior Indebtedness initiating such Payment Blockage Period,
after which the Company shall resume making any and all required payments in
respect of the Securities, including any missed payments. Only one Payment
Blockage Period may be commenced during any period of 365 consecutive days. No
event of default with respect to Designated Senior Indebtedness that existed or
was continuing on the date of the commencement of any Payment Blockage Period
with respect to the Designated Senior Indebtedness initiating such Payment
Blockage Period will be, or can be, made the basis for the commencement of a
second Payment Blockage Period whether or not within a period of 365 consecutive
days, unless such event of default has been cured or waived for a period of not
less than 90 consecutive days. In no event will a Payment Blockage Period extend
beyond 179 days. (Section 13.03)
The Indenture provides that in the event of any insolvency or bankruptcy
case or proceeding, or any receivership, liquidation, reorganization or other
similar case or proceeding in connection therewith, relative to the Company or
to its creditors, as such, or to its assets, or any liquidation, dissolution or
other winding up of the Company, whether voluntary or involuntary, or any
assignment for the benefit of creditors or other marshalling of assets or
liabilities of the Company, all Senior Indebtedness must be paid in full in cash
or cash equivalents before any payment or distribution (excluding certain
permitted equity or subordinated securities) is made on account of Subordinated
Obligations. (Section 13.02) By reason of such subordination, in the event of
liquidation or insolvency, creditors of the Company who are holders of Senior
Indebtedness may recover more, ratably, than the holders of the Securities. In
addition, the Securities will be effectively subordinated to all existing and
future liabilities of the Subsidiaries.
As of November 30, 1993, the amount of Senior Indebtedness and obligations
of the Subsidiaries (excluding intercompany indebtedness) that effectively
ranked senior to the Securities was approximately $183.9 million. After giving
effect to the Offering, the Acquisition and the other transactions contemplated
by the Financing Plan, as though they had occurred on November 30, 1993, the
amount of Senior Indebtedness and obligations of the Company's subsidiaries
(excluding intercompany indebtedness) that effectively ranked senior to the
Securities would have been approximately $726.3 million, assuming 100% of the
Specified EPIC Debt Securities is purchased in the Tender Offers. As of November
30, 1993, there were $500 million of 10 3/4% Notes outstanding and $300 million
of 8 3/4% Debentures outstanding.
CERTAIN COVENANTS OF THE COMPANY
The Indenture contains, among others, the following covenants:
Limitation on Indebtedness. The Indenture provides that the Company will
not, and will not permit any Subsidiary to, directly or indirectly, incur,
create, issue, assume, guarantee or otherwise become liable for, contingently or
otherwise, or become responsible for (any such incurrence or other such action
being an "incurrence") the payment of, contingently or otherwise, any
Indebtedness unless, after giving effect thereto, the Company's Fixed Charge
Coverage Ratio on a pro forma basis for its last four completed fiscal quarters,
taken as a whole and calculated on the assumptions that (i) such Indebtedness
and the application of the proceeds thereof and (ii) any other Indebtedness
incurred, modified or repaid by the Company or any
28
<PAGE> 30
Subsidiary and the application of the proceeds thereof and (iii) any acquisition
or disposition by the Company or any Subsidiary of assets in excess of $25
million, in each case since the end of such last four completed fiscal quarters,
had been incurred, modified, repaid, consummated or applied, as the case may be,
on the first day of such four-quarter period, would have been greater than 2.25
to 1; provided, however, that the foregoing provision shall not be effective in
any way to restrict the incurrence of Permitted Indebtedness.
For purposes of determining any particular amounts of Indebtedness of the
Company or any Subsidiary under this covenant, guarantees of (or obligations
with respect to letters of credit supporting) Indebtedness otherwise included in
the determination of such amount shall not also be included. For the purpose of
determining compliance with this covenant, in the event that an item of
Indebtedness meets the criteria of more than one of the types of Indebtedness
described in the Indenture, the Company, in its sole discretion, shall classify
such item of Indebtedness and only be required to include the amount and type of
such Indebtedness in one of such clauses. (Section 5.06)
Limitation on Restricted Payments. The Company will not, directly or
indirectly, declare or pay any dividend or make any distribution in respect of
its Capital Stock, or make or permit any Subsidiary to make any payment on
account of the purchase, redemption or other acquisition or retirement for value
of any Capital Stock of the Company or any Affiliate, or any warrants, rights or
options to purchase such Capital Stock, or make or permit any Subsidiary to make
any Investment (all such declarations, dividends, distributions, payments,
purchases, redemptions, other acquisitions, retirements and Investments other
than any such action that is a Permitted Payment, being collectively referred to
as "Restricted Payments"), unless (a) at the time of and after giving effect to
the proposed Restricted Payment, no Default or Event of Default shall have
occurred and be continuing and (b) at the time of and after giving effect to the
proposed Restricted Payment (the amount of any such payment, if other than cash,
to be determined by the Board of Directors, whose determination shall be
conclusive and evidenced by a Board Resolution), the aggregate amount of all
Restricted Payments made on or after March 1, 1992 shall not exceed the sum of
(i) 50% of the Consolidated Net Income of the Company for the period (taken as
one accounting period) from and including March 1, 1992 to the last day of the
fiscal quarter preceding the date of the proposed Restricted Payment, plus (ii)
the aggregate net proceeds, including the fair market value of property other
than cash (as determined by the Board of Directors, whose determination shall be
conclusive and evidenced by a Board Resolution), received by the Company from
the issuance or sale (other than to a Subsidiary) on or after March 1, 1992, of
shares of its Capital Stock (other than Redeemable Stock) or warrants, options
or rights to purchase such Capital Stock (other than Redeemable Stock), plus
(iii) the aggregate net proceeds received by the Company from the issue or sale
(other than to a Subsidiary) on or after March 1, 1992, of any debt securities
evidencing Indebtedness or Redeemable Stock, which thereafter have been
converted into or exchanged for Capital Stock (other than Redeemable Stock) of
the Company.
None of the foregoing provisions shall be deemed to prohibit the following
Restricted Payments: (i) the payment of any dividend within 60 days after the
date of declaration thereof, if such declaration complied with the provisions of
the Indenture on the date of such declaration, (ii) the redemption, repurchase
or other acquisition or retirement of any shares of any class of Capital Stock
of the Company or any Subsidiary in exchange for (including any such exchange
pursuant to the exercise of a conversion right or privilege in connection with
which cash is paid in lieu of the issuance of fractional shares), or out of the
proceeds of a substantially concurrent issue and sale (other than to a
Subsidiary) of, shares of Capital Stock of the Company, (iii) the payment of
dividends on the Company's Capital Stock, of up to 6% per annum of the aggregate
net proceeds received by the Company in the initial public offering of Common
Stock in December 1991 and any public offerings of Capital Stock subsequent to
such initial public offering, and (iv) the purchase or redemption of shares of
Capital Stock, options to purchase shares of Capital Stock, or stock
appreciation rights of the Company or any Subsidiary (A) issued pursuant to a
Company or Subsidiary compensation, incentive or benefit plan from any officer,
director or employee of the Company or its Subsidiaries (x) to meet the tax
obligations of any such officer, director or employee participating in any such
plan or (y) for any other purpose so long as the aggregate amount of payments
for all repurchases or redemptions contemplated by this clause (y) do not in any
fiscal year exceed $10 million or (B) in satisfaction of the Company's purchase
obligations under any nonqualified benefit plan established by the Company for
members of senior
29
<PAGE> 31
management of the Company. The Restricted Payments described in this paragraph
shall reduce the amount that would otherwise be available for Restricted
Payments under the test described in the immediately foregoing paragraph.
Nothing set forth in the Limitation on Restricted Payments covenants shall limit
or restrict the Company from making a Permitted Payment and a Permitted Payment
shall not be treated as a Restricted Payment. (Section 5.07)
Limitation on Certain Other Subordinated Indebtedness. The Indenture
provides that the Company shall not create, incur, assume or suffer to exist any
Indebtedness that is subordinate in right of payment to any Senior Indebtedness
unless such Indebtedness by its terms or the terms of the instrument creating or
evidencing such Indebtedness is subordinate in right of payment to, or ranks
pari passu with, the Securities; provided that this provision shall not prohibit
the Company from incurring Indebtedness which is subordinate in right of payment
to any Senior Indebtedness and which is not subordinate in right of payment to,
or which does not rank pari passu with, the Securities, if such Indebtedness is
assumed in connection with any permitted transaction described under
"Consolidation, Merger and Sale of Assets" below. (Section 5.05)
Purchase of Securities upon Change of Control Triggering Event. (i) Upon
the occurrence of both a Change of Control (as hereinafter defined) and a Rating
Decline (as hereinafter defined) (a "Change of Control Triggering Event")
(including a Change of Control Triggering Event involving a transaction led or
approved by Company management or in connection with a recapitalization of the
Company) each Holder shall have the right to require that the Company repurchase
such Holder's Securities in whole or in part in integral multiples of $1,000 at
a purchase price (the "Purchase Price") in cash in an amount equal to 100% of
the principal amount thereof plus accrued and unpaid interest, if any, to the
date of purchase, in accordance with the procedures set forth in this covenant.
Prior to the mailing of the notice to Holders provided for in this covenant, but
in any event within 30 days following the date upon which the Change of Control
Triggering Event occurred (the "Change of Control Date"), the Company shall (a)
repay in full all Indebtedness of the Company and its Subsidiaries under the
Bank Credit Agreement or offer to repay in full all such Indebtedness and repay
the Indebtedness of each Bank who has accepted such offer or (b) obtain the
requisite consent under the Bank Credit Agreement to permit the repurchase of
the Securities as provided for in this covenant. In general, any other
indebtedness of the Company which is senior to the Securities and would by its
terms be accelerated upon the purchase of the Securities by the Company after
the occurrence of a Change of Control Triggering Event would also have to be
repaid prior to the repurchase of the Securities. Consequently, in the event of
a Change of Control Triggering Event, the Company may be required to repay the
entire indebtedness outstanding under the Bank Credit Agreement and any other
Senior Indebtedness outstanding at the time prior to repurchasing the
Securities. In order to repay such indebtedness and repurchase the Securities,
it may be necessary for the Company to recapitalize and/or refinance some or all
of its outstanding indebtedness. There can be no assurance that such
recapitalization or refinancing, if required, could be accomplished on favorable
terms, in a timely manner or at all. Within 10 days after any Change in Control
Date requiring the Company to make an offer pursuant to this covenant, the
Company shall so notify the Trustee.
(ii) Within 30 days following any Change of Control Triggering Event, the
Company will forward a notice to each Holder stating (a) that a Change of
Control Triggering Event has occurred and that such Holder has the right to
require the Company to repurchase such Holder's Securities at the Purchase
Price; (b) the date of purchase (which shall be no earlier than 30 days nor
later than 90 days from the date such notice is mailed); (c) the circumstances
and relevant facts regarding such Change of Control Triggering Event; and (d)
the instructions a Holder must follow in order to have its Securities
repurchased. (Section 5.08)
Pursuant to the terms of the Indenture, the Company's failure to repurchase
any Securities in accordance with the foregoing provisions following a Change of
Control Triggering Event would become an Event of Default (as defined in the
Indenture) with respect to the Securities following the continuation of such
failure for 90 days after written notice thereof from the Trustee or the holders
of a majority or more in aggregate principal amount of the Securities. See
" -- Default and Certain Rights on Default." Offers by the Company to repurchase
the Securities pursuant to the provisions described above will be made in
compliance with any applicable regulations under the federal securities laws,
including Rule 14e-1 promulgated under the Exchange Act.
30
<PAGE> 32
MODIFICATION OF THE INDENTURE
The Indenture contains provisions permitting the Company and the Trustee,
without the consent of or notice to the holders of the Securities, to enter into
supplemental Indentures to, among other things, (i) add to the covenants and
agreements of the Company for the benefit of Holders of the Securities, (ii)
provide for security for the Securities, (iii) cure any ambiguity, effect or
inconsistency, (iv) provide for a successor Trustee or (v) make any change that
does not adversely affect the interests of Holders of the Securities in any
material respect. No supplemental indenture shall adversely affect the rights of
the Banks or other holders of Designated Senior Indebtedness under the
"Subordination" provisions described above (including the definitions of
capitalized terms used therein or an amendment to this sentence) unless the
Agent or the representative of such other Designated Senior Indebtedness
consents to such change. (Section 9.01)
The Company and the Trustee may, with the consent of the holders of not
less than a majority of the aggregate principal amount of the Securities at the
time outstanding, execute supplemental Indentures adding any provisions to or
changing in any manner or eliminating any of the provisions of the Indenture or
of any supplemental indenture with respect to the Securities or modifying in any
manner the rights of the holders of the Securities, provided, however, that no
such supplemental indenture shall (i) extend the fixed maturity, or the earlier
optional date of maturity, if any, of any Security or reduce the principal
amount thereof or the premium thereon, if any, or reduce the rate or extend the
time of payment of interest, if any, thereon, or make the principal thereof or
premium, if any, or interest, if any, thereon payable in any currency or
currency unit other than as provided pursuant to the Indenture or in the
Securities, (ii) reduce the aforesaid percentage of Securities, the holders of
which are required to consent to any such supplemental indenture, (iii) reduce
the percentage of Securities, the holders of which are required to consent to a
waiver of any past default under the Indenture, or (iv) modify any of the
provisions of the Indenture relating to the subordination of the Securities in a
manner adverse to the holders thereof, without in each such case the consent of
the holder of each Security so affected. An amendment pursuant to the provisions
of this paragraph may not make any change that adversely affects the rights of
the Banks or other holders of Designated Senior Indebtedness under the Indenture
unless the Agent or the representative of such other Designated Senior
Indebtedness consents to such change. (Section 9.02)
DEFAULT AND CERTAIN RIGHTS ON DEFAULT
The following are Events of Default with respect to the Securities under
the Indenture: (i) failure to pay interest when due on the Securities, continued
for 30 days; (ii) failure to pay principal or premium, if any, when due (whether
at maturity, declaration or otherwise) on the Securities; (iii) default in the
performance, or breach, of any covenant or a material breach of any warranty of
the Company in the Indenture or the Securities (other than a covenant or
warranty a default in whose performance or whose breach is specifically dealt
with elsewhere in this section or included in the Indenture or the Securities
solely for the benefit of a series of securities other than the Securities),
continued for 90 days after written notice from the Trustee or the holders of a
majority or more in aggregate principal amount of the Securities outstanding;
(iv) any acceleration of the maturity of any Indebtedness of the Company which
is outstanding in a principal amount of at least $50 million individually, shall
occur and be continuing; or any failure of the Company to pay any such
Indebtedness at final maturity; and (v) certain events of bankruptcy, insolvency
or reorganization. (Section 6.01)
Following the occurrence and continuation of an Event of Default, the
Trustee or the holders of a majority or more in aggregate principal amount of
the Securities outstanding may declare the principal amount of all Securities to
be due and payable immediately; provided that, so long as the Bank Credit
Agreement shall be in full force and effect, if an Event of Default shall have
occurred and be continuing (other than an Event of Default described in clause
(v) above), any acceleration pursuant to this section may not be effective until
the earlier of (a) five Business Days following a notice of acceleration given
to the Company (which notice shall be given only after an Event of Default has
occurred) and only if upon such fifth Business Day such Event of Default shall
be continuing or (b) the acceleration of any Indebtedness under the Bank Credit
Agreement. No action on the part of the Trustee or any Holder is required for
such acceleration if an Event of Default specified in clause (v) above occurs
and is continuing. If all defaults with respect to the
31
<PAGE> 33
Securities (other than non-payment of accelerated principal) are cured or waived
and there has been no sale of property under any judgment or decree for the
payment of moneys due which shall have been obtained or entered, the holders of
a majority in aggregate principal amount of the outstanding Securities may waive
the default and rescind the declaration and its consequences. A declaration of
acceleration because of an Event of Default specified in clause (iv) above would
be automatically annulled if the Indebtedness referred to therein was paid or
otherwise discharged, or the holders thereof rescinded their declaration of
acceleration referred to therein, within 90 days after such declaration or
acceleration and no other Event of Default had not been cured or waived during
such period. (Section 6.01)
The Indenture provides that the holders of a majority in aggregate
principal amount of the Securities outstanding may, subject to certain
exceptions, direct the time, method and place of conducting any proceeding for
early remedy available to, or exercising any power or trust conferred upon, the
Trustee with respect to Securities and may on behalf of all holders of the
Securities waive any past default and its consequences with respect to the
Securities, except a default in the payment of the principal of, premium, if
any, or interest, if any, on any of the Securities. (Section 6.06) Holders of
any Security may not institute any proceeding to enforce the Indenture unless
the Trustee shall have refused or neglected to act for 60 days after a request
and offer of satisfactory indemnity by the holders of not less than a majority
in aggregate principal amount of the Securities outstanding. (Section 6.04)
The Company is required to deliver to the Trustee each year an annual
statement as to whether the Company is in compliance with all covenants and
conditions with which it must comply under the Indenture. (Section 5.09)
CONSOLIDATION, MERGER AND SALE OF ASSETS
The Company may not consolidate or merge with or into, or sell, assign,
transfer, lease, convey or otherwise dispose of its assets substantially as an
entirety to, any Person, unless: (i) either (a) the Company shall be the
continuing corporation or (b) the Person (if other than the Company) formed by
such consolidation or into which the Company is merged or the Person that
acquires by conveyance, transfer or lease the properties and assets of the
Company substantially as an entirety shall be a corporation, partnership or
trust organized and validly existing under the laws of the United States or any
State thereof or the District of Columbia, and shall expressly assume, by a
supplemental indenture, the due and punctual payment of the principal of, and
premium, if any, and interest on all the Notes and the performance and
observance of every covenant of the Indenture on the part of the Company to be
performed or observed; (ii) immediately thereafter, the Company or such Person
(a) shall have a Consolidated Net Worth equal to or greater than the
Consolidated Net Worth of the Company immediately prior to such transaction and
(b) could incur at least $1.00 of additional Indebtedness (other than Permitted
Indebtedness) under "Limitation on Indebtedness" described above; (iii)
immediately thereafter, no Event of Default (and no event which, after notice or
lapse of time, or both, would become an Event of Default) shall have occurred
and be continuing; and (iv) the Company has delivered to the Trustee an
Officers' Certificate and an Opinion of Counsel, each stating that such
consolidation, merger or transfer and, if a supplemental indenture is required
in connection with such transaction, such supplemental indenture, comply with
this covenant and that all conditions precedent in the Indenture relating to
such transaction have been satisfied. (Section 10.01)
DEFEASANCE
The Company at its option (a) will be Discharged (as such term is defined
in the Indenture) from any and all obligations in respect of the Securities
(except for certain obligations to register the transfer and exchange of
Securities, replace stolen, lost or mutilated Securities and coupons, maintain
paying agencies and hold moneys for payment in trust) or (b) need not comply
with certain restrictive covenants of the Indenture, in each case after the
Company deposits with the Trustee thereunder, in trust, money, and U.S.
Government Obligations (as defined in the Indenture), which through the payment
of interest thereon and principal thereof in accordance with their terms will
provide money or a combination of money, and U.S. Government Obligations in an
amount sufficient to pay in the currency, currencies or currency unit or units
in which the Securities are payable all the principal of, and interest on, the
Securities on the dates such payments are due in
32
<PAGE> 34
accordance with the terms of the Securities. Among the conditions to the
Company's exercising any such option, (i) the Company is required to deliver to
the Trustee an opinion of independent counsel of recognized standing to the
effect that the deposit and related defeasance would not cause the Holders of
the Securities to recognize income, gain or loss for United States federal
income tax purposes and that the Holders will be subject to United States
federal income tax in the same amounts, in the same manner and at the same time
as would have been the case if such deposit and related defeasance had not
occurred and (ii) no event or condition shall exist that, pursuant to certain
provisions described under "Subordination" above, would prevent the Company from
making payments of principal of (and premium, if any) or interest on the
Securities on the date of the deposit referred to above or within 90 days after
the date of such deposit. (Sections 11.01 and 11.02)
CONCERNING THE TRUSTEE
The 8 3/4% Debentures were issued pursuant to the Indenture and the Trustee
serves as trustee with respect thereto. In addition, the Trustee serves as
trustee under the Indenture relating to the 10 3/4% Notes.
CERTAIN DEFINITIONS
Certain Definitions. Set forth below is a summary of certain defined terms
used in the Indenture. Reference is made to the Indenture for the full
definition of all such terms.
"Affiliate" means, with respect to any specified Person, any other
Person directly or indirectly controlling or controlled by or under direct
or indirect common control with such specified Person. For the purposes of
this definition, "control" when used with respect to any specified Person
means the power to direct the management and policies of such Person,
directly or indirectly, whether through the ownership of voting securities,
by contract or otherwise; and the terms "controlling" and "controlled" have
meanings correlative to the foregoing.
"Bank Credit Agreement" means the Credit Agreement, as such agreement
may be amended, amended and restated, supplemented or otherwise modified or
renewed, extended, substituted, refinanced or replaced from time to time
(including, without limitation, any amendment which increases the amount of
Indebtedness which may be outstanding thereunder), and includes any
agreement extending the maturity of, refinancing or otherwise restructuring
(including, but not limited to, the inclusion of additional borrowers
thereunder that are Subsidiaries of the Company or new or additional
lenders) all or any portion of the Indebtedness under such agreement or any
successor agreement.
"Capitalized Lease Obligation" means any obligation of a Person to pay
rent or other amounts under a lease with respect to any property (whether
real, personal or mixed) acquired or leased by such Person and used in its
business that is required to be accounted for as a capital lease on the
balance sheet of such Person in accordance with generally accepted
accounting principles and the amount of such Capitalized Lease Obligation
shall be the amount so required to be accounted for as a capital lease.
"Change of Control" means such time as (i) a "person" or "group"
(within the meaning of Sections 13(d) and 14(d)(2) of the Exchange Act),
other than the Company's employee stock ownership plan or other employee
benefit plan, (A) becomes the "beneficial owner" (as defined in Rule 13d-3
under the Exchange Act) of more than 50% of the total voting rights
attaching to the then outstanding voting stock of the Company or (B) have
the right or the ability by voting right, contract or otherwise to elect or
designate for election a majority of the entire Board of Directors (other
than any such right or ability which arises solely from a revocable proxy
or consent, whether given in response to a proxy or consent solicitation or
otherwise); or (ii) (A) the Company consolidates with or merges into any
other Person or conveys, transfers or leases all or substantially all of
its assets to any Person or (B) any Person merges into the Company, in
either event pursuant to a transaction in which voting stock of the Company
representing more than 50% of the total voting rights of the Company
outstanding immediately prior to the effectiveness thereof is reclassified
or changed into or exchanged for cash, securities or other property;
provided that any consolidation, merger, conveyance, transfer or lease
between the Company and any of its Subsidiaries (including, without
limitation, the reincorporation of the Company in another
33
<PAGE> 35
jurisdiction) shall be excluded from the operation of this clause (ii). The
definition of "all or substantially all" assets is generally determined
based upon the facts and circumstances of a particular transaction and the
condition of the selling entity upon consummation of the transaction.
Consequently, a holder of Securities may be required to establish that a
conveyance, transfer or lease of all or substantially all of the Company's
assets has occurred before being entitled to compel the repurchase of its
Securities in connection with a Change of Control Triggering Event.
"Change of Control Triggering Event" means the occurrence of both a
Change of Control and a Rating Decline.
"Consolidated Capital Expenditure Indebtedness" means (i) any
Indebtedness of the Company and its Subsidiaries issued to finance the
purchase or construction of any assets acquired (other than from an
Affiliate) or constructed after the date of the Indenture to the extent the
purchase or construction prices for such assets are or should be included,
in accordance with generally accepted accounting principles, in "property,
plant or equipment" in the consolidated financial statements of the Company
and its Subsidiaries and (ii) to the extent not covered by clause (i), any
Indebtedness of the Company and its Subsidiaries issued to finance the
acquisition (by purchase or otherwise) of the business, property or fixed
assets of, or other evidence of beneficial ownership of, any Person.
"Consolidated Interest Expense" means for any period, without
duplication, the sum of (a) the aggregate of the interest expense of the
Company and its consolidated Subsidiaries for such period, on a
consolidated basis, as determined in accordance with generally accepted
accounting principles plus (b) net payments in respect of Interest Rate
Contracts (if any such payment applies to a period in excess of one year it
shall be amortized accordingly).
"Consolidated Net Income" means for any period the consolidated net
income (or loss) of the Company and its consolidated Subsidiaries
(excluding any income (or loss) from any Person not controlled by the
Company or any Subsidiary other than cash dividends or distributions
received from such Person) for such period as determined in accordance with
generally accepted accounting principles adjusted by excluding (a) any gain
(or loss) realized upon the termination of any employee pension plan, (b)
net extraordinary gains or net extraordinary losses (in either case net of
related taxes that are not included in determining Consolidated Tax
Expense), as the case may be (including, any gain or loss from the
purchase, redemption, acquisition or other retirement of Indebtedness), (c)
net gains or losses in respect of dispositions of assets other than in the
ordinary course of business, (d) expenses incurred in or relating to
periods prior to March 1, 1992, relating to the Company's Employee Stock
Ownership Plan, as amended from time to time, and (e) any deferred
compensation or other charge relating to or arising out of the Company's
recapitalization completed on December 19, 1991.
"Consolidated Net Worth" means for any date of determination the sum
of the Capital Stock and additional paid-in-capital plus retained earnings
(or minus accumulated deficit) of the Company and its consolidated
Subsidiaries, less amounts attributable to Redeemable Stock, each item as
determined in accordance with generally accepted accounting principles
(excluding the effects of foreign currency exchange adjustments under
Financial Accounting Standards Board Statement No. 52).
"Consolidated Non-cash Charges" means for any period, the aggregate
depreciation, amortization and other non-cash charges (other than reserves
or expenses established in anticipation of future cash requirements such as
reserves for taxes and uncollectible accounts) of the Company and its
consolidated Subsidiaries, on a consolidated basis, for such period, as
determined in accordance with generally accepted accounting principles,
provided, that (i) any charges which are not included for the purpose of
determining Consolidated Net Income shall be excluded from Consolidated
Non-cash Charges and (ii) any charges which are included for the purpose of
determining Consolidated Interest Expense or Consolidated Tax Expense shall
be excluded from Consolidated Non-cash Charges.
"Consolidated Tax Expense" of the Company means for any period the
aggregate of the tax expense of the Company and its consolidated
Subsidiaries for such period, determined in accordance with generally
accepted accounting principles.
34
<PAGE> 36
"Credit Agreement" means the credit agreement dated as of September
29, 1992, among the Company and the financial institutions described
therein.
"Designated Senior Indebtedness" means (i) all Senior Indebtedness
under the Bank Credit Agreement and (ii) any other Senior Indebtedness
which, at the time of determination, has an aggregate principal amount
outstanding of at least $50 million and is specifically designated in the
instrument evidencing such Senior Indebtedness as "Designated Senior
Indebtedness" by the Company.
"Fixed Charge Coverage Ratio" means for any period the ratio of (a)
the sum of (without duplication) Consolidated Net Income plus Consolidated
Interest Expense, Consolidated Tax Expense and Consolidated Non-cash
Charges for such period, to (b) Consolidated Interest Expense for such
period; provided that, in making such computation, the Consolidated
Interest Expense attributable to interest on any Indebtedness computed on a
pro forma basis and bearing a floating interest rate shall be computed as
if the rate in effect on the date of computation had been the applicable
rate for the entire period, unless the borrower is a party to any Interest
Rate Contract which has the effect of reducing the interest rate below the
rate applicable on the date of computation, in which case such lower rate
shall apply.
"Healthcare Venture" means a Person at least a majority of whose
revenues result from healthcare related business or facilities (including,
without limitation, a physician).
"Indebtedness" means, without duplication, (a) any liability of any
Person (1) for borrowed money, or under any reimbursement obligation
relating to a letter of credit, or (2) evidenced by a bond, note, debenture
or similar instrument (including a purchase money obligation) given in
connection with the acquisition of any businesses, properties or assets of
any kind (other than a trade payable or a current liability arising in the
ordinary course of business), or (3) for the payment of money relating to a
Capitalized Lease Obligation; (b) all Redeemable Stock valued at the
greater of its voluntary or involuntary liquidation preference plus accrued
and unpaid dividends; and (c) any liability of others described in the
preceding clauses (a) or (b) that the Person has guaranteed or that is
otherwise its legal liability.
"Intercompany Debt Obligations" means any Indebtedness of the Company
or any Subsidiary of the Company which, in the case of the Company, is
owing to any Subsidiary and which, in the case of any Subsidiary, is owing
to the Company or any other Subsidiary of the Company.
"Investment" means (other than accrued and unpaid interest in respect
of any advance, loan or other extension of credit) any advance, loan,
account receivable or other extension of credit (other than an advance,
loan, extension of credit or account receivable arising in the ordinary
course of business) or any capital contribution (by means of transfers of
property (tangible or intangible) to others, or payments for property or
services for the account or use of others, or otherwise) to, any purchase
or ownership of any stocks, bonds, notes, debentures or other securities
(including, without limitation, any interests in any partnership or joint
venture) of, or any bank accounts with or guarantee of any Indebtedness or
other obligations of, any Person. Notwithstanding the foregoing,
"Investment" shall not include the repayment or the purchase, repurchase,
retirement, redemption or other acquisition by the Company or any
Subsidiary of any Indebtedness of the Company or any Subsidiary.
"Investment Grade" means a rating of BBB-or higher by S&P or Baa3 or
higher by Moody's or the equivalent of such ratings by S&P or Moody's. In
the event that the Company shall select any other Rating Agency, the
equivalent of such ratings by such Rating Agency shall be used.
"Moody's" means Moody's Investors Service, Inc. and its successors.
"Payment Event of Default" means any default in the payment of
principal of (or premium, if any) or interest on Designated Senior
Indebtedness beyond any applicable grace period with respect thereto.
"Permitted Indebtedness" means, without duplication, (a) Indebtedness
of the Company or any Subsidiary outstanding on the date of the Indenture
and any contractual obligation existing on the date of the Indenture of the
Company or any Subsidiary to, directly or indirectly, incur, create, issue,
assume or
35
<PAGE> 37
otherwise become liable, contingently or otherwise, or responsible for any
Indebtedness, (b) Indebtedness of the Company pursuant to the Securities,
(c) Indebtedness of the Company or any Subsidiary (including unpaid
interest thereon, including any interest accruing after the filing of a
petition initiating any bankruptcy, insolvency or reorganization
proceeding) in an aggregate principal amount at any time outstanding not to
exceed the aggregate commitment under the 1991 Credit Agreement on the date
of its execution, (d) obligations pursuant to Interest Rate Contracts and
Currency Agreements, to the extent that the notional principal amount of
such obligations does not exceed the amount of Indebtedness permitted under
the "Limitation of Indebtedness" covenant described above and outstanding
on the date such Interest Rate Contracts and Currency Agreements are
entered into, (e) any renewals, extensions, substitutions, refinancings or
replacements of any Indebtedness described in clauses (a), (b), (c) and (d)
of this definition of "Permitted Indebtedness", including replacements with
creditors other than the Banks (or successive extensions, renewals,
substitutions, refinancings or replacements) so long as (i) except as
otherwise permitted hereby, the aggregate principal amount of Indebtedness
represented thereby is not increased by such renewal, extension,
substitution, refinancing or replacement and (ii) except in the case any
Senior Indebtedness, the Average Life and the date such Permitted
Indebtedness is scheduled to mature is not shortened and (iii) except in
the case of the Senior Subordinated Debentures, the new indebtedness shall
not be senior in right of payment to the Indebtedness that is being
extended, renewed, substituted, refinanced or replaced, (f) Intercompany
Debt Obligations, (g) Consolidated Capital Expenditure Indebtedness in an
amount not to exceed $100 million during the fiscal year ending August 31,
1993 and $50 million during any fiscal year thereafter, provided that any
amounts not used in any fiscal year may be used in a subsequent year;
provided, however, that Consolidated Capital Expenditure Indebtedness
permitted to be incurred under this clause (g) shall not exceed $250
million in the aggregate during the term of the Indenture, (h) Physician
Support Obligations, (i) Indebtedness arising from agreements providing for
indemnification, adjustment of purchase price or similar obligations, or
from guarantees or letters of credit, surety bonds or performance bonds
securing any obligations of the Company or any Subsidiary incurred or
assumed in connection with the disposition of any stock, business or assets
of the Company, a Subsidiary or any Healthcare Venture, other than
guarantees or similar credit support by the Company of Indebtedness
incurred by any Person acquiring all or any portion of such business,
assets, Subsidiary or Healthcare Venture for the purpose of financing such
acquisition; provided that the maximum aggregate liability in respect of
all such Indebtedness in the nature of such guarantees shall at no time
exceed the gross proceeds actually received from the sale of such business,
assets, Subsidiary or Healthcare Venture, (j) Indebtedness consisting of
deferred payment obligations resulting from the adjudication or settlement
of any claim or litigation in an amount not to exceed $50 million in the
aggregate during the term of the Indenture, (k) Indebtedness evidenced by
(i) standby letters of credit which are issued for the purpose of
supporting the Company's, Subsidiaries' and any Healthcare Ventures'
insurance and self-insurance obligations (including to secure workers'
compensation and similar insurance coverages) and (ii) other standby
letters of credit not to exceed $50 million in the aggregate at any time,
(l) Indebtedness evidenced by trade letters of credit incurred in the
ordinary course of business which are to be repaid in full not more than
one year after the date on which such Indebtedness is originally incurred
to finance the purchase of goods and supplies by the Company or a
Subsidiary not to exceed $50 million in the aggregate at any time, (m)
Indebtedness owed to a Healthcare Venture incurred in the ordinary course
of business consistent with the Company's cash management practices, (n)
Indebtedness arising from the honoring by a bank or other financial
institution of a check, draft or similar instrument inadvertently (except
in the case of daylight overdrafts) drawn against insufficient funds in the
ordinary course of business; provided that such Indebtedness is
extinguished within three Business Days of incurrence, (o) any guaranty by
the Company or any Subsidiary of Indebtedness under the Bank Credit
Agreement and (p) Indebtedness of the Company, in addition to that
described in clauses (a) through (o) of this definition of "Permitted
Indebtedness", not in excess of $250 million aggregate principal amount
outstanding at any time, which additional amount may be under the Bank
Credit Agreement.
"Permitted Investments" means purchases of (i) readily marketable
obligations of or obligations guaranteed by the United States of America or
issued by any agency thereof and backed by the full faith
36
<PAGE> 38
and credit of the United States of America, (ii) readily marketable direct
obligations issued by any state of the United States of America or any
political subdivision or public instrumentality thereof having the highest
rating obtainable from either Moody's or S&P, (iii) commercial paper or
privately placed unsecured general obligations of a corporation, whether
redeemable at the Company's demand for next day settlement or otherwise;
provided that the issuing corporation's commercial paper has, at the time
of purchase by the Company of such commercial paper or other obligation, a
rating in one of the two highest rating categories of Moody's or S&P, (iv)
certificates of deposit issued by, bankers' acceptances and deposit
accounts of, and time deposits (A) in the ordinary course of business or
(B) with commercial banks of recognized standing chartered in the United
States of America or Canada with capital, surplus and undivided profits
aggregating in excess of $125,000,000 or foreign commercial banks with
capital, surplus and undivided profits aggregating in excess of
$250,000,000 or (v) shares of money market funds that invest solely in
Permitted Investments of the kind described in clause (i) through (iv)
above.
"Permitted Payments" means (i) Restricted Payments, other than
Restricted Payments permitted by Section 5.07(b) of the Indenture, made
after the date of the Indenture in an aggregate amount not to exceed $100
million; provided that, at the time of and after giving effect to the
proposed Restricted Payment, the Company could incur at least $1.00 of
additional Indebtedness pursuant to the "Limitation on Indebtedness"
covenant described above, (ii) Restricted Payments in the form of dividends
or distributions on shares of Capital Stock of the Company, in each cases
solely in shares of Capital Stock of the Company or in warrants, rights or
options to purchase such Capital Stock, (iii) any dividend or other
distribution payable to the Company or a Subsidiary (and, if a Subsidiary
has minority stockholders, pro rata to such stockholders), (iv) any
contractual obligation of the Company or any Subsidiary, existing on the
date of the Indenture, to make a Restricted Payment and such Restricted
Payment when made, (v) Investments existing on the date of the Indenture
and any renewal or reclassification of any such Investment, (vi) guarantees
by the Company or a Subsidiary resulting from the endorsement of negotiable
instruments for collection in the ordinary course of business, (vii) the
making of any Permitted Investment by the Company or any Subsidiary, (viii)
Investments by any qualified or nonqualified benefit plan established by
the Company made in accordance with the terms of such plan or applicable
law, (ix) in the event the Company shall establish a Subsidiary for the
purpose of insuring the healthcare businesses or facilities owned or
operated by the Company, any Subsidiary, any Healthcare Venture or any
physician employed by or on the medical staff of any such business or
facility (the "Insurance Subsidiary"), Investments in an amount which do
not exceed the minimum amount of capital required under the laws of the
jurisdiction in which the Insurance Subsidiary is formed, and any
Investment by such Insurance Subsidiary which is a legal investment for an
insurance company under the laws of the jurisdiction in which the Insurance
Subsidiary is formed, (x) any Investment made by the Company in any
Subsidiary (other than a Healthcare Venture) or by any Subsidiary in the
Company or any other Subsidiary not otherwise permitted by Section 5.07(b)
of the Indenture other than (A) the purchase of shares of Capital Stock of
the Company by a Subsidiary and (B) any guaranty by a Subsidiary of any
Indebtedness or other obligation of the Company, except for Senior
Indebtedness, (xi) Investments in an aggregate amount not exceeding $25
million at any time, (xii) any purchase or repurchase of Capital Stock or
obligations of a Healthcare Venture, (xiii) the repurchase or redemption by
a Subsidiary of its Capital Stock (other than Redeemable Stock), (xiv)
purchases of fractional shares of Capital Stock in connection with the
Company's employee benefit plans, (xv) purchases of fractional shares of
Capital Stock (or options or warrants therefor), which fractional shares
exist as the result of any stock split, (xvi) market purchases of Capital
Stock by the Company or its Subsidiaries for the purpose of contributing
such Capital Stock to the retirement plans of the Company and its
Subsidiaries in lieu of making contributions to such plans in treasury
stock or Capital Stock issued for such purpose, (xvii) the making of any
Investment in a Healthcare Venture by the Company or any Subsidiary,
(xviii) loans or advances to employees in the ordinary course of business,
and (xix) Physician Support Obligations.
"Physician Support Obligations" means any obligation or guarantee
incurred in connection with any advance, loan or payment to, or on behalf
of or for the benefit of any physician, pharmacist or other allied
healthcare professional for the purpose of recruiting, redirecting or
retaining the physician, pharmacist or other allied healthcare professional
to provide service to patients in the service area of any healthcare
37
<PAGE> 39
facility owned or operated by the Company, any of its Subsidiaries or any
Healthcare Venture; excluding, however, compensation for services provided
by physicians, pharmacists or other allied healthcare professionals to any
healthcare facility owned or operated by the Company, any of its
Subsidiaries or any Healthcare Venture.
"Rating Agencies" means (i) S&P and (ii) Moody's or (iii) if S&P or
Moody's or both shall not make a rating of the Notes publicly available, a
nationally recognized securities rating agency or agencies, as the case may
be, selected by the Company, which shall be substituted for S&P or Moody's
or both, as the case may be.
"Rating Category" means (i) with respect to S&P, any of the following
categories: BB, B, CCC, CC, C and D (or equivalent successor categories);
(ii) with respect to Moody's, any of the following categories: Ba, B, Caa,
Ca, C and D (or equivalent successor categories); and (iii) the equivalent
of any such category of S&P or Moody's used by another Rating Agency. In
determining whether the rating of the Notes has decreased by one or more
gradations, gradations within Rating Categories (+ and - for S&P; 1, 2 and
3 for Moody's; or the equivalent gradations for another Rating Agency)
shall be taken into account (e.g., with respect to S&P, a decline in a
rating from BB+ to BB, as well as from BB- to B+, will constitute a
decrease of one gradation).
"Rating Date" means the date which is 90 days prior to the earlier of
(i) a Change of Control and (ii) public notice of the occurrence of a
Change of Control or of the intention by the Company to effect a Change of
Control.
"Rating Decline" means the occurrence on or within 90 days after the
date of public notice of the occurrence of a Change of Control or of the
intention by the Company to effect a Change of Control (which period shall
be extended so long as the rating of the Securities is under publicly
announced consideration for possible downgrade by any of the Rating
Agencies) of: (a) in the event the Securities are rated by either Moody's
or S&P on the Rating Date as Investment Grade, the rating of the Securities
by both Rating Agencies shall be below Investment Grade, or (b) in the
event the Securities are rated below Investment Grade by both Rating
Agencies on the Rating Date, the rating of the Securities by either Rating
Agency shall be decreased by one or more gradations (including gradations
within Rating Categories as well as between Rating Categories).
"S&P" means Standard & Poor's Corporation and its successors.
"Senior Indebtedness" means the principal of and premium, if any, and
interest on (such interest on Senior Indebtedness, wherever referred to in
the Indenture, is deemed to include interest accruing after the filing of a
petition initiating any proceeding pursuant to any bankruptcy law in
accordance with and at the rate (including any rate applicable upon any
default or event of default, to the extent lawful) specified in any
document evidencing the Senior Indebtedness, whether or not the claim for
such interest is allowed as a claim after such filing in any proceeding
under such bankruptcy law) and other amounts due on or in connection with
any Indebtedness of the Company permitted under the "Limitation on
Indebtedness" covenant described above, whether outstanding on the date of
the Indenture or thereafter created, incurred or assumed, unless, in the
case of any particular Indebtedness, the instrument creating or evidencing
the same or pursuant to which the same is outstanding expressly provides
that such Indebtedness shall not be senior in right of payment to the
Securities. Without limiting the generality of the foregoing, "Senior
Indebtedness" shall include the principal of and premium, if any, and
interest (including interest accruing after the occurrence of an Event of
Default) on all obligations of every nature of the Company from time to
time owed to the Banks under the Bank Credit Agreement or guaranties by the
Company of Indebtedness of a Subsidiary under the Bank Credit Agreement,
including, without limitation, principal of and interest on, and all fees
related to, the revolving loans or terms loans (or any combination thereof)
made pursuant to the Bank Credit Agreement, reimbursement and other
obligations owed by the Company to the Banks with respect to any letters of
credit and any obligations owed to the Banks with respect to interest rate
protection incurred to satisfy the requirements of the Bank Credit
Agreement or otherwise. Notwithstanding the foregoing, "Senior
Indebtedness" shall not include the
38
<PAGE> 40
Securities, the 10 3/4% Notes, the 8 3/4% Debentures, Indebtedness of the
Company to Subsidiaries and all Redeemable Stock and guarantees of all
Redeemable Stock.
"Subordinated Obligations" means any principal of, premium, if any,
and interest on the Securities payable pursuant to the terms of the
Securities or upon acceleration, including any amounts received upon the
exercise of rights of rescission or other rights of action (including
claims for damages) or otherwise, to the extent relating to the purchase
price of the Securities or amounts corresponding to such principal,
premium, if any, or interest on the Securities.
"Subsidiary" means (i) a corporation a majority of the voting stock of
which is at the time owned, directly or indirectly, by the Company or by
one or more other Subsidiaries, or by the Company and one or more other
Subsidiaries or (ii) any partnership or joint venture at least a majority
of the total equity ownership of which is at the time owned, directly or
indirectly, by the Company and which the Company controls.
39
<PAGE> 41
UNDERWRITING
Subject to the terms and conditions set forth in a purchase agreement (the
"Purchase Agreement") between the Company and the Underwriters, the Company has
agreed to sell to each of the Underwriters, and each of the Underwriters
severally has agreed to purchase from the Company, the principal amount of
Securities set forth opposite its name below.
<TABLE>
<CAPTION>
UNDERWRITERS PRINCIPAL AMOUNT
--------------------------------------------------------------------- ----------------
<S> <C>
Donaldson, Lufkin & Jenrette Securities Corporation.................. $
----------------
Merrill Lynch, Pierce, Fenner & Smith
Incorporated............................................
----------------
Total........................................................... $
----------------
----------------
</TABLE>
The Purchase Agreement provides that, subject to the terms and conditions
set forth therein, the Underwriters will be obligated to purchase the entire
principal amount of the Securities if any are purchased.
The Underwriters propose to offer the Securities to the public at the
public offering price set forth on the cover page of this Prospectus, and to
certain dealers at such price less a concession not in excess of % of the
principal amount thereof. The Underwriters may allow, and such dealers may
reallow, a discount not in excess of % of the principal amount thereof to
certain other dealers. After the initial public offering, the public offering
price, concession and discount may be changed.
Prior to the Offering, there has been no public market for the Securities.
The Company may or may not list the Securities on a securities exchange. The
Company has been advised by the Underwriters that each Underwriter presently
intends to make a market in the Securities, although the Underwriters are under
no obligation to do so and may discontinue any market making at any time. No
assurance, therefore, can be given as to the liquidity of the trading market for
the Securities or that an active trading market for the Securities will develop.
If an active public market does not develop, the market price and liquidity of
the Securities may be adversely affected.
The Company and the several Underwriters have agreed to indemnify each
other against certain liabilities, including liabilities under the Securities
Act.
Each of the Underwriters, from time to time, has performed and may in the
future perform investment banking and other financial services for the Company.
Merrill Lynch and DLJ are acting as financial advisors to the Company in
connection with the Acquisition. In addition, the Company has retained Merrill
Lynch and DLJ as Dealer Managers for the Tender Offers and as managing
underwriters for the Common Stock Offering.
LEGAL MATTERS
The validity of the Securities offered hereby and certain other legal
matters relating to the Offering will be passed upon for the Company by Dewey
Ballantine, New York, New York. Certain legal matters will be passed upon for
the Underwriters by Davis Polk & Wardwell, New York, New York. Morton A. Pierce
and Robert M. Smith, both members of Dewey Ballantine, are Assistant Secretaries
of the Company. In addition, certain members of Dewey Ballantine and certain
associates of the firm beneficially own shares of Common Stock.
EXPERTS
The consolidated financial statements of Healthtrust, Inc. - The Hospital
Company, EPIC Holdings, Inc., and EPIC Healthcare Group, Inc. appearing or
incorporated by reference in this Prospectus and Registration Statement have
been audited by Ernst & Young, independent auditors, to the extent indicated in
their reports thereon also appearing elsewhere herein and in the Registration
Statement or incorporated by reference. Such consolidated financial statements
have been included herein or incorporated herein by reference in reliance upon
such reports given upon the authority of such firm as experts in accounting and
auditing.
40
<PAGE> 42
AVAILABLE INFORMATION
The Company has filed with the Securities and Exchange Commission (the
"Commission") a Registration Statement (the "Registration Statement") on Form
S-3 under the Securities Act of 1933, as amended (the "Securities Act"), for the
registration of the Securities offered hereby. This Prospectus, which
constitutes a part of the Registration Statement, does not contain all of the
information set forth in the Registration Statement, certain items of which are
contained in exhibits and schedules to the Registration Statement as permitted
by the rules and regulations of the Commission. For further information with
respect to the Company and the Securities, reference is made to the Registration
Statement, including the exhibits thereto, and the financial statements and
notes filed as a part thereof. Statements made in this Prospectus concerning the
contents of any contract, agreement or other document referred to herein are not
necessarily complete. With respect to each such contract, agreement or other
document filed with the Commission as an exhibit, reference is made to the
exhibit for a more complete description of the matter involved, and each such
statement shall be deemed qualified in its entirety by such reference.
The Company is subject to the informational requirements of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and in accordance
therewith files reports, proxy statements and other information with the
Commission. Such reports, proxy statements and other information can be
inspected and copied at the public reference facilities maintained by the
Commission at Judiciary Plaza, Room 1024, 450 Fifth Street, N.W., Washington,
D.C. 20549; at the Commission's New York Regional Office, 7 World Trade Center,
New York, New York 10048; and at its Chicago Regional Office, Northwestern
Atrium Center, 500 West Madison Street, Suite 1400, Chicago, Illinois
60661-2511. Copies of such material can be obtained from the Public Reference
Section of the Commission at Room 1024, Judiciary Plaza, 450 Fifth Street, N.W.,
Washington D.C. 20549 at prescribed rates. Such reports, proxy statements and
other information concerning the Company also can be inspected at the office of
the New York Stock Exchange, Inc., 20 Broad Street, New York, New York 10005.
---------------------
INFORMATION INCORPORATED BY REFERENCE
The Company's Annual Report on Form 10-K for the fiscal year ended August
31, 1993, Current Report on Form 8-K dated January 10, 1994 and Quarterly Report
on Form 10-Q for the quarter ended November 30, 1993, which have been filed by
the Company with the Commission pursuant to the Exchange Act, are incorporated
herein by reference.
All documents subsequently filed by the Company pursuant to Sections 13(a),
13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering
of the Securities, shall be deemed to be incorporated in this Prospectus by
reference and to be a part hereof from the respective date of filing of each
such document. Any statement contained in a document incorporated or deemed to
be incorporated by reference herein shall be deemed to be modified or superseded
for purposes of this Prospectus to the extent that a statement herein or in any
other subsequently filed document which also is, or is deemed to be,
incorporated by reference herein modifies or supersedes such statement. Any such
statement so modified or superseded shall not be deemed, except as so modified
or superseded, to constitute a part of this Prospectus.
The Company will furnish without charge to each person to whom this
Prospectus is delivered, upon written or oral request, a copy of any or all of
the documents incorporated by reference herein, other than exhibits to such
documents. Requests should be directed to Philip D. Wheeler, Esq., Senior Vice
President, General Counsel and Secretary, Healthtrust, Inc. - The Hospital
Company, 4525 Harding Road, Nashville, Tennessee 37205, telephone number (615)
383-4444.
41
<PAGE> 43
INDEX TO FINANCIAL STATEMENTS
<TABLE>
<S> <C>
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
Introduction to Unaudited Pro Forma Condensed Combined Financial Statements......... P-1
Unaudited Pro Forma Condensed Combined Balance Sheet................................ P-2
Notes to Unaudited Pro Forma Condensed Combined Balance Sheet....................... P-3
Unaudited Pro Forma Condensed Combined Statements of Operations..................... P-4
Notes to Unaudited Pro Forma Condensed Combined Statements of Operations............ P-6
EPIC HOLDINGS, INC. AND SUBSIDIARIES
THREE MONTHS ENDED DECEMBER 31, 1993:
Condensed Consolidated Balance Sheets............................................... F-1
Condensed Consolidated Statements of Operations..................................... F-3
Condensed Consolidated Statements of Cash Flows..................................... F-4
Notes to Condensed Consolidated Financial Statements................................ F-5
EPIC HOLDINGS, INC. AND SUBSIDIARIES
THREE YEARS ENDED SEPTEMBER 30, 1993:
Report of Independent Auditors...................................................... F-8
Consolidated Balance Sheets......................................................... F-9
Consolidated Statements of Operations............................................... F-11
Consolidated Statements of Stockholders' Equity (Deficit)........................... F-12
Consolidated Statements of Cash Flows............................................... F-13
Notes to Consolidated Financial Statements.......................................... F-14
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
THREE MONTHS ENDED DECEMBER 31, 1993:
Condensed Consolidated Balance Sheets............................................... F-27
Condensed Consolidated Statements of Operations..................................... F-28
Condensed Consolidated Statements of Cash Flows..................................... F-29
Notes to Condensed Consolidated Financial Statements................................ F-30
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
THREE YEARS ENDED SEPTEMBER 30, 1993:
Report of Independent Auditors...................................................... F-39
Consolidated Balance Sheets......................................................... F-40
Consolidated Statements of Operations............................................... F-42
Consolidated Statements of Stockholders' Equity (Deficit)........................... F-43
Consolidated Statements of Cash Flows............................................... F-44
Notes to Consolidated Financial Statements.......................................... F-45
</TABLE>
42
<PAGE> 44
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
The following Unaudited Pro Forma Condensed Combined Financial Statements
are based on the consolidated financial statements of the Company and EPIC
included or incorporated by reference in this Prospectus, combined and adjusted
to give effect to the Company's Acquisition of EPIC, using the purchase method
of accounting, and the related Financing Plan.
The Unaudited Pro Forma Condensed Combined Balance Sheet as of November 30,
1993 gives effect to the Acquisition and Financing Plan as if they had occurred
as of November 30, 1993. The Unaudited Pro Forma Condensed Combined Statements
of Operations for the three months ended November 30, 1993 and year ended August
31, 1993, give effect to the Acquisition and Financing Plan as if they had
occurred on September 1, 1992. The pro forma adjustments are based upon
available information and certain assumptions that management believes are
reasonable. The Unaudited Pro Forma Condensed Combined Financial Statements do
not purport to represent what the combined financial position or results of
operations would actually have been if the transactions had occurred on November
30, 1993 or September 1, 1992 or to project the combined financial position or
combined results of operations for any future period.
The Unaudited Pro Forma Condensed Combined Financial Statements should be
read in conjunction with "The Acquisition and the Financing Plan,"
"Capitalization," "Management's Discussion and Analysis of Financial Condition
and Results of Operations" and the consolidated financial statements and related
notes of the Company and EPIC included or incorporated by reference in this
Prospectus.
P-1
<PAGE> 45
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
(DOLLARS IN MILLIONS)
<TABLE>
<CAPTION>
NOVEMBER 30, 1993
--------------------------------------------------------
AS REPORTED AS REPORTED PRO FORMA COMBINED
HEALTHTRUST EPIC ADJUSTMENTS PRO FORMA
----------- ----------- ------------ ---------
<S> <C> <C> <C> <C>
CURRENT ASSETS
Cash and cash equivalents................... $ 167.4 $ 68.4 $ 142.9(1) $ 20.0
195.0(2)
(138.2)(3)
(632.7)(4)
(277.8)(5)
504.4(6)
(9.4)(8)
Marketable securities....................... 47.3 (47.3)(7) 0.0
Accounts receivable......................... 381.3 88.6 469.9
Supplies.................................... 53.2 20.8 74.0
Other current assets........................ 26.6 13.5 40.1
----------- ----------- ------------ ---------
TOTAL CURRENT ASSETS................ 628.5 238.6 (263.1) 604.0
PROPERTY, PLANT AND EQUIPMENT................. 2,198.4 797.3 (226.4)(9) 2,769.3
Less accumulated depreciation............... 629.6 226.4 (226.4)(9) 629.6
----------- ----------- ------------ ---------
1,568.8 570.9 0.0 2,139.7
EXCESS OF PURCHASE PRICE OVER NET ASSETS
ACQUIRED.................................... 177.8 52.6 16.3(3) 693.3
121.3(4)
360.1(5)
24.5(8)
(59.3)(10)
OTHER ASSETS.................................. 113.9 39.5 5.0(2) 208.7
(1.5)(3)
(16.9)(4)
9.4(8)
59.3(10)
----------- ----------- ------------ ---------
TOTAL ASSETS........................ $ 2,489.0 $ 901.6 $ 255.1 $3,645.7
----------- ----------- ------------ ---------
----------- ----------- ------------ ---------
CURRENT LIABILITIES
Accounts payable............................ $ 79.2 $ 46.0 $ 24.5(8) $ 149.7
Other current liabilities................... 243.7 151.0 (45.0)(7) 349.7
----------- ----------- ------------ ---------
322.9 197.0 (20.5) 499.4
LONG-TERM DEBT................................ 948.3 683.0 200.0(2) 1,684.0
(123.4)(3)
(528.3)(4)
504.4(6)
DEFERRED INCOME TAXES......................... 160.1 6.0 166.1
DEFERRED PROFESSIONAL LIABILITY RISKS......... 145.2 48.0 193.2
OTHER LIABILITIES............................. 216.7 47.6 264.3
STOCKHOLDERS' EQUITY
Common stock(11)............................ 0.1 0.4 (0.4)(5) 0.1
Paid-in capital............................. 827.4 245.8 142.9(1) 970.3
(245.8)(5)
Deferred compensation....................... (0.9) (137.4) 137.4(5) (0.9 )
Retained deficit............................ (130.8) (188.8) 191.1(5) (130.8 )
(2.3)(7)
----------- ----------- ------------ ---------
STOCKHOLDERS' EQUITY.......................... 695.8 (80.0) 222.9 838.7
----------- ----------- ------------ ---------
TOTAL LIABILITIES AND STOCKHOLDERS'
EQUITY............................ $ 2,489.0 $ 901.6 $ 255.1 $3,645.7
----------- ----------- ------------ ---------
----------- ----------- ------------ ---------
</TABLE>
See notes to unaudited pro forma condensed combined balance sheet.
P-2
<PAGE> 46
NOTES TO UNAUDITED PRO FORMA
CONDENSED COMBINED BALANCE SHEET
1. To record the net proceeds from the completion of the offering of 5.2
million shares of Healthtrust Common Stock at $28.625 per share, the average
of the high and low prices for the Common Stock reported on the NYSE for
February 18, 1994.
2. To record the net proceeds from the completion of the Offering at an assumed
interest rate of 8 3/4%.
3. To record the Debt Redemption.
4. To record the completion of the Tender Offers for the Specified EPIC Debt
Securities (100% tender amount assumed). Assuming 51% of each issue of the
Specified EPIC Debt Securities are purchased in the Tender Offers,
borrowings under the 1994 Credit Agreement would be reduced by approximately
$310 million.
5. To record the payment of $7 per share for all the outstanding EPIC common
stock.
6. To record borrowings under the 1994 Credit Agreement in amounts necessary to
complete the Acquisition and Financing Plan transactions and maintain a $20
million cash balance.
7. To record EPIC's required call of the outstanding 15% Senior Subordinated
Notes of EPIC Group.
8. To record certain severance agreement liabilities and transaction costs.
9. To record EPIC's property, plant and equipment at historical net book value.
No estimate of any purchase accounting adjustments to record such property,
plant and equipment at fair value has been made at this time.
10. To record the deferred tax asset for the temporary differences related to
the above transactions (assumes a 39% statutory combined federal and state
tax rate).
11. No assumption has been made as to the exercise of all or a portion of the
Warrants to purchase 3,409,219 shares of Common Stock. If all Warrants were
exercised, net proceeds to the Company would be approximately $18 million.
P-3
<PAGE> 47
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
THREE MONTHS ENDED NOVEMBER 30, 1993
(IN MILLIONS, EXCEPT ON SHARE DATA)
<TABLE>
<CAPTION>
AS REPORTED AS REPORTED PRO FORMA COMBINED
HEALTHTRUST EPIC(1) ADJUSTMENTS PRO FORMA(2)
----------- ----------- ----------- ------------
<S> <C> <C> <C> <C>
Net operating revenue................... $ 622.1 $ 272.5 $ 894.6
Costs and expenses:
Hospital service costs;
Salaries and benefits.............. 232.3 119.5 351.8
Supplies........................... 88.0 32.0 120.0
Fees............................... 64.7 20.5 85.2
Other expenses..................... 65.7 44.6 110.3
Bad debt expense................... 43.6 19.6 63.2
----------- ----------- ------------
494.3 236.2 730.5
Depreciation and amortization........... 34.6 13.1 $ 3.0(3) 50.7
Interest................................ 21.6 23.9 (10.3)(4) 35.2
ESOP/pension expense(2)................. 9.9 5.6 15.5
Deferred compensation expense........... 0.3 0.7 (0.7)(5) 0.3
Other income (net)...................... (5.5) (0.8) 3.2(6) (3.1)
----------- ----------- ----------- ------------
555.2 278.7 (4.8) 829.1
Income (Loss) before minority interests,
and income taxes...................... 66.9 (6.2) 4.8 65.5
Minority interests...................... 1.4 1.7 3.1
----------- ----------- ----------- ------------
Income (Loss) before income taxes....... 65.5 (7.9) 4.8 62.4
Income tax expense (benefit)............ 26.6 0.4 (0.7)(7) 26.3
----------- ----------- ----------- ------------
NET INCOME (LOSS)....................... $ 38.9 $ (8.3) $ 5.5 $ 36.1
----------- ----------- ----------- ------------
----------- ----------- ----------- ------------
(39,943,524)(8)
Weighted average common shares.......... 84,426,187 39,943,524 5,200,000(8) 89,626,187
----------- ----------- ----------- ------------
----------- ----------- ----------- ------------
Net income (loss) per share............. $ 0.46 $ (0.21) $ 0.40
----------- ----------- ------------
----------- ----------- ------------
</TABLE>
See notes to unaudited pro forma condensed combined statements of operations.
P-4
<PAGE> 48
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
YEAR ENDED AUGUST 31, 1993
(IN MILLIONS, EXCEPT PER SHARE DATA)
<TABLE>
<CAPTION>
AS REPORTED AS REPORTED PRO FORMA COMBINED
HEALTHTRUST EPIC(1) ADJUSTMENTS PRO FORMA(2)
----------- ----------- ----------- ------------
<S> <C> <C> <C> <C>
Net operating revenue.................... $ 2,394.6 $ 1,019.1 $ 3,413.7
Costs and expenses:
Hospital service costs;
Salaries and benefits............... 886.7 432.5 1,319.2
Supplies............................ 347.0 122.0 469.0
Fees................................ 270.1 75.7 345.8
Other expenses...................... 239.3 162.9 402.2
Bad debt expense.................... 145.5 80.6 226.1
----------- ----------- ------------
1,888.6 873.7 2,762.3
Depreciation and amortization............ 132.7 57.9 $ 12.1(3) 202.7
Interest................................. 99.8 89.9 (38.5)(4) 151.2
ESOP/pension expense..................... 39.0 20.7 59.7
Deferred compensation expense............ 4.3 3.8 (3.8)(5) 4.3
Other income (net)....................... (7.6) (7.2) 8.0(6) (6.8)
----------- ----------- ----------- ------------
2,156.8 1,038.8 (22.2) 3,173.4
Income (Loss) before minority interests,
income taxes, and extraordinary
charges................................ 237.8 (19.7) 22.2 240.3
Minority interests....................... 11.9 3.5 15.4
----------- ----------- ----------- ------------
Income (Loss) before income taxes and
extraordinary charges.................. 225.9 (23.2) 22.2 224.9
Income tax expense....................... 90.7 2.0 2.7(7) 95.4
----------- ----------- ----------- ------------
INCOME (LOSS) BEFORE EXTRAORDINARY
CHARGES................................ $ 135.2 (25.2) $ 19.5 $ 129.5
----------- ----------- ----------- ------------
----------- ----------- ----------- ------------
(40,146,915)(8)
Weighted average common shares........... 83,540,815 40,146,915 5,200,000(8) 88,740,815
----------- ----------- ----------- ------------
----------- ----------- ----------- ------------
Income (Loss) per share before
extraordinary charges.................. $ 1.62 $ (0.63) $ 1.45
----------- ----------- ------------
----------- ----------- ------------
</TABLE>
See notes to unaudited pro forma condensed combined statements of operations.
P-5
<PAGE> 49
NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENTS OF OPERATIONS
1. The Company will continue to report its financial information on the basis of
an August 31 fiscal year. EPIC reports its financial information using a
September 30 fiscal year. Therefore, the EPIC statement of operations
information for the fiscal year ended September 30, 1993 and three months
ended December 31, 1993 have been combined with the Healthtrust statement of
operations information for the fiscal year ended August 31, 1993 and three
months ended November 30, 1993, respectively.
2. The pro forma condensed combined statements of operations do not give effect
to any overhead reductions or cost savings, if any, which may be realized
after the consummation of the Acquisition. Pension expense for EPIC employees
has been assumed to be equivalent to historical EPIC ESOP expense
(approximately 5.5% of salaries).
3. To adjust amortization as follows:
<TABLE>
<CAPTION>
THREE MONTHS YEAR
ENDED ENDED
NOVEMBER 30, 1993 AUGUST 31, 1993
----------------- ---------------
<S> <C> <C>
To record amortization related to the $515.5 million
increase in the excess of purchase price over net assets
acquired................................................. $ 3.6 $ 14.4
To eliminate the EPIC historical amortization of the excess
of purchase price over net assets acquired............... (.6) (2.3)
------- -------
$ 3.0 $ 12.1
------- -------
------- -------
</TABLE>
4. To adjust interest expense as follows:
<TABLE>
<CAPTION>
THREE MONTHS YEAR
ENDED ENDED
NOVEMBER 30, 1993 AUGUST 31, 1993
----------------- ---------------
<S> <C> <C>
To record interest expense on borrowings of $504.4 million
related to the 1994 Credit Agreement (assumes average
rate of 5.19% and 5.43%, respectively)................... $ 6.6 $ 27.4
To record interest expense related to the $200 million
Subordinated Notes (assumes an 8 3/4% interest rate)..... 4.4 17.5
To eliminate historical interest expense on the tendered
Specified EPIC Debt Securities and called EPIC Redeemable
Debt..................................................... (21.3) (83.4)
------- -------
$ (10.3) $ (38.5)
------- -------
------- -------
</TABLE>
Assuming 51% of each issue of the Specified EPIC Debt Securities are
purchased in the Tender Offers, pro forma interest expense would be increased by
approximately $1.7 million and $3.0 million for the three months ended November
30, 1993 and year ended August 31, 1993, respectively.
5. To eliminate the compensation expense related to EPIC'S SAR Plan.
6. To eliminate interest income on excess cash.
7. To record the pro forma provision for income taxes at statutory rates of
39.0% and 38.3% for the three months ended November 30, 1993 and year ended
August 31, 1993, respectively (after excluding certain expenses that are not
deductible for tax purposes).
8. To reflect the Company's purchase of EPIC's outstanding equity and completion
of the offering of 5.2 million shares of Common Stock by the Company.
P-6
<PAGE> 50
EPIC HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(DOLLARS IN THOUSANDS)
ASSETS
<TABLE>
<CAPTION>
DECEMBER 31, SEPTEMBER 30,
1993 1993
------------ -------------
(UNAUDITED)
<S> <C> <C>
CURRENT ASSETS
Cash and cash equivalents....................................... $ 45,563 $ 61,362
Cash restricted for interest payment............................ 9,573 3,820
Marketable securities........................................... 34,132 47,347
Accounts receivable, net of reserves for uncompensated care of
$31,187 and $29,286.......................................... 99,392 76,957
Supply inventories.............................................. 20,973 20,687
Prepaid expenses and other...................................... 12,898 5,074
Deferred income taxes........................................... 5,384 --
------------ -------------
TOTAL CURRENT ASSETS.............................................. 227,915 215,247
PROPERTY AND EQUIPMENT............................................ 810,055 786,798
ACCUMULATED DEPRECIATION AND AMORTIZATION......................... (231,239) (218,746)
------------ -------------
578,816 568,052
EXCESS OF PURCHASE PRICE OVER NET ASSETS ACQUIRED, net of
accumulated amortization........................................ 52,461 52,965
OTHER ASSETS, net of accumulated amortization..................... 39,330 38,696
------------ -------------
TOTAL ASSETS...................................................... $ 898,522 $ 874,960
------------ -------------
------------ -------------
</TABLE>
See notes to condensed consolidated financial statements.
F-1
<PAGE> 51
EPIC HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(DOLLARS IN THOUSANDS)
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
<TABLE>
<CAPTION>
DECEMBER 31, SEPTEMBER 30,
1993 1993
------------ -------------
(UNAUDITED)
<S> <C> <C>
CURRENT LIABILITIES
Current maturities of long-term debt............................ $ 48,049 $ 47,914
Accounts payable................................................ 45,557 44,610
Accrued liabilities............................................. 96,746 87,604
------------ -------------
TOTAL CURRENT LIABILITIES......................................... 190,352 180,128
LONG-TERM DEBT.................................................... 685,187 679,605
DEFERRED INCOME TAXES............................................. 11,378 5,994
RESERVE FOR PROFESSIONAL LIABILITY RISKS.......................... 46,557 46,612
OTHER DEFERRED LIABILITIES........................................ 42,013 42,450
COMMITMENTS AND CONTINGENT LIABILITIES............................
MINORITY INTERESTS................................................ 5,909 5,472
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock, $.01 par value.................................... 399 401
Paid-in capital................................................. 245,759 245,757
Notes receivable from EPIC ESOP................................. (137,381) (148,214)
Retained earnings (deficit)..................................... (191,651) (183,245)
------------ -------------
TOTAL STOCKHOLDERS' EQUITY (DEFICIT).............................. (82,874) (85,301)
------------ -------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT).............. $ 898,522 $ 874,960
------------ -------------
------------ -------------
</TABLE>
See notes to condensed consolidated financial statements.
F-2
<PAGE> 52
EPIC HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
(DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)
<TABLE>
<CAPTION>
FOR THE THREE MONTHS ENDED
DECEMBER 31,
---------------------------
1993 1992
----------- -----------
<S> <C> <C>
NET OPERATING REVENUE............................................. $ 272,451 $ 244,352
COSTS AND EXPENSES:
Salaries and wages.............................................. 99,526 84,634
Employee benefits............................................... 21,094 22,997
ESOP expense.................................................... 5,635 5,182
Supplies........................................................ 32,025 30,041
Uncompensated care.............................................. 19,618 19,048
Other........................................................... 64,653 57,909
Depreciation and amortization................................... 13,130 13,791
Interest expense................................................ 23,834 21,954
----------- -----------
TOTAL COSTS AND EXPENSES.......................................... 279,515 255,556
INTEREST INCOME................................................... 819 612
----------- -----------
LOSS BEFORE INCOME TAX EXPENSE, MINORITY INTERESTS AND
EXTRAORDINARY ITEM.............................................. (6,245) (10,592)
INCOME TAX EXPENSE, net........................................... (375) (176)
MINORITY INTERESTS IN INCOME OF CONSOLIDATED SUBSIDIARIES, net of
income tax expense.............................................. (1,667) (631)
----------- -----------
LOSS BEFORE EXTRAORDINARY ITEM.................................... (8,287) (11,399)
EXTRAORDINARY ITEM, net of income tax expense..................... -- (570)
----------- -----------
NET LOSS.......................................................... $ (8,287) $ (11,969)
----------- -----------
----------- -----------
WEIGHTED AVERAGE NUMBER OF
COMMON SHARES OUTSTANDING....................................... 39,943,524 40,156,780
LOSS PER COMMON SHARE:
Before extraordinary item....................................... $ (.21) $ (.28)
Extraordinary item.............................................. -- (.01)
----------- -----------
Net loss........................................................ $ (.21) $ (.29)
----------- -----------
----------- -----------
</TABLE>
See notes to condensed consolidated financial statements.
F-3
<PAGE> 53
EPIC HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
FOR THE THREE MONTHS
ENDED DECEMBER 31,
---------------------
1993 1992
-------- --------
<S> <C> <C>
OPERATING ACTIVITIES
Net loss............................................................. $ (8,287) $(11,969)
Adjustments to reconcile net loss to net cash provided by operating
activities:
Depreciation and amortization..................................... 13,130 13,791
Non-cash provision for professional liability risks............... (1,111) 437
ESOP expense...................................................... 5,635 5,182
Deferred SAR Plan compensation.................................... (274) (1,496)
Minority interests in income of consolidated subsidiaries......... 1,667 631
Non-cash interest................................................. 8,995 9,227
Extraordinary item................................................ -- 570
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable............................................... (22,435) 342
Supply inventories and other assets............................... (8,399) (10,549)
Accounts payable and other liabilities............................ 9,991 8,785
-------- --------
Net cash provided by (used in) operating activities.......... (1,088) 14,951
INVESTING ACTIVITIES
Investments in marketable securities, net............................ 13,215 6,395
Cash paid for acquisitions........................................... (960) (4,100)
Additions to property and equipment.................................. (23,431) (7,410)
Other................................................................ (661) (811)
-------- --------
Net cash used in investing activities........................ (11,837) (5,926)
FINANCING ACTIVITIES
Payments on debt obligations......................................... (1,415) (76)
Line of credit borrowings, net....................................... -- 800
Purchase of Senior ESOP Notes........................................ -- (5,616)
Purchase of treasury stock........................................... (119) (11)
Distributions and dividends to minority interests.................... (1,132) (2,340)
Payments of debt issue costs and other, net.......................... (208) (59)
-------- --------
Net cash used in financing activities........................ (2,874) (7,302)
-------- --------
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS....................... (15,799) 1,723
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD....................... 61,362 37,419
-------- --------
CASH AND CASH EQUIVALENTS AT END OF PERIOD............................. $ 45,563 $ 39,142
-------- --------
-------- --------
SUPPLEMENTARY INFORMATION
Cash paid for interest............................................... $ 8,513 $ 1,598
Cash paid for income taxes........................................... $ 199 $ 176
</TABLE>
See notes to condensed consolidated financial statements.
F-4
<PAGE> 54
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements of
EPIC Holdings, Inc. and Subsidiaries ("Holdings") have been prepared in
accordance with generally accepted accounting principles for interim financial
information and with the instructions to Form 10-Q and Article 10 of Regulation
S-X. Accordingly, they do not include all of the information and footnotes
required by generally accepted accounting principles for complete financial
statements. In the opinion of management, all adjustments considered necessary
for a fair presentation have been included and are of a normal recurring nature.
Operating results for the three month period ended December 31, 1993 are not
necessarily indicative of the results that may be expected for the fiscal year
ending September 30, 1994. These financial statements should be read in
conjunction with the audited consolidated financial statements and footnotes
thereto included in Holdings' annual report on Form 10-K for the year ended
September 30, 1993.
Certain prior period amounts have been reclassified to conform with the
fiscal 1994 presentation.
2. SUBSEQUENT EVENT
On January 9, 1994, Holdings entered into an Agreement and Plan of Merger
(the "Merger Agreement") with HealthTrust, Inc. -- The Hospital Company, a
Delaware corporation ("HTI"), and Odyssey Acquisition Corp., a Delaware
corporation and wholly-owned subsidiary of HTI ("HTI Sub"), providing for the
merger (the "Merger") of HTI Sub with and into Holdings following which Holdings
would become a wholly-owned subsidiary of HTI. The Merger is expected to result
in a termination of the EPIC ESOP. Under the terms of the Merger Agreement,
which was unanimously approved by the Boards of Directors of both HTI and
Holdings, shareholders of Holdings will receive $7.00 per share of Holdings'
common stock.
HTI intends to offer to purchase the 12% Senior Deferred Coupon Notes due
2002, the 11.375% Class B-1 First Priority Mortgage Notes due 2001, the 11.5%
Class B-2 First Priority Mortgage Notes due 2001, the Class B-3 First Priority
Mortgage Notes, and the 10.875% Senior Subordinated Notes due 2003 and to redeem
other outstanding EPIC indebtedness in accordance with their terms. HTI also
plans to seek the consent of the holders of Holdings' indebtedness to amend
certain restrictive provisions.
Consummation of the Merger is subject to a number of conditions, including
the approval of Holdings' shareholders and the consummation of certain debt
consent solicitations. American Medical International, Inc. and the trustee of
the EPIC ESOP (who controls the unallocated shares of the EPIC ESOP) have
agreed, subject to the fulfillment of certain conditions, to vote their shares
of Holdings common stock (approximately 52% combined) in favor of the Merger.
The transaction is expected to close by May of 1994.
3. INCOME TAXES
Effective October 1, 1993, Holdings changed its method of accounting for
income taxes to the liability method as required by Statement of Financial
Accounting Standards ("SFAS") No. 109, "Accounting for Income Taxes", which
superseded SFAS No. 96. As permitted under the rules of SFAS No. 109, prior
years' financial statements have not been restated.
Adopting SFAS No. 109 had no effect on current period operations. Due to
the uncertainty of the realization of the net deferred federal tax liability,
Holdings established a valuation allowance against the deferred federal tax
assets so that deferred federal tax assets equalled deferred federal tax
liabilities. The net deferred tax liability reported relates primarily to state
taxes.
F-5
<PAGE> 55
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(UNAUDITED)
Deferred income taxes reflect the net tax effects of temporary differences
between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. Significant components of
Holdings' deferred tax assets and liabilities as of October 1, 1993 are as
follows (in thousands):
<TABLE>
<S> <C>
Deferred tax liabilities
Property and equipment basis difference.......................... $42,908
ESOP plan fees................................................... 1,547
ESOP contribution................................................ 3,455
State taxes and other............................................ 5,994
-------
Total deferred tax liabilities................................... 53,904
-------
Deferred tax assets
Bad debt reserve differences..................................... 6,593
Professional liability reserves.................................. 15,670
SAR compensation................................................. 14,034
Health plan and workers' compensation reserves................... 3,652
Paid time off reserve............................................ 1,788
Net operating losses............................................. 24,312
Other............................................................ 700
-------
Total deferred tax assets........................................ 66,749
Valuation allowance.............................................. (18,839)
-------
Net deferred tax assets.......................................... 47,910
-------
Net deferred tax liability....................................... $ 5,994
-------
-------
</TABLE>
No tax benefit was recorded for the current net operating loss and no
federal taxes are anticipated for fiscal 1994. Current income tax expense of
$375,000 relates to state income taxes.
4. LOSS PER COMMON SHARE
Loss per common share has been computed by dividing the net loss applicable
to common shares by the weighted average number of common shares outstanding
during the period. The exercise of the outstanding common stock warrants and
other common stock equivalents has not been assumed as the effect would be
antidilutive.
5. CHANGES IN STOCKHOLDER'S EQUITY
During the three-month period ended December 31, 1993, Holdings purchased
treasury stock for $119,000 and received a principal payment on the Notes
receivable from the EPIC ESOP of $10,833,000 which was recorded as a reduction
of the Notes receivable from EPIC ESOP.
6. GUARANTOR SUBSIDIARIES
Certain subsidiaries of EPIC (the "Guarantor Subsidiaries") guarantee the
loans under the Amended Credit Agreement, the Zero Coupon Notes, the Additional
Zero Coupon Notes, the Senior ESOP Notes, the 10.875% Senior Subordinated Notes,
the 15% Senior Subordinated Notes and the 11% Junior Subordinated Pay-In-Kind
Notes. Certain other subsidiaries, including EPIC Properties, Inc. ("EPIC
Properties") are not Guarantor Subsidiaries (the "Nonguarantor Subsidiaries").
All equity interests in the Nonguarantor Subsidiaries, other than those held by
minority interests, are held by EPIC.
F-6
<PAGE> 56
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(UNAUDITED)
Condensed consolidating financial information of EPIC Healthcare Group,
Inc. ("EPIC"), the Guarantor Subsidiaries, EPIC Properties and the other
Nonguarantor Subsidiaries are included in the footnotes to the unaudited
condensed consolidated financial statements of EPIC included elsewhere herein.
F-7
<PAGE> 57
REPORT OF ERNST & YOUNG, INDEPENDENT AUDITORS
The Board of Directors
EPIC Holdings, Inc.
We have audited the accompanying consolidated balance sheets of EPIC
Holdings, Inc. and subsidiaries as of September 30, 1993 and 1992, and the
related consolidated statements of operations, stockholder's equity (deficit),
and cash flows for each of the three years in the period ended September 30,
1993. These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the consolidated financial position of
EPIC Holdings, Inc. and subsidiaries at September 30, 1993, and 1992, and the
results of its consolidated operations and its consolidated cash flows for each
of the three years in the period ended September 30, 1993, in conformity with
generally accepted accounting principles.
ERNST & YOUNG
Dallas, Texas
December 3, 1993
F-8
<PAGE> 58
EPIC HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(DOLLARS IN THOUSANDS)
ASSETS
<TABLE>
<CAPTION>
SEPTEMBER 30,
---------------------
1993 1992
-------- --------
<S> <C> <C>
CURRENT ASSETS
Cash and cash equivalents............................................ $ 61,362 $ 37,419
Cash restricted for interest payments................................ 3,820 5,768
Marketable securities................................................ 47,347 10,607
Accounts receivable, net of reserves for uncompensated care of
$29,286 and $25,837, respectively................................. 76,957 73,398
Supply inventories................................................... 20,687 20,000
Prepaid expenses and other........................................... 5,074 5,222
-------- --------
TOTAL CURRENT ASSETS................................................... 215,247 152,414
PROPERTY AND EQUIPMENT
Land................................................................. 53,030 57,492
Buildings and improvements........................................... 476,570 451,292
Equipment............................................................ 234,656 192,367
Construction in progress............................................. 22,542 9,333
-------- --------
786,798 710,484
Accumulated depreciation and amortization............................ (218,746) (173,789)
-------- --------
568,052 536,695
EXCESS OF PURCHASE PRICE OVER NET ASSETS ACQUIRED,
net of accumulated amortization...................................... 52,965 48,140
OTHER ASSETS, net of accumulated amortization.......................... 38,696 43,502
-------- --------
TOTAL ASSETS........................................................... $874,960 $780,751
-------- --------
-------- --------
</TABLE>
See notes to consolidated financial statements.
F-9
<PAGE> 59
EPIC HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(DOLLARS IN THOUSANDS)
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
<TABLE>
<CAPTION>
SEPTEMBER 30,
-----------------------
1993 1992
--------- ---------
<S> <C> <C>
CURRENT LIABILITIES
Current maturities of long-term debt............................... $ 47,914 $ 2,330
Accounts payable................................................... 44,610 34,809
Accrued liabilities:
Salaries and wages.............................................. 36,475 33,031
Taxes other than on income...................................... 7,946 7,589
Interest........................................................ 11,027 7,658
Group health insurance.......................................... 4,902 5,656
Current reserve for professional liability risks................ 11,000 11,000
Other........................................................... 16,254 9,011
--------- ---------
TOTAL CURRENT LIABILITIES............................................ 180,128 111,084
LONG-TERM DEBT....................................................... 679,605 619,363
DEFERRED INCOME TAXES................................................ 5,994 5,994
RESERVE FOR PROFESSIONAL LIABILITY RISKS............................. 46,612 39,640
OTHER DEFERRED LIABILITIES........................................... 42,450 39,607
COMMITMENTS AND CONTINGENT LIABILITIES...............................
MINORITY INTERESTS................................................... 5,472 23,494
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock, $.01 par value -- Authorized: 100,000,000 shares;
Issued: 40,319,245 shares; Outstanding: 40,099,441 and
40,154,545 shares, respectively................................. 401 401
Paid-in capital.................................................... 245,757 245,757
Notes receivable from EPIC ESOP.................................... (148,214) (168,929)
Retained earnings (deficit)........................................ (183,245) (135,660)
--------- ---------
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)................................. (85,301) (58,431)
--------- ---------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)................. $ 874,960 $ 780,751
--------- ---------
--------- ---------
</TABLE>
See notes to consolidated financial statements.
F-10
<PAGE> 60
EPIC HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(DOLLARS IN THOUSANDS, EXCEPT PER SHARE DATA)
<TABLE>
<CAPTION>
FOR THE YEAR ENDED SEPTEMBER 30,
------------------------------------------
1993 1992 1991
----------- ----------- ----------
<S> <C> <C> <C>
NET OPERATING REVENUE................................ $ 1,019,149 $ 941,266 $ 802,689
COSTS AND EXPENSES:
Salaries and wages................................. 354,326 319,868 271,007
Employee benefits.................................. 84,615 81,365 68,434
ESOP expense....................................... 20,715 20,714 23,076
Supplies........................................... 121,986 116,145 99,882
Uncompensated care................................. 80,643 69,308 59,425
Other.............................................. 235,924 235,009 192,633
Depreciation and amortization...................... 57,917 53,013 49,354
Interest expense................................... 89,872 79,790 68,266
----------- ----------- ----------
TOTAL COSTS AND EXPENSES............................. 1,045,998 975,212 832,077
INTEREST INCOME...................................... 3,648 3,936 5,405
GAIN (LOSS) ON SALE OF ASSETS........................ 3,521 (1,123) (543)
----------- ----------- ----------
LOSS BEFORE INCOME TAX BENEFIT
(EXPENSE), MINORITY INTERESTS AND
EXTRAORDINARY ITEM................................. (19,680) (31,133) (24,526)
INCOME TAX BENEFIT (EXPENSE), net.................... (1,984) 9,252 7,603
MINORITY INTERESTS IN INCOME OF CONSOLIDATED
SUBSIDIARIES (net of income
tax benefit of $1,008, and $1,063 in 1992 and
1991, respectively)................................ (3,499) (1,958) (2,064)
----------- ----------- ----------
LOSS BEFORE EXTRAORDINARY ITEM....................... (25,163) (23,839) (18,987)
EXTRAORDINARY ITEM (net of income tax benefit of $652
and $1,330 in 1992 and 1991, respectively)......... (21,960) (1,265) (2,581)
----------- ----------- ----------
NET LOSS............................................. (47,123) (25,104) (21,568)
REDEEMABLE PREFERRED STOCK DIVIDEND OF PREDECESSOR
COMPANY............................................ -- (11,048) (22,873)
----------- ----------- ----------
NET LOSS APPLICABLE TO COMMON SHARES................. $ (47,123) $ (36,152) $ (44,441)
----------- ----------- ----------
----------- ----------- ----------
WEIGHTED AVERAGE NUMBER OF COMMON SHARES
OUTSTANDING........................................ 40,146,915 32,576,161 24,482,803
LOSS PER COMMON SHARE:
Before extraordinary item.......................... $ (.63) $ (1.07) $ (1.71)
Extraordinary item................................. (.55) (.04) (.11)
----------- ----------- ----------
Net loss........................................... $ (1.18) $ (1.11) $ (1.82)
----------- ----------- ----------
----------- ----------- ----------
</TABLE>
See notes to consolidated financial statements.
F-11
<PAGE> 61
EPIC HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
NOTES RETAINED TOTAL
COMMON PAID-IN RECEIVABLE EARNINGS STOCKHOLDERS'
STOCK CAPITAL FROM EPIC ESOP (DEFICIT) EQUITY (DEFICIT)
------ -------- -------------- --------- ----------------
<S> <C> <C> <C> <C> <C>
Balance at October 1, 1990.......... $245 $219,808 $ (212,738) $ (87,241) $(79,926)
Dividends accrued and accretion of
discount on redeemable preferred
stock............................. -- (22,873) -- -- (22,873)
Principal payments received on notes
receivable from EPIC ESOP......... -- -- 23,095 -- 23,095
Treasury stock purchased............ (1) -- -- (468) (469)
Net loss............................ -- -- -- (21,568) (21,568)
------ -------- -------------- --------- ----------------
Balance at September 30, 1991....... 244 196,935 (189,643) (109,277) (101,741)
Dividends accrued and accretion of
discount on redeemable preferred
stock............................. -- (11,048) -- -- (11,048)
Principal payments received on notes
receivable from EPIC ESOP......... -- -- 20,714 -- 20,714
Treasury stock purchased............ (2) -- -- (1,279) (1,281)
Warrant conversion.................. 65 (44) -- -- 21
Preferred stock transaction costs... -- (7,063) -- -- (7,063)
Conversion of Class C Preferred
Stock............................. 94 63,842 -- -- 63,936
Net book value of Class A and Class
B Preferred Stock over cash
paid.............................. -- 3,135 -- -- 3,135
Net loss............................ -- -- -- (25,104) (25,104)
------ -------- -------------- --------- ----------------
Balance at September 30, 1992....... 401 245,757 (168,929) (135,660) (58,431)
Principal payments received on notes
receivable from EPIC ESOP......... -- -- 20,715 -- 20,715
Treasury stock purchased............ -- -- -- (462) (462)
Net loss............................ -- -- -- (47,123) (47,123)
------ -------- -------------- --------- ----------------
Balance at September 30, 1993....... $401 $245,757 $ (148,214) $(183,245) $(85,301)
------ -------- -------------- --------- ----------------
------ -------- -------------- --------- ----------------
</TABLE>
See notes to consolidated financial statements.
F-12
<PAGE> 62
EPIC HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
FOR THE YEAR ENDED SEPTEMBER 30,
----------------------------------
1993 1992 1991
-------- -------- --------
<S> <C> <C> <C>
OPERATING ACTIVITIES
Net loss.................................................. $(47,123) $(25,104) $(21,568)
Adjustments to reconcile net loss to net cash provided by
operating activities:
Depreciation and amortization.......................... 57,917 53,013 49,354
Non-cash provision for professional liability risks.... 2,641 4,131 11,291
ESOP expense........................................... 20,715 20,714 23,076
Deferred SAR Plan compensation......................... 3,249 10,805 7,137
Minority interests in income of consolidated
subsidiaries......................................... 3,499 2,966 3,127
(Gain) loss on sale of assets.......................... (3,521) 1,123 543
Non-cash interest...................................... 36,855 27,190 13,975
Extraordinary item..................................... 21,960 1,917 3,911
Deferred income tax benefit............................ -- (11,800) (9,996)
Changes in operating assets and liabilities, net of
acquisitions:
Accounts receivable.................................. 6,054 (35,196) (3,043)
Supply inventories and other assets.................. 4,083 (3,162) (5,291)
Accounts payable and other liabilities............... 12,172 11,395 6,444
-------- -------- --------
Net cash provided by operating activities......... 118,501 57,992 78,960
INVESTING ACTIVITIES
Investments in marketable securities, net................. (36,740) 5,167 (12,091)
Cash paid for acquisitions................................ (54,536) (12,269) --
Additions to property and equipment....................... (60,784) (47,850) (25,646)
Purchase of investment securities......................... -- (4,180) --
Proceeds from sales of assets............................. 25,148 190 361
Collection on note receivable............................. 9,349 -- --
Other..................................................... (5,925) (2,046) (48)
-------- -------- --------
Net cash used in investing activities............. (123,488) (60,988) (37,424)
FINANCING ACTIVITIES
Payments on debt obligations.............................. (117,765) (1,603) (250,647)
Proceeds from long-term borrowings........................ 180,853 140,052 227,868
Purchase of Senior ESOP Notes............................. (5,616) (20,293) --
Purchase of treasury stock................................ (462) (1,281) (469)
Purchase of Class A and B Preferred Stock................. -- (130,000) --
Preferred stock transaction costs......................... -- (7,063) --
Proceeds on warrant conversion............................ -- 21 --
Contributions from minority interests..................... 520 1,884 556
Distributions and dividends to minority interests......... (21,110) (4,065) (4,122)
Payments of debt issue costs and other, net............... (7,490) (6,056) (11,294)
-------- -------- --------
Net cash provided by (used in) financing
activities...................................... 28,930 (28,404) (38,108)
-------- -------- --------
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS............ 23,943 (31,400) 3,428
Cash and cash equivalents at beginning of year............ 37,419 68,819 65,391
-------- -------- --------
Cash and cash equivalents at end of year.................. $ 61,362 $ 37,419 $ 68,819
-------- -------- --------
-------- -------- --------
SUPPLEMENTARY INFORMATION
Cash paid during the year for interest.................... $ 52,370 $ 53,343 $ 52,987
Cash paid for income taxes................................ $ 657 $ 888 $ 666
</TABLE>
See notes to consolidated financial statements.
F-13
<PAGE> 63
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
EPIC Healthcare Group, Inc. ("EPIC" or, either alone or together with its
subsidiaries, the "Company") was acquired by EPIC Holdings, Inc. ("Holdings") on
March 25, 1992, in a merger transaction (the "Merger") in which each outstanding
share of common stock of EPIC was converted into one share of Holdings common
stock. The merger was between companies under common control (i.e., a pooling of
interests for accounting purposes) and accordingly, the recorded assets and
liabilities of EPIC on an historical basis are combined with the assets and
liabilities of Holdings. Holdings had no operations prior to the merger. Results
of operations for the period prior to March 25, 1992, consist of the operations
of EPIC.
Principles of Consolidation
The consolidated financial statements include the accounts of Holdings and
its subsidiaries. Intercompany accounts and transactions have been eliminated.
Minority interests represent the minority stockholders' proportionate shares of
the equity in the income (loss) of certain consolidated subsidiaries.
Cash Equivalents, Cash Restricted for Interest Payments, and Marketable
Securities
Holdings considers all highly liquid investments with initial maturities of
three months or less from date of purchase to be cash equivalents. Cash
restricted for interest payments is cash deposited into a trust to pay principal
and interest required by the Class B-1, Class B-2 and Class B-3 First Priority
Mortgage Notes (the "Mortgage Notes"). Investments in marketable
interest-bearing securities are stated at cost which approximates market.
Holdings has $42,694,000 in cash and marketable securities restricted for the
purpose of redeeming the remaining 15% Senior Subordinated Notes (See Note 5).
Cash equivalents, cash restricted for interest payments, and marketable
securities are subject to potential concentrations of credit risk. Holdings
attempts to lessen that risk by investing only in United States Government
securities, commercial paper having at least a rating of A-1 or the equivalent,
time deposits and certificates of deposit of banks having a debt rating of at
least A, or money market funds comprised of such securities. Holdings invests in
securities with maturities no longer than 180 days and limits the amount of
credit exposure to any one commercial issuer.
Accounts Receivable
Concentration of credit risk relating to accounts receivable is limited to
some extent by the diversity and number of patients and payors and the
geographic dispersion of Holdings' hospitals. Accounts receivable (gross)
consists of amounts due from government programs (e.g., Medicare and Medicaid)
(53%) commercial insurance companies (16%), private pay patients (18%) and other
(including health maintenance organizations and other group insurance programs)
(13%). Holdings' hospitals are located throughout the southern United States,
with the largest concentration in Texas, Oklahoma, Louisiana and California.
Holdings maintains an allowance for losses (i.e., uncompensated care or bad debt
expense) based on the expected collectibility of accounts receivable.
Supply Inventories
Supply inventories are stated at the lower of cost (first-in, first-out
method) or market.
F-14
<PAGE> 64
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
Property and Equipment
Property and equipment are recorded at cost (or fair value at the date of
acquisition as a result of the original purchase from American Medical
International, Inc. and its subsidiaries ("AMI")). Depreciation and amortization
is computed using the straight-line method over estimated useful lives or term
of the lease generally ranging from 25 to 30 years for buildings and
improvements, and 3 to 10 years for equipment. Maintenance costs and repairs are
expensed as incurred.
Joint Ventures
EPIC, in the ordinary course of business, enters into joint ventures with
physicians and other companies. EPIC is the majority owner and general partner
of substantially all of the joint ventures and follows the principles of
consolidation for all majority-owned joint ventures. Minority shareholders'
investments and earnings in the joint ventures are recorded as minority
interests and minority interests in income of consolidated subsidiaries,
respectively. Any interest held by the Company in non-majority owned
partnerships with at least 20% ownership is accounted for using the equity
method. Any interest held by the Company in partnerships with less than 20%
ownership is accounted for using the cost method.
On February 1, 1990, EPIC entered into a joint venture with Healthtrust,
Inc. -- The Hospital Company ("Healthtrust") for the purpose of operating
certain hospital assets in McKinney, Texas. EPIC contributed, at net book value,
a 168 bed facility to the venture and is the managing co-general partner with a
60% equity interest in the venture. Healthtrust contributed a 99 bed facility to
the venture and was the co-general partner with a 40% interest in the venture.
The assets contributed by Healthtrust to the joint venture, including property
and equipment of $15,328,000, were recorded at fair market value which
approximated net book value. Goodwill of $2,470,000 is being amortized over 40
years. On August 31, 1993, EPIC purchased Healthtrust's interest in the joint
venture for $15,656,000 which approximated Healthtrust's interest in the net
assets of the joint venture and was recorded as a reduction to minority
interests.
Intangible Assets
The excess of the purchase price over the fair value of net asset acquired
is being amortized on a straight-line basis over periods ranging from nine to 40
years. Accumulated amortization was $9,244,000 and $6,920,000 at September 30,
1993 and 1992, respectively.
Costs incurred in obtaining long term financing are deferred and are
included in other assets. Deferred financing costs are amortized using the
effective interest method over the term of the related debt, and such
amortization is included in interest expense. Accumulated amortization of
deferred financing costs was $16,993,000 and $14,401,000 at September 30, 1993
and 1992, respectively.
EPIC has purchased licenses to use various software applications. These
costs are included in other assets and have been amortized over two or five year
periods. Accumulated amortization of the software costs was $5,750,000 and
$4,750,000 at September 30, 1993 and 1992, respectively.
Income Taxes
Holdings files a consolidated federal income tax return which includes all
of its eligible subsidiaries.
Holdings accounts for income taxes under the provisions of Statement of
Financial Accounting Standards ("SFAS") No. 96, "Accounting for Income Taxes."
Under the liability method specified by SFAS No. 96, deferred tax assets and/or
liabilities are determined by multiplying the difference between the financial
reporting and tax reporting bases of assets and liabilities (collectively, the
"temporary differences," see Note 6) by tax rates (determined in accordance with
enacted tax laws) that are expected to be effective when such temporary
differences reverse. Holdings' deferred tax liabilities originated from the
accounting for the
F-15
<PAGE> 65
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
acquisition from AMI (the "Acquisitions"), and reflect the estimated tax effect
of differences between book and tax bases of assets acquired and liabilities
assumed.
In February 1992, the Financial Accounting Standards Board issued SFAS No.
109, "Accounting for Income Taxes," which supersedes SFAS No. 96. Implementation
of SFAS No. 109 for Holdings was required October 1, 1993. SFAS No. 109 requires
that temporary differences be reflected in the same balance sheet category as
the assets and liabilities that caused the temporary differences. Deferred tax
assets, which would include tax net operating loss carryforwards, would require
the determination of a related valuation allowance, based on the assets'
expected realization. The Company has completed the analysis necessary to
determine the impact of adoption of SFAS No. 109 and it is not expected to have
a material impact on Holdings' financial position or results of operations and
will not impact cash flows.
Net Operating Revenue
Net operating revenue is recorded based on established billing rates net of
allowances and discounts for patients covered by Medicare, Medicaid and other
contractual programs. Payments received under these programs, which are based on
either the costs of services or predetermined rates, are generally less than the
established billing rates of EPIC's hospitals, and the differences are recorded
as contractual allowances and/or contracted discounts. Reserves provided have
been deducted from accounts receivable pending final audit and appeal
settlement. Contractual adjustments, contracted discounts and other discounts
amounted to $627,757,000, $576,572,000, and $482,158,000 for fiscal 1993, 1992
and 1991, respectively.
It is generally EPIC's policy to attempt to collect compensation for all
services performed.
Reclassifications
Certain prior period amounts have been reclassified to conform with the
fiscal 1993 presentation.
2. ACQUISITION AND DIVESTITURES
On August 24, 1993 the Company entered into a 20-year lease agreement with
two ten-year renewal options with the County of Galveston, Texas for Mainland
Center Hospital, a 310-bed hospital in Texas City, Texas. The lease payments of
$27,535,000 were paid in full upon the execution of the lease, which has been
accounted for as a capital lease. The Company also purchased certain net current
assets and equipment of the hospital, which included $5,639,000 in cash, for
$17,965,000 which has been accounted for by the purchase method of accounting.
The Company also has a commitment for $20,000,000 in capital improvements over
the term of the lease. The Company has a purchase option beginning after the
first year of the lease. The option price ranges from $500,000 to $851,000 over
the term of the lease.
On January 6, 1993, the Company sold Westpark Community Hospital in
Hammond, Louisiana for $6,200,000. A loss of $624,000 was recorded as gain
(loss) on sale of assets in fiscal 1993. A charge of $800,000 to reflect the
anticipated loss on the sale was recorded as gain (loss) on sale of assets in
fiscal 1992. The net book value of the assets sold before the fiscal 1992
charge, less liabilities assumed by the buyer, was $7,624,000.
On March 15, 1993, the Company sold Valley Medical Center in El Cajon,
California for $16,950,000. A gain of $4,632,000 was recorded as gain (loss) on
sale of assets in fiscal 1993. The net book value of the assets sold, less
liabilities assumed by the buyer, was $12,318,000.
On October 1, 1991, the Company purchased Colonial Hospital, a 49-bed
hospital in Terrell, Texas for $10,403,000 in cash. The acquisition has been
accounted for by the purchase method of accounting. The excess of purchase price
over net assets acquired will be amortized over 40 years.
F-16
<PAGE> 66
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
3. EMPLOYEE STOCK OWNERSHIP PLAN ("ESOP")
Employee-owners of EPIC have beneficial ownership of approximately 60% of
the Holdings Common Stock through their participation in the EPIC ESOP.
At EPIC's inception, the EPIC ESOP purchased 24,500,000 shares of EPIC
Common Stock with the proceeds obtained from the issuance of loans aggregating
$245 million payable to EPIC. The terms of the original ESOP loan agreement
segregated the EPIC ESOP's obligation to EPIC into two components, the terms of
the first of which mirrored the terms of the Senior ESOP Bank Debt (the "First
ESOP Loan") and the second of which mirrored the terms of the Senior ESOP Notes
(see Note 5). Concurrent with the issuance of the Mortgage Notes (see Note 5),
the First ESOP Loan was replaced by a loan agreement which provides for
mandatory principal payments in amounts that are substantially in conformance
with the remaining mandatory principal payments of the Senior ESOP Bank Debt as
if the issuance of the Mortgage Notes had not occurred (the "New ESOP Loan").
The interest rate on the New ESOP Loan is determined quarterly based on .85
times the sum of the London InterBank Offered Rates plus 2.5% (5.1% at September
30, 1993). The EPIC ESOP has pledged all of its shares of the Holdings Common
Stock as collateral for the ESOP-related borrowings. These shares are released
from the pledge as the loans are paid. The EPIC ESOP receives contributions from
EPIC to service and extinguish the loans.
The EPIC ESOP is an individual account, defined contribution plan. Nonunion
employee-owners who work a specified number of hours are eligible to participate
in the EPIC ESOP if they have attained age 21 and completed one year of service.
No employee-owner contributions are required or permitted to be made to the EPIC
ESOP. No rollover contributions are permitted to be made to the EPIC ESOP.
Allocations are made to participants' accounts in an amount which reflects each
participant's proportionate share of the contributions made by EPIC to the EPIC
ESOP, as determined on the basis of each participant's compensation.
Contributions made to the EPIC ESOP and the value of shares of common stock
allocated to the account of a participant as a result of such contributions are
intended to be treated as tax-deferred contributions. Such contributions, and
earnings thereon, generally are includable in a participant's compensation for
federal income tax purposes when distributed.
As of the plan year ended December 31, 1992, cumulative allocations of
10,650,517 shares of Holdings Common Stock at a market value of $8.00 per share
based on an independent valuation, or $85,204,136 in total have been made to
10,183 participants. Shares of Holdings Common Stock relating to the plan year
ending December 31, 1993 will be allocated during fiscal 1994.
Subject to limitations contained in the Internal Revenue Code of 1986, as
amended (the "Code"), Holdings is entitled to claim an income tax deduction for
contributions to the EPIC ESOP. Holdings has received a favorable determination
from the Internal Revenue Service that the EPIC ESOP is qualified as an
"employee stock ownership plan" within the meaning of Section 4975(e)(7) of the
Code. Contributions to the EPIC ESOP are used by the EPIC ESOP to pay interest
and principal on the loans owed to EPIC. These payments are used by EPIC to pay
interest and principal on the Class B-1 First Priority Mortgage Notes and the
Senior ESOP Notes.
EPIC recorded net ESOP expense, using the cash method, and corresponding
reductions in the EPIC ESOP notes receivable, of $20,715,000, $20,714,000, and
$23,076,000 for fiscal 1993, 1992 and 1991, respectively. Interest income
recognized on the EPIC ESOP notes receivable totaled $14,984,000, $16,885,000,
and $20,483,000 for fiscal 1993, 1992 and 1991, respectively, which in turn was
contributed to the EPIC ESOP to pay interest expense incurred on the
ESOP-related debt. Interest expense incurred on ESOP-related debt totaled
$20,856,000, $21,734,000, and $21,731,000, which included discount amortization
of $559,000, $551,000, and $511,000 for fiscal 1993, 1992 and 1991,
respectively.
F-17
<PAGE> 67
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
4. OPERATING LEASES
Holdings leases office space, office equipment and medical equipment.
Generally, real estate leases are for primary terms of from one to 12 years with
options to renew for additional periods, and equipment leases are for terms of
from one to seven years. Future minimum lease payments for all operating leases
having initial or remaining noncancellable lease terms in excess of one year as
of September 30, 1993 are as follows (dollars in thousands):
<TABLE>
<S> <C>
1994............................................................... $ 4,560
1995............................................................... 4,225
1996............................................................... 3,337
1997............................................................... 2,693
1998............................................................... 1,835
1999 and thereafter................................................ 3,485
-------
20,135
Sublease income.................................................... (1,116)
-------
$19,019
-------
-------
</TABLE>
Rent expense under operating leases was as follows (dollars in thousands):
<TABLE>
<CAPTION>
FOR THE YEAR ENDED
SEPTEMBER 30,
-------------------------------
1993 1992 1991
------- ------- -------
<S> <C> <C> <C>
Minimum rent.................................. $18,496 $16,107 $13,609
Sublease income............................... (795) (609) (317)
------- ------- -------
$17,701 $15,498 $13,292
------- ------- -------
------- ------- -------
</TABLE>
F-18
<PAGE> 68
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
Holdings' long-term debt, net of discounts, is summarized below (dollars in
thousands):
<TABLE>
<CAPTION>
SEPTEMBER 30,
-------------------
1993 1992
-------- --------
<S> <C> <C>
12% Senior Deferred Coupon Notes, principal of $250,000 due
2002........................................................... $167,197 $148,628
11.375% Class B-1 First Priority Mortgage Notes payable in
semi-annual payments of $9,000 commencing in July 1996 with a
final payment of $10,000 in July 2001.......................... 99,579 99,500
11.5% Class B-2 First Priority Mortgage Notes payable in
semi-annual payments of $500 through July 1994, increasing to
$750 in January 1995, to $1,500 in January 1997, to $8,000 in
January 1998, to $9,000 in January 1999, with a final payment
of $15,500 in July 2001........................................ 83,112 84,046
Class B-3 First Priority Mortgage Notes payable in semi-annual
payments of $750 commencing in January 1995, increasing to
$3,000 in January 1997 through July 1998, with a fluctuating
interest rate (6.5% at September 30, 1993)..................... 15,000 15,000
Other mortgage debt and capital lease obligations with varying
maturities and interest rates ranging from 4.75% to 12.9%...... 20,651 20,351
Acquisition loan payable in quarterly installments of $1,250
commencing in October 1993 with a fluctuating interest rate
(8.0% at September, 1993)...................................... 19,542 --
Zero Coupon Notes, principal of $89,313 due 2001 with an
effective interest rate of 14.8%............................... 28,564 24,770
Additional Zero Coupon Notes, principal of $7,079 due 2001 with
an effective interest rate of 14.8%............................ 2,265 1,964
11.875% Senior ESOP Notes payable in three equal annual payments
commencing in September 1996 with an effective interest
rate of 13.03%................................................. 72,141 76,840
10.875% Senior Subordinated Notes due 2003....................... 160,000 --
15% Senior Subordinated Notes payable in three equal annual
payments commencing in 1999.................................... 40,320 104,852
11% Junior Subordinated Pay-In-Kind Notes payable in three equal
annual payments commencing in September 2001................... 19,148 45,742
-------- --------
727,519 621,693
Current maturities............................................... (47,914) (2,330)
-------- --------
$679,605 $619,363
-------- --------
-------- --------
</TABLE>
The 12% Senior Deferred Coupon Notes are reflected at their fair value of
$140,053,000 at March 25, 1992, plus accretion of discount through September 30,
1993. Interest is payable semi-annually beginning March 16, 1997.
The Mortgage Notes are the indebtedness of EPIC Properties, Inc. ("EPIC
Properties"), an indirect wholly-owned subsidiary of EPIC. The Mortgage Notes
are secured by mortgages on 24 acute care hospital complexes ("the Mortgaged
Hospitals") and the land on which such buildings are located, and by a first
priority security interest in certain furnishings and equipment located at each
of the Mortgaged Hospitals. The Mortgage Notes are fully and unconditionally
guaranteed by EPIC (see Note 18).
The interest rate on the Class B-1 First Priority Mortgage Notes (the
"Class B-1 Notes") will increase to 11.5% after September 30, 1995. If the
Internal Revenue Service determines that interest on the Class B-1 Notes does
not qualify for a 50% exclusion from federal taxable income, the interest rate
on the Class B-1 Notes will increase to 11.5% for all periods through September
30, 1995 during which such interest exclusion is not available.
EPIC incurred losses on refinancing concurrent with the issuance of the
Mortgage Notes, due primarily to the write-off of loan issue costs. These
losses, totalling $3,911,000, are recorded as an extraordinary item (net of
income tax benefit of $1,330,000) in the consolidated statement of operations
for the fiscal year ended September 30, 1991.
F-19
<PAGE> 69
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
The Zero Coupon Notes are reflected at their fair value of $14,008,000, as
estimated by EPIC at September 30, 1988, plus accretion of discount through
September 30, 1993. No interest or principal is payable until maturity.
Additional Zero Coupon Notes were issued under an interest rate cap
agreement with AMI (see Note 13) and are reflected at their original fair value
plus accretion of discount through September 30, 1993. No interest or principal
is payable until maturity.
A subsidiary of EPIC purchased $5,400,000 and $19,850,000 face value of the
11.875% Senior ESOP Notes on the open market for $5,616,000 and $20,293,000 plus
accrued interest in fiscal 1993 and 1992, respectively (the "Senior ESOP Note
Purchases"). Losses of $570,000 and $1,917,000 due to the write-off of debt
issue costs and unamortized discounts and the payment of a premium on the Senior
ESOP Note Purchase are recorded as extraordinary items (net of income tax
benefit of $652,000 in 1992) in the consolidated statements of operations for
the fiscal years ended September 30, 1993 and 1992.
The 11.875% Senior ESOP Notes, which carry detached stock purchase warrants
(see Note 9), have a stated principal amount of $100,000,000 and are reflected
at their fair value of $93,988,000, as estimated by EPIC at September 30, 1988,
less the Senior ESOP Note Purchases, plus accretion of discount through
September 30, 1993.
On June 18, 1993, EPIC refinanced $74,680,000 in principal of the 15%
Senior Subordinated Notes and $53,697,000 in principal of the 11% Junior
Subordinated Pay-In-Kind Notes (the "Refinancing") through the issuance of the
10.875% Senior Subordinated Notes. The 10.875% Senior Subordinated Notes are
guaranteed by certain subsidiaries of EPIC (see Note 18).
Under the terms of the Second Amended and Restated Credit Agreement dated
as of September 30, 1988, and amended and restated as of July 30, 1991, and
September 1, 1993 (the "Amended Credit Agreement"), EPIC is required to call the
remaining $40,320,000 in principal of the 15% Senior Subordinated Notes by
February 28, 1994, with the remaining proceeds of the Refinancing. The remaining
principal of the 15% Senior Subordinated Notes at September 30, 1993, has been
recorded as current maturities of long term debt in the consolidated balance
sheets.
EPIC incurred a loss before taxes of $21,390,000 on the Refinancing, which
resulted from the write-off of loan issue costs and unamortized discount on the
15% Senior Subordinated Notes and the redeemed portion of the 11% Junior
Subordinated Pay-In-Kind Notes, payments to the holders of the 15% Senior
Subordinated Notes and the 11.875% Senior ESOP Notes for waivers of certain
provisions of the respective indentures and the accrual of the call premium to
be paid on redeeming the remaining principal on the 15% Senior Subordinated
Notes. These losses are recorded as an extraordinary item in the consolidated
statements of operations.
The 15% Senior Subordinated Notes are guaranteed by certain wholly-owned
subsidiaries of EPIC (see Note 18) and are secured by a fourth pledge of the
common stock of such subsidiaries.
Interest on the 11% Junior Subordinated Pay-in-Kind Notes is payable
semiannually by the issuance of additional 11% Junior Subordinated Pay-in-Kind
Notes through September 30, 1995, and thereafter, if Holdings is prohibited from
making cash interest payments by the terms of any senior debt existing on
September 30, 1988 less the amount retired in the Refinancing. The notes, which
have a stated principal amount of $50,000,000, have been recorded at their fair
value estimated by EPIC at September 30, 1988, of $22,900,000 plus accretion of
discount through September 30, 1993, less the amount retired as a result of the
Refinancing. The effective interest rate for these notes is 18.07%.
The Amended Credit Agreement provides EPIC with revolving loan commitments
and an acquisition loan to be used for working capital and acquisition funds for
EPIC. As of September 30, 1993, revolving loan commitments aggregated $30
million. Any revolving loan commitments outstanding are due July 31, 1997.
F-20
<PAGE> 70
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
Interest is generally payable monthly at the following rates per annum, at
EPIC's option: (i) 1.5% in excess of the higher of the prime rate in effect from
time to time or the annual yield on ninety-day commercial paper or (ii) 2.5% in
excess of the LIBOR rate. There were no revolving loans outstanding as of
September 30, 1993, and 1992, respectively. The acquisition term loan principal
amount outstanding is payable in quarterly installments commencing on October
31, 1993 through July 31, 1997. Interest is generally payable quarterly at the
following rates per annum, at EPIC's option: (i) 2.0% in excess of the higher of
the prime rate in effect from time to time or the annual yield on ninety-day
commercial paper or (ii) 3.0% in excess of the LIBOR rate.
In connection with the issuance of the Mortgage Notes, EPIC Properties
obtained a revolving line of credit. The line of credit can only be used for the
purpose of paying interest or principal on the Mortgage Notes. The maximum loan
amount available is the lesser of $22 million or the annual interest accrual of
the Mortgage Notes. The line of credit would bear an interest rate of the Prime
Lending Rate of AmSouth Bank plus 2%. There were no loans outstanding under the
line of credit as of September 30, 1993 and 1992, respectively.
The Amended Credit Agreement and other long-term debt agreements contain a
number of restrictive covenants, including restrictions on incurrence of debt,
sales of assets, payment of cash dividends, requirements to maintain certain
financial ratios and a specified level of net worth, as defined, and other
limitations, including limitations on the use of funds from the sale of certain
assets.
As of September 30, 1993, the maturities of long-term debt were as follows
(dollars in thousands):
<TABLE>
<S> <C>
1994.............................................................. $ 47,914
1995.............................................................. 9,498
1996.............................................................. 43,545
1997.............................................................. 58,546
1998.............................................................. 67,207
1999 and thereafter............................................... 671,160
---------
897,870
Unamortized discounts and unaccreted interest..................... (170,351)
---------
$ 727,519
---------
---------
</TABLE>
6. INCOME TAXES
The income tax benefit for fiscal 1992 and 1991 was comprised of deferred
federal benefits of $11,800,000 and $9,996,000 respectively, arising from
reported financial losses and state income tax expense of $1,984,000 and
$888,000 in fiscal 1993 and 1992, respectively. For financial reporting
purposes, Holdings has utilized all of its deferred federal tax liability and
has not recognized a benefit for the current net operating loss pursuant to the
provisions of SFAS No. 96. Taxes paid during 1993 and 1992 primarily relate to
state income taxes and estimated federal tax payments.
F-21
<PAGE> 71
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
Holdings' consolidated effective federal tax rate differed from the federal
statutory rate as set forth in the following table:
<TABLE>
<CAPTION>
FOR THE YEAR ENDED
SEPTEMBER 30,
--------------------------------
1993 1992 1991
-------- ------- -------
<S> <C> <C> <C>
Tax benefit computed at federal statutory rate
(34%)............................................... $ 16,022 $12,547 $10,732
Amortization of excess purchase price over net assets
acquired............................................ (790) (614) (601)
Losses not subject to benefit......................... (15,089) -- --
Other, net............................................ (143) (133) (135)
-------- ------- -------
Income tax benefit.................................... $ -- $11,800 $ 9,996
-------- ------- -------
-------- ------- -------
</TABLE>
The deferred income tax benefit results from the following temporary
differences in reporting for financial and income tax purposes:
<TABLE>
<CAPTION>
FOR THE YEAR ENDED
SEPTEMBER 30,
-------------------------------
1993 1992 1991
------- ------- -------
(IN THOUSANDS)
<S> <C> <C> <C>
Book/tax difference on sale of assets................. $ 3,835 $ -- $ --
Book/tax depreciation differences..................... 475 221 (3,392)
Net operating loss recognized currently for financial
reporting........................................... 2,976 1,412 6,134
SAR compensation not currently deductible............. 968 3,673 2,426
Professional liability reserves not currently
deductible.......................................... 383 1,013 4,345
Other reserves for estimated losses and contingencies
not currently deductible............................ 1,348 2,217 508
Paid time off accrued for financial reporting, not
currently deductible................................ 339 719 89
Difference arising from ESOP loan fees initially
expensed for tax purposes but capitalized and
amortized for financial reporting purposes.......... 197 427 (480)
Difference in methods used to reserve for bad debts... 802 1,014 55
Difference in ESOP contribution deduction............. (162) 207 (1,317)
Difference in methods for reporting interest.......... 1,553 562 694
Losses not subject to benefit......................... (15,089) -- --
Other................................................. 2,375 335 934
------- ------- -------
Deferred income tax benefit........................... $ -- $11,800 $ 9,996
------- ------- -------
------- ------- -------
</TABLE>
Net operating loss carryforwards of approximately $72,106,000 (expiring in
the years 2004, 2005, 2006, 2007 and 2008) are available to offset future income
for federal and state tax purposes. The utilization of these net operating loss
carryforwards is dependent upon future taxable income. Net operating loss
carryforwards of $47,123,000 are available for financial reporting purposes.
7. DEFERRED COMPENSATION
Holdings has adopted a deferred compensation plan (the "SAR Plan") as part
of its overall executive compensation program to attract, motivate and retain
key employee-owners. As of September 30, 1993, 5,873,582 SAR Plan units, each
exchangeable for one share of Holdings Common Stock or redeemable for cash or
other property under certain circumstances, were held by certain key
employee-owners and former employee-owners. During fiscal 1993, 1992 and 1991,
309,500, 1,481,065 and 1,002,000 SAR Plan units were granted and 427,800,
218,000, and 243,000 SAR Plan units were cancelled, respectively. The
outstanding SAR Plan units vest in varying amounts at varying periods not
exceeding five years beginning on each respective grant date. A maximum of
6,587,565 SAR Plan units, reduced by all units redeemed may be
F-22
<PAGE> 72
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
outstanding at any time. During fiscal 1993, 1992, and 1991, Holdings accrued
SAR Plan compensation expense of $3,848,000, $11,805,000, and $8,135,000,
respectively.
During fiscal 1993, 123,417 SAR Plan units were redeemed for $974,994 in
cash ($7.90 per unit) and 3,125 units were redeemed for $25,000 in cash ($8.00
per unit); in October 1993, 121,874 SAR Plan units were redeemed for $974,996 in
cash ($8.00 per unit).
During fiscal 1992, 129,998 SAR Plan units were redeemed for $974,985 in
cash ($7.50 per unit) and 3,164 SAR Plan units were redeemed for $24,996 in cash
($7.90 per unit).
8. REDEEMABLE PREFERRED STOCK
Pursuant to the Merger, the EPIC Class A and Class B Preferred Stock was
converted to Holdings Preferred Stock and the EPIC Class C Preferred Stock was
converted to Holdings Common Stock. The EPIC Class A and Class B Preferred
Stock, which had a book value of $66,360,000 and $66,776,000, respectively, was
repurchased from AMI for $130,000,000. The EPIC Class C Preferred Stock, which
had a book value of $63,935,000 was converted into 9,423,075 shares of Holdings
Common Stock.
At September 30, 1988, redeemable preferred stock of EPIC was recorded at
fair value estimated by EPIC, based on an independent valuation. The recorded
amounts were less than the mandatory redemption amounts for the EPIC Class A and
Class B Preferred Stock and were increased by the recording of dividends at the
stated rate and by accretion of the discount, and reduced by the discount
recorded on declared and accrued dividends, so that the carrying amounts would
equal the mandatory redemption amounts at the mandatory redemption dates.
Dividends on the EPIC Class A and Class B Preferred Stock were cumulative
and payable quarterly at annual rates of $10.00 and $10.50 per share,
respectively, out of funds legally available. EPIC declared and paid such
dividends in like stock three quarters in arrears, however, such dividends were
accrued quarterly. For the dividend periods after September 30, 1988, to
conversion, dividends were paid in additional shares of the same class of stock
at the rate of 0.025 and 0.02625, respectively, of a share of stock. During
fiscal 1992, EPIC declared dividends of 26,144 shares of EPIC Class A Preferred
Stock and 28,182 shares of EPIC Class B Preferred Stock.
Holders of shares of EPIC Class C Preferred Stock were entitled to receive
cumulative dividends out of funds legally available at the annual rate of $8.00
per share. No dividends were declared on the EPIC Class C Preferred Stock;
however, EPIC had recorded accruals of $1,935,000 during fiscal year 1992 and
$4,000,000 during fiscal year 1991 for undeclared dividends.
9. COMMON STOCK WARRANTS AND OPTIONS
The Senior ESOP Notes and 15% Senior Subordinated Notes carried detachable
stock purchase warrants to purchase 1,884,615 and 3,795,000 shares of EPIC
Common Stock for $.01 and $.001 per share, subject to anti-dilution adjustments.
The aggregate fair values of these warrants estimated by EPIC, based on an
independent valuation, at date of issuance were $6,012,000 and $12,103,000,
respectively. In addition, EPIC agreed to issue to AMI certain warrants to
purchase 925,129 shares of EPIC Common Stock at an exercise price of $.001 per
share. Immediately prior to the Merger, 6,306,395 of the warrants outstanding
were exercised for 63,064 shares of EPIC Common Stock. In conjunction with the
Merger, all of the remaining warrants outstanding became warrants to acquire the
same number of shares of Holdings Common Stock. During fiscal 1992, after the
Merger, 152,692 of the warrants outstanding were exercised for Holdings Common
Stock. During fiscal 1993, 3,300 of the warrants outstanding were exercised.
Warrants to purchase 142,357 shares of Holdings Common Stock were outstanding at
September 30, 1993.
F-23
<PAGE> 73
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
On December 14, 1988, EPIC adopted the EPIC Healthcare Group, Inc. Stock
Option Plan (the "Stock Option Plan"). Under the Stock Option Plan, the Board of
Directors is authorized to grant options to EPIC directors, officers and
salaried employee-owners to purchase up to 500,000 shares of Holdings Common
Stock. Options granted vest in five equal annual installments. No options were
granted during fiscal 1993, 1992 or 1991. At September 30, 1993, options for
32,000 shares were exercisable.
10. COMMON STOCK
Prior to the Merger, warrants were exercised for 63,064 shares of EPIC
Common Stock and 1,452 shares were repurchased by EPIC from participants of the
EPIC ESOP. Pursuant to the Merger, 30,739,378 shares of EPIC Common Stock were
converted to Holdings Common Stock and the EPIC Class C Preferred Stock was
converted to 9,423,075 shares of Holdings Common Stock. Since the Merger,
warrants have been exercised for 155,992 shares of Holdings Common Stock.
Additionally, 219,004 shares have been distributed to participants of the EPIC
ESOP, which were repurchased by Holdings.
Holdings has reserved 142,357 shares of Holdings Common Stock for issuance
upon the exercise of outstanding warrants to purchase Holdings Common Stock and
5,902,116 shares have been reserved for future issuance under the SAR Plan.
11. LOSS PER COMMON SHARE
Loss per common share has been computed by dividing the net loss to common
stockholders by the average number of common shares outstanding during the
period. The exercise of the outstanding common stock warrants and other common
stock equivalents has not been assumed as the effect would be antidilutive.
Assuming conversion of the EPIC redeemable preferred stock as of October 1,
1991, the net loss per common share of Holdings would have been $32,645,000 as a
result of the elimination of the redeemable preferred stock dividend of
$11,048,000 and additional interest expense of $8,806,000 on the Holdings Notes
(from the period from October 1, 1991, to March 24, 1992). The weighted average
number of common shares outstanding would have been 40,183,036 shares. As a
result, the net loss per common share in fiscal 1992 would have been $0.84.
12. PROFESSIONAL AND GENERAL LIABILITY RISKS
Holdings is self-insured for its professional and general liability risks.
As of September 30, 1993, the unfunded reserve for this self insurance was
$45,130,000 of which $11,000,000 was included in current liabilities. EPIC has
funded $12,482,000 of the reserves through a wholly-owned captive insurance
company at September 30, 1993. The reserves for losses and related expenses are
discounted to their present value based on expected loss reporting patterns
determined by independent actuaries using a rate of 9%. AMI has retained the
liability for all professional liability claims with a date of occurrence prior
to October 1, 1988.
13. RELATED PARTY TRANSACTIONS
EPIC and AMI entered into an interest rate cap agreement (the "Senior
Interest Cap Agreement") whereby AMI agreed to pay to EPIC the amounts by which
EPIC's interest costs under certain tranches of indebtedness exceeded, during
each of the three fiscal years after September 30, 1988, certain specified
rates, net of the effect of any reimbursement to EPIC by Medicare, Medicaid, or
Blue Cross for any interest expense incurred by EPIC in excess of such rates in
connection with such loans.
On August 28, 1991, EPIC and AMI agreed that it was mutually in their best
interest to terminate the Senior Interest Cap Agreement prior to its scheduled
expiration of October 1, 1991. EPIC and AMI further agreed that each party had
fully performed all of its obligations under the Senior Interest Cap Agreement
and each party released the other from future obligations thereunder.
F-24
<PAGE> 74
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
Pursuant to the terms of the Senior Interest Cap Agreement, EPIC issued
Additional Zero Coupon Notes to AMI in the principal amounts of $1,612,000 and
$2,844,000 during fiscal 1990 and 1989, respectively, in exchange for cash of a
like amount paid to EPIC by AMI during such years. In fiscal 1991, EPIC paid to
AMI $2,864,000 and issued Additional Zero Coupon Notes to AMI with a present
value of $626,000 in exchange for the cancellation of the zero coupon notes
issued in 1989. AMI has sold their interest in the Additional Zero Coupon Notes.
Net interest expense of $839,000 was recognized during fiscal 1991 relating to
this agreement.
EPIC and AMI have entered into certain other agreements, including a
registration rights agreement pursuant to which EPIC has agreed to register the
securities issued to AMI under the Securities Act of 1933. AMI has also agreed
to indemnify EPIC against certain liabilities associated with the breach of
representations and warrants made by AMI, certain tax liabilities that may
arise, certain reimbursements still pending related to the Acquisitions and
certain fees, costs, and expenses.
During fiscal 1993, AMI reimbursed $1,621,000 relating to AMI's
indemnifications of EPIC for certain intermediary adjustments to reimburse costs
relating to cost report years that preceded the formation of EPIC.
EPIC entered into a three year group purchasing agreement, effective
September 1, 1993, with a subsidiary of AMI, which allows the Company to
purchase supplies at lower group rates. The Company expects to purchase more
than $30,000,000 per year of supplies under terms of the agreement. The Company
will pay $180,000 per year to participate in this program.
David R. Belle-Isle, a former officer of EPIC, borrowed $181,000 from EPIC
in December 1988 in connection with his relocation to Texas. The loan was
interest free until it was restructured in October 1990. Effective as of the
30th day of September 1991, this debt, totalling $160,000, was forgiven. The
Company reimbursed Mr. Belle-Isle for the tax liability associated with the
forgiveness of the loan.
EPIC has a consulting agreement with The Elder Group, of which Thomas H.
Elder, who formerly served as EPIC's Management Services Officer, is the
Managing Principal. EPIC paid The Elder Group approximately $1,300,000 and
$1,000,000 in fiscal 1992 and 1991, respectively.
EPIC has an investment in the preferred stock of the Compucare Company
("Compucare"), who is developing and installing one of EPIC's new information
systems. The chief executive officer of EPIC is on the board of directors of
Compucare. Payments to Compucare for fiscal 1993 totalled $5,651,000.
14. FAIR VALUES OF FINANCIAL INSTRUMENTS
SFAS No. 107 "Disclosures about Fair Value of Financial Instruments",
requires disclosure of fair value information about financial instruments,
whether or not recognized in the balance sheet, for which it is practicable to
estimate that value. In cases where quoted market prices are not available, fair
values are based on estimates using present value or other valuation techniques.
Those techniques are significantly affected by the assumptions used, including
the discount rate and estimates of future cash flows. In that regard, the
derived fair value estimates cannot be substantiated by comparison to
independent markets and, in any cases, could not be realized in immediate
settlement of the instrument. SFAS No. 107 excluded certain financial
instruments and all nonfinancial instruments from its disclosure requirements.
Accordingly, the aggregate fair value amounts presented do not represent the
underlying value of Holdings. The following methods and assumptions were used by
Holdings in estimating its fair value disclosures for financial instruments.
Cash Equivalents, Cash Restricted for Interest Payments, and Marketable
Securities
The carrying amounts reported in the consolidated balance sheets for cash
equivalents, cash restricted for interest payments, and marketable interest
bearing securities approximates their fair values.
F-25
<PAGE> 75
EPIC HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
Long-Term Debt (Including Current Maturities)
The fair values of Holdings' long-term debt, except the Class B-1 and Class
B-2 First Priority Mortgage Notes, are estimated using quoted market prices or
the call price. The fair value of the Class B-1 and Class B-2 First Priority
Mortgage Notes are estimated using discounted cash flow analysis based on
Holdings' incremental borrowing rate for similar types of borrowing
arrangements.
The carrying amounts and estimated fair values of Holdings' financial
instruments at September 30, 1993 are as follows (in thousands):
<TABLE>
<CAPTION>
CARRYING FAIR
AMOUNT VALUE
-------- --------
<S> <C> <C>
Cash equivalents, cash restricted for interest payments, and
marketable securities.......................................... $112,529 $112,529
Long-term debt................................................... $727,519 $772,006
</TABLE>
15. EXTRAORDINARY ITEMS
Extraordinary items of $21,960,000 in 1993, $1,265,000 ($1,917,000, net of
income tax benefit of $652,000) in 1992 and $2,581,000 ($3,911,000, net of
income tax benefit of $1,330,000) in 1991 were primarily due to the write-offs
of loan issue costs and unamortized discounts on retirements of long-term debt
(see Note 5).
16. SUPPLEMENTARY INCOME STATEMENT INFORMATION
Maintenance and repair expense was $17,101,000, $17,564,000, and
$16,159,000 for fiscal 1993, 1992, and 1991, respectively.
17. CONTINGENCIES
Final determination of amounts earned under prospective payment and
cost-reimbursement programs is subject to review by appropriate governmental
authorities or their agents. In the opinion of management, adequate provision
has been made for any adjustments that could result from such reviews.
Holdings is currently, and from time to time is expected to be, subject to
claims and suits arising in the ordinary course of business. In the opinion of
management, the ultimate resolution of such matters will not have a material
effect on Holding's results of operations, financial position, or liquidity.
Pursuant to the terms of the Acquisitions, claims relating to litigation,
medical benefits, and workers' compensation occurring prior to October 1, 1988,
remain the obligation of AMI.
18. GUARANTOR SUBSIDIARIES
Certain subsidiaries of EPIC (the "Guarantor Subsidiaries") guarantee the
loans under the Bank Credit Agreement, AMI Zero Coupon Notes, Additional AMI
Zero Coupon Notes, 11.875% Senior ESOP Notes, 10.875% Senior Subordinated Notes,
15% Senior Subordinated Notes and 11% Junior Subordinated Pay-In-Kind Notes.
Certain other subsidiaries, including EPIC Properties, are not Guarantor
Subsidiaries (the Nonguarantor Subsidiaries) (see Note 5). All equity interests
in the Nonguarantor Subsidiaries, other than those held by minority interests,
are held by EPIC.
Condensed consolidating financial information of EPIC, the Guarantor
Subsidiaries, EPIC Properties and the other Nonguarantor Subsidiaries are
included in the footnotes to the consolidated financial statements of EPIC
included elsewhere herein.
F-26
<PAGE> 76
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(DOLLARS IN THOUSANDS)
ASSETS
<TABLE>
<CAPTION>
DECEMBER 31, SEPTEMBER 30,
1993 1993
------------ -------------
(UNAUDITED)
<S> <C> <C>
CURRENT ASSETS
Cash and cash equivalents......................................... $ 40,940 $ 56,756
Cash restricted for interest payment.............................. 9,573 3,820
Marketable securities............................................. 34,132 47,347
Accounts receivable, net of reserves for uncompensated care of
$31,187 and $29,286............................................ 99,392 76,957
Supply inventories................................................ 20,973 20,687
Prepaid expenses and other........................................ 12,398 4,574
Deferred income taxes............................................. 5,384 --
TOTAL CURRENT ASSETS................................................ 222,792 210,141
PROPERTY AND EQUIPMENT.............................................. 810,055 786,798
ACCUMULATED DEPRECIATION AND AMORTIZATION........................... (231,239) (218,746)
------------ -------------
578,816 568,052
EXCESS OF PURCHASE PRICE OVER NET ASSETS ACQUIRED, net of
accumulated amortization.......................................... 52,461 52,965
OTHER ASSETS, net of accumulated amortization....................... 34,551 33,818
------------ -------------
TOTAL ASSETS........................................................ $ 888,620 $ 864,976
------------ -------------
------------ -------------
</TABLE>
LIABILITIES AND STOCKHOLDER'S EQUITY
<TABLE>
<S> <C> <C>
CURRENT LIABILITIES
Current maturities of long-term debt.............................. $ 48,049 $ 47,914
Accounts payable.................................................. 45,551 44,610
Accrued liabilities............................................... 96,636 87,531
------------ -------------
TOTAL CURRENT LIABILITIES........................................... 190,236 180,055
LONG-TERM DEBT...................................................... 512,999 512,408
DEFERRED INCOME TAXES............................................... 11,378 5,994
RESERVE FOR PROFESSIONAL LIABILITY RISKS............................ 46,557 46,612
OTHER DEFERRED LIABILITIES.......................................... 42,013 42,450
COMMITMENTS AND CONTINGENT LIABILITIES..............................
MINORITY INTERESTS.................................................. 5,909 5,472
STOCKHOLDER'S EQUITY
Common stock, $.01 par value...................................... -- --
Paid-in capital................................................... 373,719 373,838
Notes receivable from EPIC ESOP................................... (137,381) (148,214)
Retained earnings (deficit)....................................... (156,810) (153,639)
------------ -------------
TOTAL STOCKHOLDER'S EQUITY.......................................... 79,528 71,985
------------ -------------
TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY.......................... $ 888,620 $ 864,976
------------ -------------
------------ -------------
</TABLE>
See notes to condensed consolidated financial statements.
F-27
<PAGE> 77
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
FOR THE THREE MONTHS
ENDED DECEMBER 31,
-----------------------
1993 1992
-------- --------
<S> <C> <C>
NET OPERATING REVENUE................................................ $272,451 $244,352
COSTS AND EXPENSES:
Salaries and wages................................................. 99,526 84,634
Employee benefits.................................................. 21,094 22,997
ESOP expense....................................................... 5,635 5,182
Supplies........................................................... 32,025 30,041
Uncompensated care................................................. 19,618 19,048
Other.............................................................. 64,613 57,871
Depreciation and amortization...................................... 13,130 13,791
Interest expense................................................... 18,745 17,426
-------- --------
TOTAL COSTS AND EXPENSES............................................. 274,386 250,990
INTEREST INCOME...................................................... 806 636
-------- --------
LOSS BEFORE INCOME TAX BENEFIT (EXPENSE), MINORITY INTERESTS AND
EXTRAORDINARY ITEM................................................. (1,129) (6,002)
INCOME TAX BENEFIT (EXPENSE)......................................... (375) 431
MINORITY INTERESTS IN INCOME OF CONSOLIDATED SUBSIDIARIES, net of
income tax benefit (expense)....................................... (1,667) (556)
-------- --------
LOSS BEFORE EXTRAORDINARY ITEM....................................... (3,171) (6,127)
EXTRAORDINARY ITEM, net of income tax benefit........................ -- (503)
-------- --------
NET LOSS............................................................. $ (3,171) $ (6,630)
-------- --------
-------- --------
</TABLE>
See notes to condensed consolidated financial statements.
F-28
<PAGE> 78
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
FOR THE THREE MONTHS
ENDED
DECEMBER 31,
-----------------------
1993 1992
-------- --------
<S> <C> <C>
OPERATING ACTIVITIES
Net loss........................................................... $ (3,171) $ (6,630)
Adjustments to reconcile net loss to net cash provided by operating
activities:
Depreciation and amortization................................... 13,130 13,791
Non-cash provision for professional liability risks............. (1,111) 437
ESOP expense.................................................... 5,635 5,182
Deferred SAR Plan compensation.................................. (274) (1,496)
Minority interests in income of consolidated subsidiaries....... 1,667 631
Non-cash interest............................................... 3,906 4,698
Deferred income tax benefit..................................... -- (749)
Extraordinary item.............................................. -- 570
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable............................................. (22,435) 342
Supply inventories and other assets............................. (8,390) (10,549)
Accounts payable and other liabilities.......................... 9,938 8,747
-------- --------
Net cash provided by (used in) operating activities........ (1,105) 14,974
INVESTING ACTIVITIES
Investments in marketable securities, net.......................... 13,215 6,395
Cash paid for acquisitions......................................... (960) (4,100)
Additions to property and equipment................................ (23,431) (7,410)
Other.............................................................. (661) (811)
-------- --------
Net cash used in investing activities...................... (11,837) (5,926)
FINANCING ACTIVITIES
Payments on debt obligations....................................... (1,415) (76)
Line of credit borrowings, net..................................... -- 800
Purchase of Senior ESOP Notes...................................... -- (5,616)
Dividends paid to EPIC Holdings.................................... (119) (11)
Distributions and dividends to minority interests.................. (1,132) (2,340)
Payments of debt issue costs and other, net........................ (208) (59)
-------- --------
Net cash used in financing activities...................... (2,874) (7,302)
-------- --------
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS..................... (15,816) 1,746
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD..................... 56,756 32,641
-------- --------
CASH AND CASH EQUIVALENTS AT END OF PERIOD........................... $ 40,940 $ 34,387
-------- --------
-------- --------
SUPPLEMENTARY INFORMATION
Cash paid for interest............................................. $ 8,513 $ 1,598
Cash paid for income taxes......................................... $ 199 $ 176
</TABLE>
See notes to condensed consolidated financial statements.
F-29
<PAGE> 79
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1) BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements of
EPIC Healthcare Group, Inc. and Subsidiaries (the "Company" or "EPIC"), a
wholly-owned subsidiary of EPIC Holdings, Inc. ("Holdings"), have been prepared
in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10-Q and Article 10 of
Regulation S-X. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements. In the opinion of management, all adjustments considered
necessary for a fair presentation have been included and are of a normal
recurring nature. Operating results for the three month period ended December
31, 1993 are not necessarily indicative of the results that may be expected for
the fiscal year ending September 30, 1994. These financial statements should be
read in conjunction with the audited consolidated financial statements and
footnotes thereto included in the Company's annual report on Form 10-K for the
year ended September 30, 1993.
Certain prior period amounts have been reclassified to conform with the
fiscal 1994 presentation.
2) SUBSEQUENT EVENT
On January 9, 1994, Holdings entered into an Agreement and Plan of Merger
(the "Merger Agreement") with HealthTrust, Inc. -- The Hospital Company, a
Delaware corporation ("HTI"), and Odyssey Acquisition Corp., a Delaware
corporation and wholly-owned subsidiary of HTI ("HTI Sub"), providing for the
merger (the "Merger") of HTI Sub with and into Holdings following which Holdings
would become a wholly-owned subsidiary of HTI. The Merger is expected to result
in a termination of the EPIC ESOP. Under the terms of the Merger Agreement,
which was unanimously approved by the Boards of Directors of both HTI and
Holdings, shareholders of Holdings will receive $7.00 per share of Holdings'
common stock.
HTI intends to offer to purchase Holdings' 12% Senior Deferred Coupon Notes
due 2002, and EPIC's 11.375% Class B-1 First Priority Mortgage Notes due 2001,
11.5% Class B-2 First Priority Mortgage Notes due 2001, Class B-3 First Priority
Mortgage Notes, and 10.875% Senior Subordinated Notes due 2003 and to redeem
other outstanding EPIC indebtedness in accordance with their terms. HTI also
plans to seek the consent of the holders of Holdings' and EPIC's indebtedness to
amend certain restrictive provisions.
Consummation of the Merger is subject to a number of conditions, including
the approval of Holdings' shareholders and the consummation of certain debt
consent solicitations. American Medical International, Inc. and the trustee of
the EPIC ESOP (who controls the unallocated shares of the EPIC ESOP) have
agreed, subject to the fulfillment of certain conditions, to vote their shares
of Holdings common stock (approximately 52% combined) in favor of the Merger.
The transaction is expected to close by May of 1994.
3) INCOME TAXES
Effective October 1, 1993, the Company changed its method of accounting for
income taxes to the liability method as required by Statement of Financial
Accounting Standards ("SFAS") No. 109, "Accounting for Income Taxes", which
superseded SFAS No. 96. As permitted under the rules of SFAS No. 109, prior
years' financial statements have not been restated.
Adoption of SFAS No. 109 had no effect on current period operations. Due to
the uncertainty of the realization of the net deferred federal tax liability,
the Company established a valuation allowance against the deferred federal tax
assets so that deferred federal tax assets equalled deferred federal tax
liabilities. The net deferred tax liability reported relates primarily to state
taxes.
F-30
<PAGE> 80
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(UNAUDITED)
Deferred income taxes reflect the net tax effects of temporary differences
between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes. Significant components of
the Company's deferred tax assets and liabilities as of October 1, 1993 are as
follows (in thousands):
<TABLE>
<S> <C>
DEFERRED TAX LIABILITIES
Property and equipment basis difference....................... $ 42,908
Loan fees.................................................... 1,547
ESOP contribution............................................ 3,455
State taxes and other........................................ 5,994
--------
Total deferred tax liabilities............................... 53,904
--------
DEFERRED TAX ASSETS
Bad debt reserve differences.................................. 6,593
Professional liability reserves.............................. 15,670
SAR compensation............................................. 14,034
Health plan and workers' compensation reserve................ 3,652
Paid time off reserve........................................ 1,788
Net operating losses......................................... 24,312
Other........................................................ 700
--------
Total deferred tax assets.................................... 66,749
Valuation allowance.......................................... (18,839)
--------
--------
Net deferred tax assets...................................... 47,910
--------
Net deferred tax liability................................... $ 5,994
--------
</TABLE>
No tax benefit was recorded for the current net operating loss and no
federal taxes are anticipated for fiscal 1994. Current income tax expense of
$375,000 relates to state income taxes.
4) CHANGES IN STOCKHOLDER'S EQUITY
During the three-month period ended December 31, 1993, the Company paid
dividends of $119,000 to Holdings, which were recorded as a reduction in paid-in
capital, and received a principal payment on the Notes receivable from the EPIC
ESOP of $10,833,000, which was recorded as a reduction of the Notes receivable
from EPIC ESOP.
5) GUARANTOR SUBSIDIARIES
Certain subsidiaries of EPIC (the "Guarantor Subsidiaries") guarantee the
loans under the Amended Credit Agreement, the Zero Coupon Notes, the Additional
Zero Coupon Notes, the 11.875% Senior ESOP Notes, the 10.875% Senior
Subordinated Notes, the 15% Senior Subordinated Notes and the 11% Junior
Subordinated Pay-In-Kind Notes. Certain other subsidiaries, including EPIC
Properties, Inc. ("EPIC Properties") are not Guarantor Subsidiaries (the
"Nonguarantor Subsidiaries"). All equity interests in the Nonguarantor
Subsidiaries, other than those held by minority interests, are held by EPIC.
F-31
<PAGE> 81
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(UNAUDITED)
Following is condensed consolidating financial information of EPIC, the
Guarantor Subsidiaries, EPIC Properties and the other Nonguarantor Subsidiaries:
CONDENSED CONSOLIDATING BALANCE SHEETS
DECEMBER 31, 1993
(DOLLARS IN THOUSANDS)
ASSETS
<TABLE>
<CAPTION>
EPIC
HEALTHCARE
EPIC OTHER GROUP, INC.
HEALTHCARE GUARANTOR EPIC NONGUARANTOR AND
GROUP, INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
----------- ------------ ----------- ------------ ------------ -------------
<S> <C> <C> <C> <C> <C> <C>
CURRENT ASSETS
Cash and cash equivalents.............. $ 4,948 $ 29,826 $ 1,918 $ 4,248 $ -- $ 40,940
Cash restricted for interest payment... -- -- 9,573 -- -- 9,573
Marketable securities.................. -- 22,672 -- 11,460 -- 34,132
Accounts receivable, net............... 558 72,307 470 31,320 (5,263) 99,392
Supply inventories..................... -- 16,820 -- 4,153 -- 20,973
Prepaid expenses and other............. 5,931 5,044 237 1,186 -- 12,398
Deferred income taxes.................. 5,384 -- -- -- -- 5,384
Receivables from affiliates............ 160,997 34,140 -- 5,930 (201,067) --
----------- ------------ ----------- ------------ ------------ -------------
TOTAL CURRENT ASSETS............. 177,818 180,809 12,198 58,297 (206,330) 222,792
PROPERTY AND EQUIPMENT................... -- 283,970 444,673 81,412 -- 810,055
ACCUMULATED DEPRECIATION AND
AMORTIZATION........................... -- (55,974) (146,387) (28,878) -- (231,239)
----------- ------------ ----------- ------------ ------------ -------------
-- 227,996 298,286 52,534 -- 578,816
INVESTMENTS IN SUBSIDIARIES.............. 64,684 89,641 -- -- (154,325) --
EXCESS OF PURCHASE PRICE OVER NET ASSETS
ACQUIRED, net.......................... -- 38,107 -- 14,354 -- 52,461
OTHER ASSETS, net........................ 11,844 89,786 895 3,427 (71,401) 34,551
RECEIVABLES FROM AFFILIATES.............. 297,673 4,117 -- -- (301,790) --
----------- ------------ ----------- ------------ ------------ -------------
TOTAL ASSETS..................... $ 552,019 $630,456 $ 311,379 $128,612 $ (733,846) $ 888,620
----------- ------------ ----------- ------------ ------------ -------------
----------- ------------ ----------- ------------ ------------ -------------
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Current maturities of long-term debt... $ 45,332 $ 686 $ 1,020 $ 1,011 $ -- $ 48,049
Accounts payable....................... 235 41,308 (71) 6,301 (2,222) 45,551
Accrued liabilities.................... 9,602 69,137 12,417 8,521 (3,041) 96,636
Payables to affiliates................. -- 166,927 -- 34,140 (201,067) --
----------- ------------ ----------- ------------ ------------ -------------
TOTAL CURRENT LIABILITIES........ 55,169 278,058 13,366 49,973 (206,330) 190,236
LONG-TERM DEBT........................... 322,906 8,879 241,964 10,651 (71,401) 512,999
DEFERRED INCOME TAXES.................... 11,378 -- -- -- -- 11,378
RESERVE FOR PROFESSIONAL LIABILITY
RISKS.................................. -- 32,011 -- 13,054 1,492 46,557
OTHER DEFERRED LIABILITIES............... -- 40,786 -- 1,227 -- 42,013
MINORITY INTERESTS....................... -- 5,226 -- 683 -- 5,909
PAYABLES TO AFFILIATES................... 1,363 297,673 564 1,330 (300,930) --
STOCKHOLDERS' EQUITY
Common stock......................... -- -- 1 -- (1) --
Paid-in capital...................... 373,719 61,855 92,865 5,434 (160,154) 373,719
Notes receivable from EPIC ESOP...... (100,000) -- (37,381) -- -- (137,381)
Retained earnings (deficit).......... (112,516) (94,032) -- 46,260 3,478 (156,810)
----------- ------------ ----------- ------------ ------------ -------------
TOTAL STOCKHOLDERS' EQUITY
(DEFICIT)...................... 161,203 (32,177) 55,485 51,694 (156,677) 79,528
----------- ------------ ----------- ------------ ------------ -------------
TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY
(DEFICIT)...................... $ 552,019 $630,456 $ 311,379 $128,612 $ (733,846) $ 888,620
----------- ------------ ----------- ------------ ------------ -------------
----------- ------------ ----------- ------------ ------------ -------------
</TABLE>
F-32
<PAGE> 82
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(UNAUDITED)
CONDENSED CONSOLIDATED BALANCE SHEETS
SEPTEMBER 30, 1993
(DOLLARS IN THOUSANDS)
ASSETS
<TABLE>
<CAPTION>
EPIC
EPIC HEALTHCARE
HEALTHCARE OTHER GROUP, INC.
GROUP, GUARANTOR EPIC NONGUARANTOR AND
INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
---------- ------------ ---------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
CURRENT ASSETS
Cash and cash equivalents............. $ 8,944 $ 40,846 $ 2,062 $ 4,904 $ -- $ 56,756
Cash restricted for interest
payment............................. -- -- 3,820 -- -- 3,820
Marketable securities................. -- 35,972 -- 11,375 -- 47,347
Accounts receivable, net.............. 474 56,000 1,071 21,321 (1,909) 76,957
Supply inventories.................... -- 16,589 -- 4,098 -- 20,687
Prepaid expenses and other............ 777 2,714 -- 1,083 -- 4,574
Receivables from affilaites........... 156,437 29,013 -- 13,663 (199,113) --
---------- ------------ ---------- ------------ ------------ ------------
TOTAL CURRENT ASSETS.................... 166,632 181,134 6,953 56,444 (201,023) 210,141
PROPERTY AND EQUIPMENT.................. -- 264,044 444,673 78,081 -- 786,798
ACCUMULATED DEPRECIATION AND
AMORTIZATION.......................... -- (50,548) (140,665) (27,533) -- (218,746)
---------- ------------ ---------- ------------ ------------ ------------
-- 213,496 304,008 50,548 -- 568,052
INVESTMENTS IN SUBSIDIARIES............. 64,684 109,474 -- -- (174,158) --
EXCESS OF PURCHASE PRICE OVER NET ASSETS
ACQUIRED, net......................... -- 38,577 -- 14,388 -- 52,965
OTHER ASSETS, net....................... 12,440 89,314 936 2,529 (71,401) 33,818
RECEIVABLES FROM AFFILIATES............. 297,673 -- -- -- (297,673) --
---------- ------------ ---------- ------------ ------------ ------------
TOTAL ASSETS............................ $ 541,429 $631,995 $ 311,897 $123,909 $ (744,254) $864,976
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Current maturities of long-term
debt................................ $ 45,333 $ 643 $ 1,020 $ 918 $ -- $ 47,914
Accounts payable...................... 236 39,225 (65) 5,450 (236) 44,610
Accrued liabilities................... 9,294 64,070 5,624 10,216 (1,673) 87,531
Payables to affiliates................ -- 164,963 -- 34,150 (199,113) --
---------- ------------ ---------- ------------ ------------ ------------
TOTAL CURRENT LIABILITIES............... 54,863 268,901 6,579 50,734 (201,022) 180,055
LONG-TERM DEBT.......................... 321,895 8,948 241,927 11,039 (71,401) 512,408
DEFERRED INCOME TAXES................... 5,994 -- -- -- -- 5,994
RESERVE FOR PROFESSIONAL LIABILITY
RISKS................................. -- 34,053 -- 11,206 1,353 46,612
OTHER DEFERRED LIABILITIES.............. -- 41,258 -- 1,192 -- 42,450
MINORITY INTERESTS...................... -- 4,947 -- 525 -- 5,472
PAYABLES TO AFFILIATES.................. -- 297,673 -- -- (297,673) --
STOCKHOLDERS' EQUITY
Common stock.......................... -- -- 1 -- (1) --
Paid-in capital....................... 373,838 61,855 111,604 5,434 (178,893) 373,838
Notes receivable from EPIC ESOP....... (100,000) -- (48,214) -- -- (148,214)
Retained earnings (deficit)........... (115,161) (85,640) -- 43,779 3,383 (153,639)
---------- ------------ ---------- ------------ ------------ ------------
TOTAL STOCKHOLDERS' EQUITY (DEFICIT).... 158,677 (23,785) 63,391 49,213 (175,511) 71,985
---------- ------------ ---------- ------------ ------------ ------------
TOTAL LIABILITIES AND STOCKHOLDERS'
EQUITY
(DEFICIT)............................. $ 541,429 $631,995 $ 311,897 $123,909 $ (744,254) $864,976
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
</TABLE>
F-33
<PAGE> 83
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(UNAUDITED)
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED DECEMBER 31, 1993
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
EPIC
HEALTHCARE
EPIC GROUP,
HEALTHCARE OTHER INC.
GROUP, GUARANTOR EPIC NONGUARANTOR AND
INC. SUBSIDIARIES PROPERTIES SUBSIDIARES ELIMINATIONS SUBSIDIARIES
---------- ------------ ---------- ------------ ------------ ----------
<S> <C> <C> <C> <C> <C> <C>
NET OPERATING REVENUE............... $ -- $212,740 $ 13,649 $ 62,212 $(16,150) $272,451
COSTS AND EXPENSES:
Operating expenses................ 11 203,002 11 55,420 (15,933) 242,511
Depreciation and amortization..... -- 5,935 5,669 1,603 (77) 13,130
Interest expense.................. 12,617 17,454 6,962 840 (19,128) 18,745
---------- ------------ ---------- ------------ ------------ ----------
TOTAL COSTS AND EXPENSES............ 12,628 226,391 12,642 57,863 (35,138) 274,386
INTEREST INCOME..................... 16,636 2,536 652 110 (19,128) 806
---------- ------------ ---------- ------------ ------------ ----------
INCOME (LOSS) BEFORE INCOME TAX
BENEFIT (EXPENSE), MINORITY
INTERESTS AND EXTRAORDINARY
ITEM.............................. 4,008 (11,115) 1,659 4,459 (140) (1,129)
INCOME TAX BENEFIT (EXPENSE)........ (1,363) 3,503 (564) (1,657) (294) (375)
MINORITY INTERESTS IN INCOME OF
CONSOLIDATED SUBSIDIARIES, net of
income tax benefit (expense)...... -- (780) -- (321) (566) (1,667)
---------- ------------ ---------- ------------ ------------ ----------
NET INCOME (LOSS)................... $ 2,645 $ (8,392) $ 1,095 $ 2,481 $ (1,000) $ (3,171)
---------- ------------ ---------- ------------ ------------ ----------
---------- ------------ ---------- ------------ ------------ ----------
</TABLE>
F-34
<PAGE> 84
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(UNAUDITED)
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED DECEMBER 31, 1992
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
EPIC
EPIC HEALTHCARE
HEALTHCARE OTHER GROUP, INC.
GROUP, GUARANTOR EPIC NONGUARATOR AND
INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
---------- ------------ ---------- ------------ ------------ -----------
<S> <C> <C> <C> <C> <C> <C>
NET OPERATING REVENUE.......... $ -- $178,988 $ 13,649 $ 69,156 $(17,441) $ 244,352
COST AND EXPENSES:
Operating expenses........... 50 172,362 40 64,553 (17,232) 219,773
Depreciation and
amortization............... 407 4,463 7,281 1,747 (107) 13,791
Interest expense............. 11,911 12,520 6,961 1,504 (15,470) 17,426
---------- ------------ ---------- ------------ ------------ -----------
TOTAL COSTS AND EXPENSES....... 12,368 189,345 14,282 67,804 (32,809) 250,990
INTEREST INCOME................ 12,500 2,480 1,025 101 (15,470) 636
---------- ------------ ---------- ------------ ------------ -----------
INCOME (LOSS) BEFORE INCOME TAX
BENEFIT (EXPENSE), MINORITY
INTERESTS AND EXTRAORDINARY
ITEM......................... 132 (7,877) 392 1,453 (102) (6,002)
INCOME TAX BENEFIT (EXPENSE)... 607 (122) -- (54) -- 431
MINORITY INTERESTS IN INCOME OF
CONSOLIDATED SUBSIDIARIES,
net of income tax benefit
(expense).................... 75 (552) -- (79) -- (556)
---------- ------------ ---------- ------------ ------------ -----------
INCOME (LOSS) BEFORE
EXTRAORDINARY ITEM........... 814 (8,551) 392 1,320 (102) (6,127)
EXTRAORDINARY ITEM,
net of income tax benefit
(expense).................. (503) -- -- -- -- (503)
---------- ------------ ---------- ------------ ------------ -----------
NET INCOME (LOSS).............. $ 311 $ (8,551) $ 392 $ 1,320 $ (102) $ (6,630)
---------- ------------ ---------- ------------ ------------ -----------
---------- ------------ ---------- ------------ ------------ -----------
</TABLE>
F-35
<PAGE> 85
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(UNAUDITED)
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED DECEMBER 31, 1993
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
EPIC
HEALTHCARE
EPIC OTHER GROUP, INC.
HEALTHCARE GUARANTOR EPIC NONGUARANTOR AND
GROUP, INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
----------- ------------ ---------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
Net cash provided by (used in)
operating activities............. $(2,627) $(11,483) $ 8,856 $ 4,149 $ -- $ (1,105)
INVESTING ACTIVITIES:
Investments in marketable
securities, net................ -- 13,300 -- (85) -- 13,215
Cash paid for acquisitions....... -- -- -- (960) -- (960)
Additions to property and
equipment...................... -- (20,100) -- (3,331) -- (23,431)
Principal collected on note
receivable from EPIC ESOP...... -- -- 10,833 -- (10,833) --
Other............................ -- (601) -- (60) -- (661)
----------- ------------ ---------- ------------ ------------ ------------
Net cash provided by (used in)
investing activities............. -- (7,401) 10,833 (4,436) (10,833) (11,837)
FINANCING ACTIVITIES
Payments on debt obligations..... (1,250) (26) -- (139) -- (1,415)
Contributions to EPIC ESOP....... -- (10,833) -- -- 10,833 --
Dividends paid to EPIC
Holdings....................... (119) -- -- -- -- (119)
Dividends and capital
distributions received from
EPIC Properties................ -- 19,833 -- -- (19,833) --
Dividends and capital
distributions paid by EPIC
Properties..................... -- -- (19,833) -- 19,833 --
Distributions and dividends to
minority interests............. -- (902) -- (230) -- (1,132)
Payments of debt issue costs and
other, net..................... -- (208) -- -- -- (208)
----------- ------------ ---------- ------------ ------------ ------------
Net cash provided by (used in)
financing activities............. (1,369) 7,864 (19,833) (369) 10,833 (2,874)
DECREASE IN CASH AND CASH
EQUIVALENTS...................... (3,996) (11,020) (144) (656) -- (15,816)
CASH AND CASH EQUIVALENTS AT
BEGINNING OF PERIOD.............. 8,944 40,846 2,062 4,904 -- 56,756
----------- ------------ ---------- ------------ ------------ ------------
CASH AND CASH EQUIVALENTS AT END OF
PERIOD........................... $ 4,948 $ 29,826 $ 1,918 $ 4,248 $ -- $ 40,940
----------- ------------ ---------- ------------ ------------ ------------
----------- ------------ ---------- ------------ ------------ ------------
</TABLE>
F-36
<PAGE> 86
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(UNAUDITED)
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED DECEMBER 31, 1992
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
EPIC
HEALTHCARE
EPIC OTHER GROUP, INC.
HEALTHCARE GUARANTOR EPIC NONGUARANTOR AND
GROUP, INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
----------- ------------ ---------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
Net cash provided by (used in)
operating activities............. $(771) $ 11,646 $ 7,269 $ (3,170) $ -- $ 14,974
INVESTING ACTIVITIES:
Investments in marketable
securities, net................ -- 256 -- 6,139 -- 6,395
Cash paid for acquisitions....... -- (4,100) -- -- -- (4,100)
Additions to property and
equipment...................... -- (7,410) -- -- -- (7,410)
Principal collected on note
receivable from EPIC ESOP...... -- -- 10,357 -- (10,357) --
Other............................ (103) (708) -- -- -- (811)
----------- ------------ ---------- ------------ ------------ ------------
Net cash provided by (used in)
investing activities............. (103) (11,962) 10,357 6,139 (10,357) (5,926)
FINANCING ACTIVITIES
Payments on debt obligations..... -- (20) -- (56) -- (76)
Line of credit borrowings, net... 800 -- -- -- -- 800
Purchase of Senior ESOP notes.... -- (5,616) -- -- -- (5,616)
Contributions to EPIC ESOP....... -- (10,357) -- -- 10,357 --
Dividends paid to EPIC
Holdings....................... (11) -- -- -- -- (11)
Dividends and capital
distributions received from
EPIC Properties................ -- 17,012 -- 888 (17,900) --
Dividends and capital
distributions paid by EPIC
Properties..................... -- -- (17,900) -- 17,900 --
Distributions and dividends to
minority interests............. -- (680) -- (1,660) -- (2,340)
Payment of debt issue costs and
other, net..................... -- (59) -- -- -- (59)
----------- ------------ ---------- ------------ ------------ ------------
Net cash provided by (used in)
financing activities............. 789 280 (17,900) (828) 10,357 (7,302)
----------- ------------ ---------- ------------ ------------ ------------
INCREASE (DECREASE) IN CASH AND
CASH EQUIVALENTS................. (85) (36) (274) 2,141 -- 1,746
CASH AND CASH EQUIVALENTS AT
BEGINNING OF PERIOD.............. 86 22,381 4,506 5,668 -- 32,641
----------- ------------ ---------- ------------ ------------ ------------
CASH AND CASH EQUIVALENTS AT END OF
PERIOD........................... $ 1 $ 22,345 $ 4,232 $ 7,809 $ -- $ 34,387
----------- ------------ ---------- ------------ ------------ ------------
----------- ------------ ---------- ------------ ------------ ------------
</TABLE>
F-37
<PAGE> 87
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
(UNAUDITED)
NOTES TO CONDENSED CONSOLIDATING FINANCIAL STATEMENTS
The subsidiaries comprising the Guarantor Subsidiaries change from year to
year due to new and/or revised agreements relating to the various subsidiaries
of the Company. As a result, the investment in subsidiaries is presented on the
cost basis.
Receivables from (payables to) affiliates include cash transfers between
entities on collection of accounts receivable and payment of accounts payable
and are included in cash flows provided by (used in) operating activities. Cash
flows from operating, financing and investing activities for each subisidary are
presented in the consolidating statements of cash flows based on that
subsidiary's designation as a guarantor or nonguarantor subsidiary at the end of
the period.
Deferred income taxes and deferred income tax benefit (expense) were
recorded in the accounts of EPIC Healthcare Group, Inc. and were not allocated
to the subsidiaries in fiscal 1993. SFAS No. 109, "Accounting for Income Taxes"
requires that the consolidated amount of current and deferred tax expense for a
group that files a consolidated tax return shall be allocated among the members
of the group when those members issue separate financial statements on a basis
consistent with SFAS No. 109. The Company adopted SFAS No. 109, including
allocation of taxes within the consolidating financial statements, effective
October 1, 1993. For fiscal 1994, deferred income tax benefit (expense) is
allocated to the subsidiaries using the effective tax rate applicable and
deferred income taxes for the subsidiaries are included in receivables from
(payables to) affiliates.
F-38
<PAGE> 88
REPORT OF ERNST & YOUNG, INDEPENDENT AUDITORS
The Board of Directors
EPIC Holdings, Inc.
We have audited the accompanying consolidated balance sheets of EPIC
Healthcare Group, Inc. and subsidiaries (a wholly-owned subsidiary of EPIC
Holdings, Inc.) as of September 30, 1993 and 1992, and the related consolidated
statements of operations, stockholder's equity (deficit), and cash flows for
each of the three years in the period ended September 30, 1993. These financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the consolidated financial position of
EPIC Healthcare Group, Inc. and subsidiaries at September 30, 1993, and 1992,
and the results of its consolidated operations and its consolidated cash flows
for each of the three years in the period ended September 30, 1993, in
conformity with generally accepted accounting principles.
ERNST & YOUNG
Dallas, Texas
December 3, 1993
F-39
<PAGE> 89
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(DOLLARS IN THOUSANDS)
ASSETS
<TABLE>
<CAPTION>
SEPTEMBER 30,
---------------------
1993 1992
--------- ---------
<S> <C> <C>
CURRENT ASSETS
Cash and cash equivalents............................................ $ 56,756 $ 32,641
Cash restricted for interest payment................................. 3,820 5,768
Marketable securities................................................ 47,347 10,607
Accounts receivable, net of reserves for uncompensated care of
$29,286 and $25,837............................................... 76,957 73,398
Supply inventories................................................... 20,687 20,000
Prepaid expenses and other........................................... 4,574 5,222
--------- ---------
TOTAL CURRENT ASSETS......................................... 210,141 147,636
PROPERTY AND EQUIPMENT
Land................................................................. 53,030 57,492
Buildings and improvements........................................... 476,570 451,292
Equipment............................................................ 234,656 192,367
Construction in progress............................................. 22,542 9,333
--------- ---------
786,798 710,484
Accumulated depreciation and amortization............................ (218,746) (173,789)
--------- ---------
568,052 536,695
EXCESS OF PURCHASE PRICE OVER NET ASSETS ACQUIRED, net of accumulated
amortization......................................................... 52,965 48,140
OTHER ASSETS, net of accumulated amortization.......................... 33,818 38,315
--------- ---------
TOTAL ASSETS................................................. $ 864,976 $ 770,786
--------- ---------
--------- ---------
</TABLE>
See notes to consolidated financial statements.
F-40
<PAGE> 90
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(DOLLARS IN THOUSANDS)
LIABILITIES AND STOCKHOLDER'S EQUITY
<TABLE>
<CAPTION>
SEPTEMBER 30,
---------------------
1993 1992
-------- --------
<S> <C> <C>
CURRENT LIABILITIES
Current maturities of long-term debt................................. $ 47,914 $ 2,330
Accounts payable..................................................... 44,610 34,809
Accrued liabilities:
Salaries and wages................................................ 36,475 33,031
Taxes other than on income........................................ 7,874 7,476
Interest.......................................................... 11,027 7,658
Group health insurance............................................ 4,902 5,656
Current reserve for professional liability risks.................. 11,000 11,000
Other............................................................. 16,253 9,011
-------- --------
TOTAL CURRENT LIABILITIES.............................................. 180,055 110,971
LONG-TERM DEBT......................................................... 512,408 470,735
DEFERRED INCOME TAXES.................................................. 5,994 8,988
RESERVE FOR PROFESSIONAL LIABILITY RISKS............................... 46,612 39,640
OTHER DEFERRED LIABILITIES............................................. 42,450 39,607
COMMITMENTS AND CONTINGENT LIABILITIES.................................
MINORITY INTERESTS..................................................... 5,472 23,494
STOCKHOLDER'S EQUITY
Common stock, $.01 par value -- Authorized: 100,000,000 shares;
Issued and outstanding: 1,000 shares.............................. -- --
Paid-in capital...................................................... 373,838 374,860
Notes receivable from EPIC ESOP...................................... (148,214) (168,929)
Retained earnings (deficit).......................................... (153,639) (128,580)
-------- --------
TOTAL STOCKHOLDER'S EQUITY............................................. 71,985 77,351
-------- --------
TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY............................. $864,976 $770,786
-------- --------
-------- --------
</TABLE>
See notes to consolidated financial statements.
F-41
<PAGE> 91
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
FOR THE YEAR ENDED SEPTEMBER 30,
---------------------------------------
1993 1992 1991
----------- ----------- -----------
<S> <C> <C> <C>
NET OPERATING REVENUE................................... $ 1,019,149 $ 941,266 $ 802,689
COSTS AND EXPENSES:
Salaries and wages.................................... 354,326 319,868 271,007
Employee benefits..................................... 84,615 81,365 68,434
ESOP expense.......................................... 20,715 20,714 23,076
Supplies.............................................. 121,986 116,145 99,882
Uncompensated care.................................... 80,643 69,308 59,425
Other................................................. 235,770 234,879 192,633
Depreciation and amortization......................... 57,917 53,013 49,354
Interest expense...................................... 70,934 71,000 68,266
----------- ----------- -----------
TOTAL COSTS AND EXPENSES...................... 1,026,906 966,292 832,077
INTEREST INCOME......................................... 3,627 3,822 5,405
GAIN (LOSS) ON SALE OF ASSETS........................... 3,521 (1,123) (543)
----------- ----------- -----------
LOSS BEFORE INCOME TAX BENEFIT, MINORITY INTERESTS AND
EXTRAORDINARY ITEM.................................... (609) (22,327) (24,526)
INCOME TAX BENEFIT, net................................. 243 6,258 7,603
MINORITY INTERESTS IN INCOME OF CONSOLIDATED
SUBSIDIARIES (net of income tax benefit of $106,
$1,008 and $1,063, respectively)...................... (3,394) (1,958) (2,064)
----------- ----------- -----------
LOSS BEFORE EXTRAORDINARY ITEM.......................... (3,760) (18,027) (18,987)
EXTRAORDINARY ITEM (net of income tax benefit of $661,
$652 and $1,330, respectively......................... (21,299) (1,265) (2,581)
----------- ----------- -----------
NET LOSS...................................... $ (25,059) $ (19,292) $ (21,568)
----------- ----------- -----------
----------- ----------- -----------
</TABLE>
See notes to consolidated financial statements.
F-42
<PAGE> 92
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY (DEFICIT)
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
NOTES RETAINED TOTAL
COMMON PAID-IN RECEIVABLE EARNINGS STOCKHOLDERS'
STOCK CAPITAL FROM EPIC ESOP (DEFICIT) EQUITY (DEFICIT)
------ -------- -------------- --------- ----------------
<S> <C> <C> <C> <C> <C>
Balance at October 1, 1990......... $ 245 $219,808 $ (212,738) $ (87,241) $ (79,926)
Dividends accrued and accretion of
discount on redeemable preferred
stock............................ -- (22,873) -- -- (22,873)
Principal payments received on
notes receivable from EPIC
ESOP............................. -- -- 23,095 -- 23,095
Treasury stock purchased........... (1 ) -- -- (468) (469)
Net loss........................... -- -- -- (21,568) (21,568)
------ -------- -------------- --------- ----------------
Balance at September 30, 1991...... 244 196,935 (189,643) (109,277) (101,741)
Dividends accrued and accretion of
discount on redeemable preferred
stock............................ -- (11,048) -- -- (11,048)
Principal payments received on
notes receivable from EPIC
ESOP............................. -- -- 20,714 -- 20,714
Treasury stock purchased........... -- -- -- (11) (11)
Warrant conversion................. 63 (42) -- -- 21
Contribution of redeemable
preferred stock, net of
expenses......................... -- 190,008 -- -- 190,008
Exchange of common stock in
connection with merger........... (307 ) 307 -- -- --
Dividends paid to EPIC Holdings.... -- (1,300) -- -- (1,300)
Net loss........................... -- -- -- (19,292) (19,292)
------ -------- -------------- --------- ----------------
Balance at September 30, 1992...... -- 374,860 (168,929) (128,580) 77,351
Principal payments received on
notes receivable from EPIC
ESOP............................. -- -- 20,715 -- 20,715
Dividends paid to EPIC Holdings.... -- (1,022) -- -- (1,022)
Net loss........................... -- -- -- (25,059) (25,059)
------ -------- -------------- --------- ----------------
Balance at September 30, 1993...... $ -- $373,838 $ (148,214) $(153,639) $ 71,985
------ -------- -------------- --------- ----------------
------ -------- -------------- --------- ----------------
</TABLE>
See notes to consolidated financial statements.
F-43
<PAGE> 93
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(DOLLARS IN THOUSANDS)
<TABLE>
<CAPTION>
FOR THE YEAR ENDED
SEPTEMBER 30,
---------------------------------
1993 1992 1991
--------- --------- ---------
<S> <C> <C> <C>
OPERATING ACTIVITIES
Net loss.................................................. $ (25,059) $ (19,292) $ (21,568)
Adjustments to reconcile net loss to net cash provided by
operating activities:
Depreciation and amortization.......................... 57,917 53,013 49,354
Non-cash provision for professional liability risks.... 2,641 4,131 11,291
ESOP expense........................................... 20,715 20,714 23,076
Deferred SAR Plan compensation......................... 3,249 10,805 7,137
Minority interests in income of consolidated
subsidiaries......................................... 3,499 2,966 3,127
(Gain) loss on sale of assets.......................... (3,521) 1,123 543
Non-cash interest...................................... 18,286 18,417 13,975
Extraordinary item..................................... 21,960 1,917 3,911
Deferred federal income tax benefit.................... (2,994) (8,806) (9,996)
Changes in operating assets and liabilities, net of
acquisitions:
Accounts receivable.................................. 6,054 (35,196) (3,043)
Supply inventories and other assets.................. 4,284 (3,162) (5,291)
Accounts payable and other liabilities............... 12,202 11,282 6,444
--------- --------- ---------
Net cash provided by operating activities......... 119,233 57,912 78,960
INVESTING ACTIVITIES
Investments in marketable securities, net................. (36,740) 5,167 (12,091)
Cash paid for acquisitions................................ (54,536) (12,269) --
Additions to property and equipment....................... (60,784) (47,850) (25,646)
Purchase of investment securities......................... -- (4,180) --
Proceeds from sales of assets............................. 25,148 190 361
Collection on note receivable............................. 9,349 -- --
Other..................................................... (5,925) (2,046) (48)
--------- --------- ---------
Net cash used in investing activities............. (123,488) (60,988) (37,424)
FINANCING ACTIVITIES
Payments on debt obligations.............................. (117,765) (1,603) (250,647)
Proceeds from long-term borrowings........................ 180,853 -- 227,868
Purchase of Senior ESOP Notes............................. (5,616) (20,293) --
Purchase of treasury stock................................ -- (11) (469)
Dividends paid to EPIC Holdings........................... (1,022) (1,300) --
Preferred stock transaction costs......................... -- (7,063) --
Proceeds of warrant conversion............................ -- 21 --
Contributions from minority interests..................... 520 1,884 556
Distributions and dividends to minority interests......... (21,110) (4,065) (4,122)
Payments of debt issue costs and other, net............... (7,490) (672) (11,294)
--------- --------- ---------
Net cash provided by (used in) financing
activities...................................... 28,370 (33,102) (38,108)
--------- --------- ---------
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS............ 24,115 (36,178) 3,428
Cash and cash equivalents at beginning of year............ 32,641 68,819 65,391
--------- --------- ---------
Cash and cash equivalents at end of year.................. $ 56,756 $ 32,641 $ 68,819
SUPPLEMENTARY INFORMATION
Cash paid during the year for interest.................... $ 52,370 $ 53,343 $ 52,987
Cash paid for income taxes................................ $ 657 $ 888 $ 666
</TABLE>
See notes to consolidated financial statements
F-44
<PAGE> 94
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
EPIC Healthcare Group, Inc. ("EPIC" or, either alone or together with its
subsidiaries, the "Company") was acquired by EPIC Holdings, Inc. ("Holdings") on
March 25, 1992, in a merger transaction (the "Merger") in which each outstanding
share of common stock of EPIC was converted into one share of Holdings common
stock. Because the Merger was between companies under common ownership, and as
EPIC is a wholly-owned subsidiary of Holdings, the recorded assets and
liabilities of EPIC have retained their historical cost basis.
Principles of Consolidation
The consolidated financial statements include the accounts of EPIC and its
subsidiaries. Intercompany accounts and transactions have been eliminated.
Minority interests represent the minority stockholders' proportionate shares of
the equity in the income (loss) of certain consolidated subsidiaries.
Cash Equivalents, Cash Restricted for Interest Payments, and Marketable
Securities
The Company considers all highly liquid investments with initial maturities
of three months or less from date of purchase to be cash equivalents. Cash
restricted for interest payments is cash deposited into a trust to pay principal
and interest required by the Class B-1, Class B-2 and Class B-3 First Priority
Mortgage Notes (the "Mortgage Notes"). Investments in marketable
interest-bearing securities are stated at cost which approximates market. The
Company has $42,694,000 in cash and marketable securities restricted for the
purpose of redeeming the remaining 15% Senior Subordinated Notes (See Note 5).
Cash equivalents, cash restricted for interest payments, and marketable
securities are subject to potential concentrations of credit risk. The Company
attempts to lessen that risk by investing only in United States Government
securities, commercial paper having at least a rating of A-1 or the equivalent,
time deposits and certificates of deposit of banks having a debt rating of at
least A, or money market funds comprised of such securities. The Company invests
in securities with maturities no longer than 180 days and limits the amount of
credit exposure to any one commercial issuer.
Accounts Receivable
Concentration of credit risk relating to accounts receivable is limited to
some extent by the diversity and number of patients and payors and the
geographic dispersion of the Company's hospitals. Accounts receivable (gross)
consists of amounts due from government programs (e.g., Medicare and Medicaid)
(53%), commercial insurance companies (16%), private pay patients (18%) and
other (including health maintenance organizations and other group insurance
programs) (13%). The Company's hospitals are located throughout the southern
United States, with the largest concentration in Texas, Oklahoma, Louisiana and
California. The Company maintains an allowance for losses (i.e., uncompensated
care or bad debt expense) based on the expected collectibility of accounts
receivable.
Supply Inventories
Supply inventories are stated at the lower of cost (first-in, first-out
method) or market.
Property and Equipment
Property and equipment are recorded at cost (or fair value at the date of
acquisition as a result of the original purchase from American Medical
International, Inc. and its subsidiaries ("AMI")). Depreciation
F-45
<PAGE> 95
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
and amortization is computed using the straight-line method over estimated
useful lives or the term of the lease generally ranging from 25 to 30 years for
buildings and improvements, and 3 to 10 years for equipment. Maintenance costs
and repairs are expensed as incurred.
Joint Ventures
The Company, in the ordinary course of business, enters into joint ventures
with physicians and other companies. The Company is the majority owner and
general partner of substantially all of the joint ventures and follows the
principles of consolidation for all majority-owned joint ventures. Minority
shareholders' investments and earnings in the joint ventures are recorded as
minority interests and minority interests in income of consolidated
subsidiaries, respectively. Any interest held by the Company in non-majority
owned partnerships with at least 20% ownership is accounted for using the equity
method. Any interest held by the Company in partnerships with less than 20%
ownership is accounted for using the cost method.
On February 1, 1990, the Company entered into a joint venture with
Healthtrust, Inc. - The Hospital Company ("Healthtrust") for the purpose of
operating certain hospital assets in McKinney, Texas. The Company contributed,
at net book value, a 168 bed facility to the venture and was the managing
co-general partner with a 60% equity interest in the venture. Healthtrust
contributed a 99 bed facility to the venture and was the co-general partner with
a 40% interest in the venture. The assets contributed by Healthtrust to the
joint venture, including property and equipment of $15,328,000, were recorded at
fair market value which approximated net book value. Goodwill of $2,470,000, is
being amortized over 40 years. On August 31, 1993, the Company purchased
Healthtrust's interest in the joint venture for $15,656,000, which approximated
Healthtrust's interest in the net assets of the joint venture and was recorded
as a reduction to minority interests.
Intangible Assets
The excess of the purchase price over the fair value of net assets acquired
is being amortized on a straight-line basis over periods ranging from nine to 40
years. Accumulated amortization was $9,244,000 and $6,920,000 at September 30,
1993 and 1992, respectively.
Costs incurred in obtaining long term financing are deferred and are
included in other assets. Deferred financing costs are amortized using the
effective interest method over the term of the related debt, and such
amortization is included in interest expense. Accumulated amortization of
deferred financing costs was $16,427,000 and $14,203,000 at September 30, 1993
and 1992, respectively.
The Company has purchased licenses to use various software applications.
These costs are recorded as other assets and have been amortized over two or
five year periods. Accumulated amortization of the software costs was $5,750,000
and $4,750,000 at September 30, 1993 and 1992, respectively.
Income Taxes
The Company is included in the consolidated federal income tax return of
Holdings. The Company's tax provision is determined as if the Company, along
with its subsidiaries, prepared its tax return on a separate return basis.
EPIC accounts for income taxes under the provisions of Statement of
Financial Accounting Standards ("SFAS") No. 96, "Accounting for Income Taxes."
Under the liability method specified by SFAS No. 96, deferred tax assets and/or
liabilities are determined by multiplying the difference between the financial
reporting and tax reporting bases of assets and liabilities (collectively, the
"temporary differences," see Note 6) by tax rates (determined in accordance with
enacted tax laws) that are expected to be effective when such temporary
differences reverse. EPIC's deferred tax liabilities originated from the
accounting for the
F-46
<PAGE> 96
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
acquisition from AMI (the "Acquisitions"), and reflect the estimated tax effect
of differences between book and tax bases of assets acquired and liabilities
assumed.
In February 1992, the Financial Accounting Standards Board issued SFAS No.
109, "Accounting for Income Taxes," which supersedes SFAS No. 96. Implementation
of SFAS No. 109 for the Company was required October 1, 1993. SFAS No. 109
requires that temporary differences be reflected in the same balance sheet
category as the assets and liabilities that caused the temporary differences.
Deferred tax assets, which would include tax net operating loss carryforwards,
would require the determination of a related valuation allowance, based on the
assets' expected realization. The Company has completed the analysis necessary
to determine the impact of adoption of SFAS No. 109 and it is not expected to
have a material impact on the Company's financial position or results of
operations and will not impact cash flows.
Net operating revenue
Net operating revenue is recorded based on established billing rates net of
allowances and discounts for patients covered by Medicare, Medicaid and other
contractual programs. Payments received under these programs, which are based on
either the costs of services or predetermined rates, are generally less than the
established billing rates of the Company's hospitals, and the differences are
recorded as contractual allowances and/or contracted discounts. Reserves
provided have been deducted from accounts receivable pending final audit and
appeal settlement. Contractual adjustments, contracted discounts and other
discounts amounted to $627,757,000, $576,572,000, and $482,158,000 for fiscal
1993, 1992 and 1991, respectively.
It is generally the Company's policy to attempt to collect compensation for
all services performed.
Reclassifications
Certain prior period amounts have been reclassified to conform with the
fiscal 1993 presentation.
2. ACQUISITIONS AND DIVESTITURES
On August 24, 1993, the Company entered into a 20-year lease agreement with
two ten year renewal options, with the County of Galveston, Texas for Mainland
Center Hospital, a 310-bed hospital in Texas City, Texas. The lease payment of
$27,535,000 was paid in full upon the execution of the lease, which has been
accounted for as a capital lease. The Company also purchased certain net current
assets and equipment of the hospital, which included $5,639,000 in cash, for
$17,965,000 which has been accounted for by the purchase method of accounting.
The Company also has a commitment to carry out $20,000,000 of capital
improvements over the term of the lease. The lease agreement contains a purchase
option which becomes effective on August 24, 1994. The option price ranges from
$500,000 to $851,000 over the term of the lease.
On January 6, 1993, the Company sold Westpark Community Hospital in
Hammond, Louisiana for $6,200,000. A charge of $624,000 to reflect the loss on
the sale was recorded in fiscal 1993. A charge of $800,000 to reflect the
anticipated loss on the sale was recorded in fiscal 1992. The net book value of
the assets sold before the fiscal 1992 charge, less liabilities assumed by the
buyer, was $7,624,000.
On March 15, 1993, the Company sold Valley Medical Center in El Cajon,
California for $16,950,000. A gain on the sale of $4,632,000 was recorded in
fiscal 1993. The net book value of the assets sold, less liabilities assumed by
the buyer, was $12,318,000.
On October 1, 1991, the Company purchased Colonial Hospital, a 49-bed
hospital in Terrell, Texas for $10,403,000 in cash. The acquisition has been
accounted for by the purchase method of accounting. The excess of purchase price
over net assets acquired is being amortized over 40 years.
3. EMPLOYEE STOCK OWNERSHIP PLAN ("ESOP")
Employee-owners of EPIC have beneficial ownership of approximately 60% of
the Holdings Common Stock through their participation in the EPIC ESOP.
F-47
<PAGE> 97
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
At the Company's inception, the EPIC ESOP purchased 24,500,000 shares of
the EPIC Common Stock with the proceeds obtained from the issuance of loans
aggregating $245 million payable to the Company. The terms of the original ESOP
loan agreement segregated the EPIC ESOP's obligation to the Company into two
components, the terms of the first of which mirrored the terms of the Senior
ESOP Bank Debt (the "First ESOP Loan") and the second of which mirrored the
terms of the Senior ESOP Notes (see Note 5). Concurrent with the issuance of the
Mortgage Notes (see Note 5), the First ESOP Loan was replaced by a loan
agreement which provides for mandatory principal payments in amounts that are
substantially in conformance with the remaining mandatory principal payments of
the Senior ESOP Bank Debt as if the issuance of the Mortgage Notes had not
occurred (the "New ESOP Loan"). The interest rate on the New ESOP Loan is
determined quarterly based on .85 times the sum of the London InterBank Offered
Rates plus 2.5% (5.1% at September 30, 1993). The EPIC ESOP has pledged all of
its shares of the Holdings Common Stock as collateral for the ESOP-related
borrowings. These shares are released from the pledge as the loans are paid. The
EPIC ESOP receives contributions from the Company to service and extinguish the
loans.
The EPIC ESOP is an individual account, defined contribution plan. Nonunion
employee-owners who work a specified number of hours are eligible to participate
in the EPIC ESOP if they have attained age 21 and completed one year of service.
No employee-owner contributions are required or permitted to be made to the EPIC
ESOP. No rollover contributions are permitted to be made to the EPIC ESOP.
Allocations are made to participants' accounts in an amount which reflects each
participant's proportionate share of the contributions made by the Company to
the EPIC ESOP, as determined on the basis of each participant's compensation.
Contributions made to the EPIC ESOP and the value of shares of common stock
allocated to the account of a participant as a result of such contributions are
intended to be treated as tax-deferred contributions. Such contributions, and
earnings thereon, generally are includable in a participant's compensation for
federal income tax purposes when distributed.
As of the plan year ended December 31, 1992, cumulative allocations of
10,650,517 shares of Holdings Common Stock at a market value of $8.00 per share
based on an independent valuation, or $85,204,136 in total have been made to
10,183 participants. Shares of Holdings Common Stock relating to the plan year
ending December 31, 1993 will be allocated during fiscal 1994.
Subject to limitations contained in the Internal Revenue Code of 1986, as
amended (the "Code"), Holdings is entitled to claim an income tax deduction for
contributions to the EPIC ESOP. The Company has received a favorable
determination from the Internal Revenue Service that the EPIC ESOP is qualified
as an "employee stock ownership plan" within the meaning of Section 4975(e)(7)
of the Code. Contributions to the EPIC ESOP are used by the EPIC ESOP to pay
interest and principal on the loans owed to the Company. The Company uses
payments from the EPIC ESOP to pay interest and principal on the Class B-1 First
Priority Mortgage Notes and the Senior ESOP Notes.
The Company recorded net ESOP expense, using the cash method, and
corresponding reductions in the EPIC ESOP notes receivable, of $20,715,000,
$20,714,000, and $23,076,000 for fiscal 1993, 1992 and 1991, respectively.
Interest income recognized on the EPIC ESOP notes receivable totaled
$14,984,000, $16,885,000, and $20,483,000 for fiscal 1993, 1992 and 1991,
respectively, which in turn was contributed to the EPIC ESOP to pay interest
expense incurred on the ESOP-related debt. Interest expense incurred on ESOP-
related debt totaled $20,856,000, $21,734,000, and $21,731,000 which included
discount amortization of $559,000, $551,000, and $511,000 for fiscal 1993, 1992
and 1991, respectively.
F-48
<PAGE> 98
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
4. OPERATING LEASES
The Company leases office space, office equipment and medical equipment.
Generally, real estate leases are for primary terms of from one to 12 years with
options to renew for additional periods, and equipment leases are for terms of
from one to seven years. Future minimum lease payments for all operating leases
having initial or remaining noncancellable lease terms in excess of one year as
of September 30, 1993 are as follows (dollars in thousands):
<TABLE>
<S> <C>
1994....................................................................... $ 4,560
1995....................................................................... 4,225
1996....................................................................... 3,337
1997....................................................................... 2,693
1998....................................................................... 1,835
1999 and thereafter........................................................ 3,485
-------
20,135
Sublease income............................................................ (1,116)
-------
$19,019
-------
-------
</TABLE>
Rent expense under operating leases was as follows (dollars in thousands):
<TABLE>
<CAPTION>
FOR THE YEAR ENDED
SEPTEMBER 30,
---------------------------
1993 1992 1991
------- ------- -------
<S> <C> <C> <C>
Minimum rent.............................................. $18,496 $16,107 $13,609
Sublease income........................................... (795) (609) (317)
------- ------- -------
$17,701 $15,498 $13,292
------- ------- -------
------- ------- -------
</TABLE>
F-49
<PAGE> 99
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
5. LONG-TERM DEBT
The Company's long-term debt, net of discounts, is summarized below
(dollars in thousands):
<TABLE>
<CAPTION>
SEPTEMBER 30,
---------------------
1993 1992
--------- ---------
<S> <C> <C>
11.375% Class B-1 First Priority Mortgage Notes payable in
semi-annual payments of $9,000 commencing in July 1996 with
a final payment of $10,000 in July 2001.................... $ 99,579 $ 99,500
11.5% Class B-2 First Priority Mortgage Notes payable in
semi-annual payments of $500 through July 1994, increasing
to $750 in January 1995, to $1,500 in January 1997, to
$8,000 in January 1998, to $9,000 in January 1999, with a
final payment of $15,500 in July 2001...................... 83,112 84,046
Class B-3 First Priority Mortgage Notes payable in
semi-annual payments of $750 commencing in January 1995,
increasing to $3,000 in January 1997 through July 1998,
with a fluctuating interest rate (6.5% at September 30,
1993)...................................................... 15,000 15,000
Other mortgage debt and capital lease obligations with
varying maturities and interest rates ranging from 4.75% to
12.9%...................................................... 20,651 20,351
Acquisition Loan, payable in quarterly installments of $1,250
commencing in October, 1993 with a fluctuating interest
rate (8.0% at September 30, 1993).......................... 19,542 --
Zero Coupon Notes, principal of $89,313 due 2001 with an
effective interest rate of 14.8%........................... 28,564 24,770
Additional Zero Coupon Notes, principal of $7,079 due 2001
with an effective interest rate of 14.8%................... 2,265 1,964
11.875% Senior ESOP Notes payable in three equal annual
payments commencing in September 1996 with an effective
interest rate of 13.03%.................................... 72,141 76,840
10.875% Senior Subordinated Notes due 2003................... 160,000 --
15% Senior Subordinated Notes payable in three equal annual
payments commencing in 1999................................ 40,320 104,852
11% Junior Subordinated Pay-In-Kind Notes payable in three
equal annual payments commencing in September 2001......... 19,148 45,742
--------- ---------
560,322 473,065
Current maturities........................................... (47,914) (2,330)
--------- ---------
$ 512,408 $ 470,735
--------- ---------
--------- ---------
</TABLE>
The Mortgage Notes are the indebtedness of EPIC Properties, Inc. ("EPIC
Properties"), an indirect wholly-owned subsidiary of EPIC. The Mortgage Notes
are secured by mortgages on 24 acute care hospital complexes (the "Mortgaged
Hospitals") and the land on which such buildings are located, and by a first
priority security interest in certain furnishings and equipment located at each
of the Mortgaged Hospitals. The Mortgage Notes are fully and unconditionally
guaranteed by EPIC (see Note 17).
The interest rate on the Class B-1 First Priority Mortgage Notes (the
"Class B-1 Notes") will increase to 11.5% after September 30, 1995. If the
Internal Revenue Service determines that interest on the Class B-1 Notes does
not qualify for a 50% exclusion from federal taxable income, the interest rate
on the Class B-1 Notes will increase to 11.5% for all periods through September
30, 1995 during which such interest exclusion is not available.
F-50
<PAGE> 100
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
The Company incurred losses on refinancing concurrent with the issuance of
the Mortgage Notes due primarily to the write-off of loan issue costs. These
losses, totalling $3,911,000, are recorded as an extraordinary item (net of
income tax benefit of $1,330,000) in the consolidated statement of operations
for the fiscal year ended September 30, 1991.
The Zero Coupon Notes are reflected at their fair value of $14,008,000, as
estimated by the Company at September 30, 1988, plus accretion of discount
through September 30, 1993. No interest or principal is payable until maturity.
Additional Zero Coupon Notes were issued under an interest rate cap
agreement with AMI (see Note 12) and are reflected at their original fair value
plus accretion of discount through September 30, 1993. No interest or principal
is payable until maturity.
A subsidiary of EPIC purchased $5,400,000 and $19,850,000 face value of the
11.875% Senior ESOP Notes on the open market for $5,616,000 and $20,293,000 plus
accrued interest in fiscal 1993 and 1992, respectively (the "Senior ESOP Note
Purchases"). Losses of $570,000 and $1,917,000 due to the write-off of debt
issue costs and unamortized discounts and the payment of a premium on the Senior
ESOP Note Purchases are recorded as extraordinary items (net of income tax
benefit of $17,000 and $652,000, respectively) in the consolidated statements of
operations for the fiscal years ended September 30, 1993 and 1992, respectively.
The 11.875% Senior ESOP Notes, which carry detachable stock purchase
warrants (see Note 9), have a stated principal amount of $100,000,000 and are
reflected at their fair value of $93,988,000, as estimated by the Company at
September 30, 1988, less the Senior ESOP Note Purchases, plus accretion of
discount through September 30, 1993.
On June 18, 1993, the Company refinanced $74,680,000 in principal of the
15% Senior Subordinated Notes and $53,697,000 in principal of the 11% Junior
Subordinated Pay-In-Kind Notes (the "Refinancing") through the issuance of the
10.875% Senior Subordinated Notes. The 10.875% Senior Subordinated Notes are
guaranteed by certain subsidiaries of the Company (see Note 17).
Under the terms of the Second Amended and Restated Credit Agreement dated
as of September 30, 1988, and amended and restated as of July 30, 1991, and
September 1, 1993 (the "Amended Credit Agreement"), the Company is required to
call the remaining $40,320,000 in principal of the 15% Senior Subordinated Notes
by February 28, 1994, with the remaining proceeds of the Refinancing. The
remaining principal of the 15% Senior Subordinated Notes at September 30, 1993,
has been recorded as current maturities of long term debt in the consolidated
balance sheets.
The Company incurred a loss before taxes of $21,390,000 on the Refinancing,
which resulted from the write-off of loan issue costs and unamortized discount
on the 15% Senior Subordinated Notes and the redeemed portion of the 11% Junior
Subordinated Pay-In-Kind Notes, payments to the holders of the 15% Senior
Subordinated Notes and the 11.875% Senior ESOP Notes for waivers of certain
provisions of the respective indentures and the accrual of the call premium to
be paid on redeeming the remaining principal on the 15% Senior Subordinated
Notes. These losses are recorded as an extraordinary item (net of income tax
benefit of $644,000) in the consolidated statements of operations.
The 15% Senior Subordinated Notes are guaranteed by certain wholly-owned
subsidiaries of the Company (see Note 17) and are secured by a fourth pledge of
the common stock of such subsidiaries.
Interest on the 11% Junior Subordinated Pay-in-Kind Notes is payable
semi-annually by the issuance of additional 11% Junior Subordinated Pay-in-Kind
Notes through September 30, 1995, and thereafter, if the Company is prohibited
from making cash interest payments by the terms of any senior debt existing on
September 30, 1988, less the amount retired in the Refinancing. The notes, which
have a stated principal amount of $50,000,000, have been recorded at their fair
value estimated by the Company at September 30,
F-51
<PAGE> 101
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
1988, of $22,900,000 plus accretion of discount through September 30, 1993, less
the amount retired as a result of the Refinancing. The effective interest rate
for these notes is 18.07%.
The Amended Credit Agreement provides the Company with revolving loan
commitments and an acquisition loan to be used for working capital and
acquisition funds for the Company. As of September 30, 1993, revolving loan
commitments aggregated $30 million. Any revolving loan commitments outstanding
are due July 31, 1997. Interest is generally payable monthly at the following
rates per annum, at the Company's option: (i) 1.5% in excess of the higher of
the prime rate in effect from time to time or the annual yield on ninety-day
commercial paper or (ii) 2.5% in excess of the LIBOR rate. There were no
revolving loans outstanding as of September 30, 1993, and 1992, respectively.
The acquisition term loan principal amount outstanding is payable in quarterly
installments commencing on October 31, 1993 through July 31, 1997. Interest is
generally payable quarterly at the following rates per annum, at the Company's
option: (i) 2.0% in excess of the higher of the prime rate in effect from time
to time or the annual yield on ninety-day commercial paper or (ii) 3.0% in
excess of the LIBOR rate.
In connection with the issuance of the Mortgage Notes, EPIC Properties
obtained a revolving line of credit. The line of credit can only be used for the
purpose of paying interest or principal on the Mortgage Notes. The maximum loan
amount available is the lesser of $22 million or the annual interest accrual of
the Mortgage Notes. The line of credit bears an interest rate of the Prime
Lending Rate of AmSouth Bank plus 2%. There were no loans outstanding under the
line of credit as of September 30, 1993, and 1992, respectively.
The Amended Credit Agreement and other long-term debt agreements contain a
number of restrictive covenants, including restrictions on incurrence of debt,
sales of assets, payment of cash dividends, requirements to maintain certain
financial ratios and a specified level of net worth, as defined, and other
limitations, including limitations on the use of funds from the sale of certain
assets.
As of September 30, 1993, the maturities of long-term debt were as follows
(dollars in thousands):
<TABLE>
<S> <C>
1994..................................................................... $ 47,914
1995..................................................................... 9,498
1996..................................................................... 43,545
1997..................................................................... 58,546
1998..................................................................... 67,207
1999 and thereafter...................................................... 421,160
---------
647,870
Unamortized discounts and unaccreted interest............................ (87,548)
---------
$ 560,322
---------
---------
</TABLE>
6. INCOME TAXES
Subsequent to the Merger, the Company files a consolidated federal income
tax return with Holdings. The Company's income tax benefit for fiscal 1993, 1992
and 1991 was comprised of deferred federal benefits of $2,994,000, $8,806,000
and $9,996,000, respectively, arising from reported financial losses and state
income tax expense of $1,984,000 and $888,000 in fiscal 1993 and 1992,
respectively. For financial reporting purposes, Holdings has utilized
substantially all of its deferred federal tax liability and has limited the
benefit recognized for the current net operating loss pursuant to the provisions
of SFAS No. 96. Taxes paid during 1993 and 1992 primarily relate to state income
taxes and estimated federal tax payments.
F-52
<PAGE> 102
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
The Company's consolidated effective federal tax rate differed from the
federal statutory rate as set forth in the following table:
<TABLE>
<CAPTION>
FOR THE YEAR ENDED
SEPTEMBER 30
---------------------------
1993 1992 1991
-------- ------ -------
(DOLLARS IN THOUSANDS)
<S> <C> <C> <C>
Tax benefit computed at federal statutory rate (34%)...... $ 9,538 $9,553 $10,732
Amortization of excess purchase price over net assets
acquired................................................ (790) (614) (601)
Losses not subject to benefit............................. (5,611) -- --
Other, net................................................ (143) (133) (135)
-------- ------ -------
Deferred income tax benefit............................... $ 2,994 $8,806 $ 9,996
-------- ------ -------
-------- ------ -------
</TABLE>
The deferred income tax benefit results from the following temporary
differences in reporting for financial and income tax purposes:
<TABLE>
<CAPTION>
FOR THE YEAR ENDED
SEPTEMBER 30,
------------------------------
1993 1992 1991
-------- ------- -------
(DOLLARS IN THOUSANDS)
<S> <C> <C> <C>
Book/tax difference on sale of assets.................. $ 3,835 $ -- $ --
Book/tax depreciation differences...................... 475 221 (3,392)
Net operating (benefit) loss recognized currently for
financial reporting.................................. (3,508) (1,582) 6,134
SAR compensation not currently deductible.............. 968 3,673 2,426
Professional liability reserves not currently
deductible........................................... 383 1,013 4,345
Other reserves for estimated losses and contingencies
not currently deductible............................. 1,348 2,217 508
Paid time off accrued for financial reporting, not
currently deductible................................. 339 719 89
Difference arising from ESOP loan fees initially
expensed for tax purposes but capitalized and
amortized for financial reporting purposes........... 197 427 (480)
Difference in methods used to reserve for bad debts.... 802 1,014 55
Difference in ESOP contribution deduction.............. (162) 207 (1,317)
Difference in methods for reporting interest........... 1,553 562 694
Losses not subject to benefit.......................... (5,611) -- --
Other.................................................. 2,375 335 934
-------- ------- -------
Deferred income tax benefit............................ $ 2,994 $ 8,806 $ 9,996
-------- ------- -------
-------- ------- -------
</TABLE>
7. DEFERRED COMPENSATION
The Company has adopted a deferred compensation plan (the "SAR Plan") as
part of its overall executive compensation program to attract, motivate and
retain key employee-owners. As of September 30, 1993, 5,873,582 SAR Plan units,
each exchangeable for one share of Holdings Common Stock or redeemable for cash
or other property under certain circumstances, were held by certain key
employee-owners and former employee-owners. During fiscal 1993, 1992 and 1991,
309,500, 1,481,065, and 1,002,000 SAR Plan units were granted and 427,800,
218,000, and 243,000 SAR Plan units were cancelled, respectively. The
outstanding SAR Plan units vest in varying amounts at varying periods not
exceeding five years beginning on each respective grant date. A maximum of
6,587,565 SAR Plan units, reduced by all units redeemed, may be
F-53
<PAGE> 103
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
outstanding at any time. During fiscal 1993, 1992 and 1991, the Company accrued
SAR Plan compensation expense of $4,249,000, $11,805,000, and $8,135,000,
respectively.
During fiscal 1993, 123,417 SAR Plan units were redeemed for $974,994 in
cash ($7.90 per unit) and 3,125 units were redeemed for $25,000 in cash ($8.00
per unit); in October 1993, 121,874 SAR Plan units were redeemed for $974,996 in
cash ($8.00 per unit).
During fiscal 1992, 129,998 SAR Plan units were redeemed for $974,985 in
cash ($7.50 per unit) and 3,164 SAR Plan units were redeemed for $24,996 in cash
($7.90 per unit).
8. COMMON STOCK OPTIONS
On December 14, 1988, the Company adopted the EPIC Healthcare Group, Inc.
Stock Option Plan (the "Stock Option Plan"). Under the Stock Option Plan, the
Board of Directors is authorized to grant options to EPIC directors, officers
and salaried employee-owners to purchase up to 500,000 shares of Holdings Common
Stock. Options granted vest in five equal annual installments. No options were
granted during fiscal 1993, 1992 or 1991. At September 30, 1993, options for
32,000 shares were exercisable.
9. COMMON STOCK AND COMMON STOCK WARRANTS
The Company sold 24,500,000 shares of EPIC Common Stock to the EPIC ESOP on
September 30, 1988. Since that time through the Merger, 69,445 shares were
distributed to participants in the EPIC ESOP, of which 66,684 shares were
repurchased by the Company. In addition, immediately prior to the Merger,
6,306,395 of warrants outstanding were exercised for 63,064 shares of EPIC
Common Stock. Pursuant to the Merger, each share of EPIC Common Stock was
converted to Holdings Common Stock and the Company issued 1,000 shares of EPIC
Common Stock to Holdings.
10. LOSS PER COMMON SHARE
Because EPIC is a wholly-owned subsidiary of Holdings, loss per common
share is not meaningful and, therefore, is not presented.
11. PROFESSIONAL AND GENERAL LIABILITY RISKS
The Company is self-insured for its professional and general liability
risks. As of September 30, 1993, the unfunded reserve for this self insurance
was $45,130,000 of which $11,000,000 was included in current liabilities. The
Company has funded $12,482,000 of the reserves through a wholly-owned captive
insurance company at September 30, 1993. The reserves for losses and related
expenses are discounted to their present value based on expected loss reporting
patterns determined by independent actuaries using a rate of 9%. AMI has
retained the liability for all professional liability claims with a date of
occurrence prior to October 1, 1988.
12. RELATED PARTY TRANSACTIONS
EPIC and AMI entered into an interest rate cap agreement (the "Senior
Interest Cap Agreement") whereby AMI agreed to pay to EPIC the amounts by which
EPIC's interest costs under certain tranches of indebtedness exceeded, during
each of the three fiscal years after September 30, 1988, certain specified
rates, net of the effect of any reimbursement to EPIC by Medicare, Medicaid, or
Blue Cross for any interest expense incurred by EPIC in excess of such rates in
connection with such loans.
On August 28, 1991, EPIC and AMI agreed that it was mutually in their best
interest to terminate the Senior Interest Cap Agreement prior to its scheduled
expiration of October 1, 1991. EPIC and AMI further agreed that each party had
fully performed all of its obligations under the Senior Interest Cap Agreement
and each party released the other from future obligations thereunder.
F-54
<PAGE> 104
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
Pursuant to the terms of the Senior Interest Cap Agreement, EPIC issued
Additional Zero Coupon Notes to AMI in the principal amounts of $1,612,000 and
$2,844,000 during fiscal 1990 and 1989, respectively, in exchange for cash of a
like amount paid to EPIC by AMI during such years. In fiscal 1991, EPIC paid to
AMI $2,864,000 and issued Additional Zero Coupon Notes to AMI with a present
value of $626,000 in exchange for the cancellation of the Zero Coupon Notes
issued in 1989. AMI has sold their interest in the Additional Zero Coupon Notes.
Net interest expense of $839,000 was recognized during fiscal 1991 relating to
this agreement.
The Company and AMI have entered into certain other agreements, including a
registration rights agreement pursuant to which EPIC has agreed to register the
securities issued to AMI under the Securities Act of 1933. AMI has also agreed
to indemnify the Company against certain liabilities associated with the breach
of representations and warrants made by AMI, certain tax liabilities that may
arise, certain reimbursements still pending related to the Acquisitions, and
certain fees, costs, and expenses.
During fiscal 1993, AMI reimbursed $1,621,000 relating to AMI's
indemnifications of EPIC for certain intermediary adjustments to reimburse costs
relating to cost report years that preceded the formation of EPIC.
The Company entered into a three year group purchasing agreement, effective
September 1, 1993, with a subsidiary of AMI, which allows the Company to
purchase supplies at lower group rates. The Company expects to purchase more
than $30,000,000 per year of supplies under the terms of the agreement. The
Company will pay $180,000 per year to participate in this program.
David R. Belle-Isle, a former officer of EPIC, borrowed $181,000 from EPIC
in December 1988 in connection with his relocation to Texas. The loan was
interest free until it was restructured in October 1990. Effective as of the
30th day of September 1991, this debt, totalling $160,000, was forgiven. The
Company reimbursed Mr. Belle-Isle for the tax liability associated with the
forgiveness of the loan.
The Company has a consulting agreement with The Elder Group, of which
Thomas H. Elder, who formerly served as the Company's Management Services
Officer, is the Managing Principal. The Company paid The Elder Group
approximately $1,300,000 and $1,000,000 in fiscal 1992 and 1991, respectively.
The Company has an investment in the preferred stock of the Compucare
Company ("Compucare"), who is developing and installing one of the Company's new
information systems. The chief executive officer of the Company is on the board
of directors of Compucare. Payments to Compucare for fiscal 1993 totalled
$5,651,000.
13. FAIR VALUES OF FINANCIAL INSTRUMENTS
SFAS No. 107, "Disclosures About Fair Value of Financial Instruments",
requires disclosure of fair value information about financial instruments,
whether or not recognized in the balance sheet, for which it is practicable to
estimate that value. In cases where quoted market prices are not available, fair
values are based on estimates using present value or other valuation techniques.
Those techniques are significantly affected by the assumptions used, including
the discount rate and estimates of future cash flows. In that regard, the
derived fair value estimates cannot be substantiated by comparison to
independent markets and, in many cases, could not be realized in immediate
settlement of the instrument. SFAS No. 107 excluded certain financial
instruments and all nonfinancial instruments from its disclosure requirements.
Accordingly, the aggregate fair value amounts presented do not represent the
underlying value of the Company. The following methods and assumptions were used
by the Company in estimating its fair value disclosures for financial
instruments.
F-55
<PAGE> 105
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
Cash Equivalents, Cash Restricted for Interest Payments, and Marketable
Securities
The carrying amounts reported in the consolidated balance sheets for cash
equivalents, cash restricted for interest payments, and marketable interest
bearing securities approximates their fair values.
Long-Term Debt (Including Current Maturities)
The fair values of the Company's long-term debt, except the Class B-1 and
B-2 First Priority Mortgage Notes, are estimated using quoted market prices or
the call price. The fair values of the Class B-1 and B-2 First Priority Mortgage
Notes are estimated using discounted cash flow analysis, based on the Company's
incremental borrowing rate for similar types of borrowing arrangements.
The carrying amounts and estimated fair values of the Company's financial
instruments at September 30, 1993 are as follows (in thousands):
<TABLE>
<CAPTION>
CARRYING FAIR
AMOUNT VALUE
-------- --------
<S> <C> <C>
Cash equivalents, cash restricted for interest payments, and
marketable securities.......................................... $107,923 $107,923
Long-term debt................................................... 560,322 605,131
</TABLE>
14. EXTRAORDINARY ITEMS
Extraordinary items of $21,299,000 ($21,960,000, net of income tax benefit
of $661,000) in 1993, $1,265,000 ($1,917,000, net of income tax benefit of
$652,000) in 1992 and $2,581,000 ($3,911,000, net of income tax benefit of
$1,330,000) in 1991 were primarily due to the write-offs of loan issue costs and
unamortized discounts on retirements of long-term debt (see Note 5).
15. SUPPLEMENTARY INCOME STATEMENT INFORMATION
Maintenance and repair expense was $17,101,000, $17,564,000, and
$16,159,000 for fiscal 1993, 1992 and 1991, respectively.
16. CONTINGENCIES
Final determination of amounts earned under prospective payment and
cost-reimbursement programs is subject to review by appropriate governmental
authorities or their agents. In the opinion of management, adequate provision
has been made for any adjustments that could result from such reviews.
The Company is currently, and from time to time expects to be, subject to
claims and suits arising in the ordinary course of business. In the opinion of
management, the ultimate resolution of such matters will not have a material
effect on the Company's results of operations, financial position, or liquidity.
Pursuant to the terms of the Acquisitions, claims relating to litigation,
medical benefits, and workers' compensation occurring prior to October 1, 1988,
remain the obligation of AMI.
17. GUARANTOR SUBSIDIARIES
Certain subsidiaries of EPIC (the "Guarantor Subsidiaries") guarantee the
loans under the Amended Credit Agreement, Zero Coupon Notes, Additional Zero
Coupon Notes, 11.875% Senior ESOP Notes, 10.875% Senior Subordinated Notes, 15%
Senior Subordinated Notes and 11% Junior Subordinated Pay-In-Kind Notes. Certain
other subsidiaries, including EPIC Properties, are not Guarantor Subsidiaries
(the "Nonguarantor Subsidiaries") (see Note 5). All equity interests in the
Nonguarantor Subsidiaries, other than those held by minority interests, are held
by EPIC.
F-56
<PAGE> 106
Following is condensed consolidating financial information of EPIC, the
Guarantor Subsidiaries, EPIC Properties and the other Nonguarantor Subsidiaries:
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING BALANCE SHEETS
SEPTEMBER 30, 1993
(DOLLARS IN THOUSANDS)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
ASSETS
<TABLE>
<CAPTION>
EPIC
EPIC HEALTHCARE
HEALTHCARE OTHER GROUP, INC.
GROUP, GUARANTOR EPIC NONGUARANTOR AND
INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
---------- ------------ ---------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
CURRENT ASSETS
Cash and cash equivalents............... $ 8,944 $ 40,846 $ 2,062 $ 4,904 $ -- $ 56,756
Cash restricted for interest payment.... -- -- 3,820 -- -- 3,820
Marketable securities................... -- 35,972 -- 11,375 -- 47,347
Accounts receivable, net................ 474 56,000 1,071 21,321 (1,909) 76,957
Supply inventories...................... -- 16,589 -- 4,098 -- 20,687
Prepaid expenses and other.............. 777 2,714 -- 1,083 -- 4,574
Receivables from affiliates............. 156,437 29,013 -- 13,663 (199,113) --
---------- ------------ ---------- ------------ ------------ ------------
TOTAL CURRENT ASSETS.............. 166,632 181,134 6,953 56,444 (201,022) 210,141
---------- ------------ ---------- ------------ ------------ ------------
PROPERTY AND EQUIPMENT.................... -- 264,044 444,673 78,081 -- 786,798
ACCUMULATED DEPRECIATION AND
AMORTIZATION............................ -- (50,548) (140,665) (27,533) -- (218,746)
---------- ------------ ---------- ------------ ------------ ------------
-- 213,496 304,008 50,548 -- 568,052
---------- ------------ ---------- ------------ ------------ ------------
INVESTMENTS IN SUBSIDIARIES............... 64,684 109,474 -- -- (174,158) --
EXCESS OF PURCHASE PRICE OVER NET ASSETS
ACQUIRED, net........................... -- 38,577 -- 14,388 -- 52,965
OTHER ASSETS, net......................... 12,440 89,314 936 2,529 (71,401) 33,818
RECEIVABLES FROM AFFILIATES............... 297,673 -- -- -- (297,673) --
---------- ------------ ---------- ------------ ------------ ------------
TOTAL ASSETS...................... $ 541,429 $631,995 $ 311,897 $123,909 $ (744,254) $ 864,976
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
CURRENT LIABILITIES
Current maturities of long-term debt.... $ 45,333 $ 643 $ 1,020 $ 918 $ -- $ 47,914
Accounts payable........................ 236 39,225 (65) 5,450 (236) 44,610
Accrued liabilities..................... 9,294 64,070 5,624 10,216 (1,673) 87,531
Payables to affiliates.................. -- 164,963 -- 34,150 (199,113) --
---------- ------------ ---------- ------------ ------------ ------------
TOTAL CURRENT LIABILITIES......... 54,863 268,901 6,579 50,734 (201,022) 180,055
---------- ------------ ---------- ------------ ------------ ------------
LONG-TERM DEBT............................ 321,895 8,948 241,927 11,039 (71,401) 512,408
DEFERRED INCOME TAXES..................... 5,994 -- -- -- -- 5,994
RESERVE FOR PROFESSIONAL LIABILITY
RISKS................................... -- 34,053 -- 11,206 1,353 46,612
OTHER DEFERRED LIABILITIES................ -- 41,258 -- 1,192 -- 42,450
MINORITY INTERESTS........................ -- 4,947 -- 525 -- 5,472
PAYABLES TO AFFILIATES.................... -- 297,673 -- -- (297,673) --
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock............................ -- -- 1 -- (1) --
Paid-in capital......................... 373,838 61,855 111,604 5,434 (178,893) 373,838
Notes receivable from EPIC ESOP......... (100,000 ) -- (48,214) -- -- (148,214)
Retained earnings (deficit)............. (115,161 ) (85,640) -- 43,779 3,383 (153,639)
---------- ------------ ---------- ------------ ------------ ------------
TOTAL STOCKHOLDERS' EQUITY
(DEFICIT)....................... 158,677 (23,785) 63,391 49,213 (175,511) 71,985
---------- ------------ ---------- ------------ ------------ ------------
TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY
(DEFICIT)....................... $ 541,429 $631,995 $ 311,897 $123,909 $ (744,254) $ 864,976
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
</TABLE>
F-57
<PAGE> 107
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING BALANCE SHEETS
SEPTEMBER 30, 1992
(DOLLARS IN THOUSANDS)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
ASSETS
<TABLE>
<CAPTION>
EPIC
EPIC HEALTHCARE
HEALTHCARE OTHER GROUP, INC.
GROUP, GUARANTOR EPIC NONGUARANTOR AND
INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
---------- ------------ ---------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
CURRENT ASSETS
Cash and cash equivalents.............. $ 86 $ 22,381 $ 4,506 $ 5,668 $ -- $ 32,641
Cash restricted for interest payment... -- -- 5,768 -- -- 5,768
Marketable securities.................. -- 4,468 -- 6,139 -- 10,607
Accounts receivable, net............... 352 35,530 1,455 38,601 (2,540) 73,398
Supply inventories..................... -- 15,345 -- 4,655 -- 20,000
Prepaid expenses and other............. 240 8,447 259 826 (4,550) 5,222
Receivables from affiliates............ 132,015 26,543 -- 12,023 (170,581) --
---------- ------------ ---------- ------------ ------------ ------------
TOTAL CURRENT ASSETS............. 132,693 112,714 11,988 67,912 (177,671) 147,636
---------- ------------ ---------- ------------ ------------ ------------
PROPERTY AND EQUIPMENT................... -- 185,431 450,259 74,794 -- 710,484
ACCUMULATED DEPRECIATION AND
AMORTIZATION........................... -- (34,377) (116,355 ) (23,057) -- (173,789)
---------- ------------ ---------- ------------ ------------ ------------
-- 151,054 333,904 51,737 -- 536,695
---------- ------------ ---------- ------------ ------------ ------------
INVESTMENTS IN SUBSIDIARIES.............. 66,219 146,521 -- 11,502 (224,242) --
EXCESS OF PURCHASE PRICE OVER NET ASSETS
ACQUIRED, net.......................... -- 35,576 -- 12,564 -- 48,140
OTHER ASSETS, net........................ 21,387 77,466 1,102 4,362 (66,002) 38,315
RECEIVABLES FROM AFFILIATES.............. 229,544 12,113 -- -- (241,657) --
---------- ------------ ---------- ------------ ------------ ------------
TOTAL ASSETS..................... $ 449,843 $535,444 $ 346,994 $148,077 $ (709,572) $ 770,786
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
LIABILITIES AND STOCKHOLDER'S EQUITY (DEFICIT)
CURRENT LIABILITIES
Current maturities of long-term debt... $ -- $ 597 $ 1,018 $ 715 $ -- $ 2,330
Accounts payable....................... -- 29,440 260 5,350 (241) 34,809
Accrued liabilities.................... 4,323 53,190 10,016 13,152 (6,849) 73,832
Payables to affiliates................. -- 140,007 -- 30,574 (170,581) --
---------- ------------ ---------- ------------ ------------ ------------
TOTAL CURRENT LIABILITIES........ 4,323 223,234 11,294 49,791 (177,671) 110,971
---------- ------------ ---------- ------------ ------------ ------------
LONG-TERM DEBT........................... 274,018 9,363 242,803 10,553 (66,002) 470,735
DEFERRED INCOME TAXES.................... 8,988 -- -- -- -- 8,988
RESERVE FOR PROFESSIONAL LIABILITY
RISKS.................................. -- 32,095 -- 6,749 796 39,640
OTHER DEFERRED LIABILITIES............... -- 37,492 -- 2,115 -- 39,607
MINORITY INTERESTS....................... -- 3,847 -- 19,647 23,494 --
PAYABLES TO AFFILIATES................... -- 199,942 -- 41,715 (241,657) --
STOCKHOLDER'S EQUITY (DEFICIT)
Common stock........................... -- -- 1 -- (1) --
Paid-in capital........................ 374,860 51,853 159,351 13,037 (224,241) 374,860
Notes receivable from EPIC ESOP........ (100,000 ) -- (68,929 ) -- -- (168,929)
Retained earnings (deficit)............ (112,346 ) (22,382) 2,474 4,470 (796) (128,580)
---------- ------------ ---------- ------------ ------------ ------------
TOTAL STOCKHOLDER'S EQUITY
(DEFICIT)...................... 162,514 29,471 92,897 17,507 (225,038) 77,351
---------- ------------ ---------- ------------ ------------ ------------
TOTAL LIABILITIES AND
STOCKHOLDER'S EQUITY
(DEFICIT)...................... $ 449,843 $535,444 $ 346,994 $148,077 $ (709,572) $ 770,786
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
</TABLE>
F-58
<PAGE> 108
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
FOR THE YEAR ENDED SEPTEMBER 30, 1993
(DOLLARS IN THOUSANDS)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
<TABLE>
<CAPTION>
EPIC
EPIC HEALTHCARE
HEALTHCARE OTHER GROUP, INC.
GROUP, GUARANTOR EPIC NONGUARANTOR AND
INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
---------- ------------ ---------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
NET OPERATING REVENUE.................... $ -- $792,442 $ 54,596 $237,072 $ (64,961) $1,019,149
COSTS AND EXPENSES:
Operating expenses..................... 269 747,344 482 214,040 (64,080) 898,055
Depreciation and amortization.......... 1,618 21,289 27,602 7,733 (325) 57,917
Interest expense....................... 48,089 68,744 27,778 3,230 (76,907) 70,934
---------- ------------ ---------- ------------ ------------ ------------
TOTAL COSTS AND EXPENSES......... 49,976 837,377 55,862 225,003 (141,312) 1,026,906
INTEREST INCOME.......................... 66,148 10,165 3,528 693 (76,907) 3,627
GAIN (LOSS) ON SALE OF ASSETS............ -- 3,524 1 (4) -- 3,521
---------- ------------ ---------- ------------ ------------ ------------
INCOME (LOSS) BEFORE INCOME TAX BENEFIT
(EXPENSE), MINORITY INTERESTS AND
EXTRAORDINARY ITEM..................... 16,172 (31,246) 2,263 12,758 (556) (609)
INCOME TAX BENEFIT (EXPENSE), net........ 2,207 (1,910) -- (54) -- 243
MINORITY INTERESTS IN INCOME OF
CONSOLIDATED SUBSIDIARIES (net of
income tax benefit).................... 105 (2,659) -- (840) -- (3,394)
---------- ------------ ---------- ------------ ------------ ------------
INCOME (LOSS) BEFORE EXTRAORDINARY
ITEM................................... 18,484 (35,815) 2,263 11,864 (556) (3,760)
EXTRAORDINARY ITEM (net of income tax
benefit)............................... (21,299) -- -- -- -- (21,299)
---------- ------------ ---------- ------------ ------------ ------------
NET INCOME (LOSS)........................ $ (2,815) $(35,815) $ 2,263 $ 11,864 $ (556) $ (25,059)
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
</TABLE>
F-59
<PAGE> 109
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
FOR THE YEAR ENDED SEPTEMBER 30, 1992
(DOLLARS IN THOUSANDS)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
<TABLE>
<CAPTION>
EPIC
EPIC HEALTHCARE
HEALTHCARE OTHER GROUP, INC.
GROUP, GUARANTOR EPIC NONGUARANTOR AND
INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
---------- ------------ ---------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
NET OPERATING REVENUE.................... $ -- $700,752 $ 54,596 $254,183 $ (68,265) $941,266
COSTS AND EXPENSES:
Operating expenses..................... 557 675,277 425 233,876 (67,856) 842,279
Depreciation and amortization.......... 1,627 15,021 30,132 6,233 -- 53,013
Interest expense....................... 47,501 62,796 27,864 10,124 (77,285) 71,000
---------- ------------ ---------- ------------ ------------ ------------
TOTAL COSTS AND EXPENSES......... 49,685 753,094 58,421 250,233 (145,141) 966,292
INTEREST INCOME.......................... 65,453 9,815 5,609 617 (77,672) 3,822
GAIN (LOSS) ON SALE OF ASSETS............ -- (972) (151) -- -- (1,123)
---------- ------------ ---------- ------------ ------------ ------------
INCOME (LOSS) BEFORE INCOME TAX BENEFIT
(EXPENSE), MINORITY INTERESTS AND
EXTRAORDINARY ITEM..................... 15,768 (43,499) 1,633 4,567 (796) (22,327)
INCOME TAX BENEFIT (EXPENSE), net........ 7,146 (888) -- -- -- 6,258
MINORITY INTERESTS IN INCOME OF
CONSOLIDATED SUBSIDIARIES (net of
income tax benefit).................... 1,008 (473) -- (2,493) -- (1,958)
---------- ------------ ---------- ------------ ------------ ------------
INCOME (LOSS) BEFORE EXTRAORDINARY
ITEM................................... 23,922 (44,860) 1,633 2,074 (796) (18,027)
EXTRAORDINARY ITEM (net of income tax
benefit)............................... (1,265) -- -- -- -- (1,265)
---------- ------------ ---------- ------------ ------------ ------------
NET INCOME (LOSS)........................ $ 22,657 $(44,860) $ 1,633 $ 2,074 $ (796) $(19,292)
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
</TABLE>
F-60
<PAGE> 110
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
FOR THE YEAR ENDED SEPTEMBER 30, 1991
(DOLLARS IN THOUSANDS)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
<TABLE>
<CAPTION>
EPIC
EPIC HEALTHCARE
HEALTHCARE OTHER GROUP, INC.
GROUP, GUARANTOR EPIC NONGUARANTOR AND
INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
---------- ------------ ---------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
NET OPERATING REVENUE.................... $ -- $633,401 $ 9,394 $173,480 $(13,586) $802,689
COSTS AND EXPENSES:
Operating expenses..................... 146 570,706 -- 157,191 (13,586) 714,457
Depreciation and amortization.......... 1,627 36,272 4,953 6,502 -- 49,354
Interest expense....................... 59,387 63,096 4,860 5,942 (65,019) 68,266
---------- ------------ ---------- ------------ ------------ ------------
TOTAL COSTS AND EXPENSES......... 61,160 670,074 9,813 169,635 (78,605) 832,077
INTEREST INCOME.......................... 64,014 4,931 1,260 219 (65,019) 5,405
GAIN (LOSS) ON SALE OF ASSETS............ -- 105 1 (649) -- (543)
---------- ------------ ---------- ------------ ------------ ------------
INCOME (LOSS) BEFORE INCOME TAX BENEFIT,
MINORITY INTERESTS AND EXTRAORDINARY
ITEM................................... 2,854 (31,637) 842 3,415 -- (24,526)
INCOME TAX BENEFIT....................... 7,603 -- -- -- -- 7,603
MINORITY INTERESTS IN INCOME OF
CONSOLIDATED SUBSIDIARIES (net of
income tax benefit).................... 1,069 (1,366) -- (1,767) -- (2,064)
---------- ------------ ---------- ------------ ------------ ------------
INCOME (LOSS) BEFORE EXTRAORDINARY
ITEM................................... 11,526 (33,003) 842 1,648 -- (18,987)
EXTRAORDINARY ITEM (net of income tax
benefit)............................... (2,581) -- -- -- -- (2,581)
---------- ------------ ---------- ------------ ------------ ------------
NET INCOME (LOSS)........................ $ 8,945 $(33,003) $ 842 $ 1,648 $ -- $(21,568)
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
</TABLE>
F-61
<PAGE> 111
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
FOR THE YEAR ENDED SEPTEMBER 30, 1993
(DOLLARS IN THOUSANDS)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
<TABLE>
<CAPTION>
EPIC
EPIC HEALTHCARE
HEALTHCARE OTHER GROUP, INC.
GROUP, GUARANTOR EPIC NONGUARANTOR AND
INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
---------- ------------ ---------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
Net cash provided by (used in) operating
activities............................. $ (46,950 ) $125,482 $ 28,428 $ 12,273 $ -- $119,233
INVESTING ACTIVITIES
Investments in marketable securities,
net.................................. -- (31,504) -- (5,236) -- (36,740)
Cash paid for acquisitions............. -- (50,835) -- (3,701) -- (54,536)
Additions to property and equipment.... -- (57,957) (6,432) (2,827) 6,432 (60,784)
Proceeds from sale of assets........... -- 31,580 -- -- (6,432) 25,148
Collection on note receivable.......... -- 9,349 -- -- -- 9,349
Principal collected on note receivable
from EPIC ESOP....................... -- -- 20,715 -- (20,715) --
Other.................................. -- (5,925) -- -- -- (5,925)
---------- ------------ ---------- ------------ ------------ ------------
Net cash provided by (used in)
investing activities................. -- (105,292) 14,283 (11,764) (20,715) (123,488)
FINANCING ACTIVITIES
Payments on debt obligations........... (115,180 ) (498) (1,018) (1,069) -- (117,765)
Proceeds from long-term borrowings..... 179,500 1,353 -- -- -- 180,853
Purchase of Senior ESOP Notes.......... -- (5,616) -- -- -- (5,616)
Dividends paid to EPIC Holdings........ (1,022 ) -- -- -- -- (1,022)
Contribution to EPIC ESOP.............. -- (20,715) -- -- 20,715 --
Dividends and capital distributions
received from EPIC Properties........ -- 44,137 -- -- (44,137) --
Dividends and capital distributions
paid by EPIC Properties.............. -- -- (44,137) -- 44,137 --
Contributions from minority
interests............................ -- 520 -- -- -- 520
Distributions and dividends to minority
interests............................ -- (20,906) -- (204) -- (21,110)
Payment of debt issue costs and other,
net.................................. (7,490 ) -- -- -- -- (7,490)
---------- ------------ ---------- ------------ ------------ ------------
Net cash provided by (used in)
financing activities................. 55,808 (1,725) (45,155) (1,273) 20,715 28,370
---------- ------------ ---------- ------------ ------------ ------------
INCREASE (DECREASE) IN CASH AND CASH
EQUIVALENTS............................ 8,858 18,465 (2,444) (764) -- 24,115
CASH AND CASH EQUIVALENTS AT BEGINNING OF
YEAR................................... 86 22,381 4,506 5,668 -- 32,641
---------- ------------ ---------- ------------ ------------ ------------
CASH AND CASH EQUIVALENTS AT END OF
YEAR................................... $ 8,944 $ 40,846 $ 2,062 $ 4,904 $ -- $ 56,756
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
</TABLE>
F-62
<PAGE> 112
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
FOR THE YEAR ENDED SEPTEMBER 30, 1992
(DOLLARS IN THOUSANDS)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
<TABLE>
<CAPTION>
EPIC
EPIC HEALTHCARE
HEALTHCARE OTHER GROUP, INC.
GROUP, GUARANTOR EPIC NONGUARANTOR AND
INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
---------- ------------ ---------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
Net cash provided by (used in) operating
activities............................. $ 9,427 $ (3,682) $ 34,846 $ 17,321 $ -- $ 57,912
INVESTING ACTIVITIES
Investments in marketable securities,
net.................................. -- 11,306 -- (6,139) -- 5,167
Cash paid for acquisitions............. -- (9,903) -- (2,366) -- (12,269)
Additions to property and equipment.... -- (31,503) (9,764) (6,583) -- (47,850)
Purchase of investment securities...... (4,180) -- -- -- -- (4,180)
Principal collected on note receivable
from EPIC ESOP....................... -- -- 20,714 -- (20,714) --
Other.................................. 612 (2,704) 236 -- -- (1,856)
---------- ------------ ---------- ------------ ------------ ------------
Net cash provided by (used in)
investing activities................. (3,568) (32,804) 11,186 (15,088) (20,714) (60,988)
FINANCING ACTIVITIES
Payments on debt obligations........... -- (76) (516) (1,011) -- (1,603)
Purchase of Senior ESOP Notes.......... -- (20,293) -- -- -- (20,293)
Contribution to EPIC ESOP.............. -- (20,714) -- -- 20,714 --
Dividends paid to EPIC Holdings........ (1,300) -- -- -- -- (1,300)
Dividends and capital distributions
received from EPIC Properties........ -- 54,519 -- 2,844 (57,363) --
Dividends and capital distributions
paid by EPIC Properties.............. -- -- (57,363) -- 57,363 --
Preferred stock transaction costs...... (7,063) -- -- -- -- (7,063)
Contributions from minority
interests............................ -- -- -- 1,884 -- 1,884
Distributions and dividends to minority
interests............................ -- (335) -- (3,730) -- (4,065)
Contribution to subsidiary............. (1,500) -- -- -- 1,500 --
Issuance of capital stock by
subsidiary........................... -- -- -- 1,500 (1,500) --
Payment of debt issue costs and other,
net.................................. (294) (236) (132) -- -- (662)
---------- ------------ ---------- ------------ ------------ ------------
Net cash provided by (used in)
financing activities................. (10,157) 12,865 (58,011) 1,487 20,714 (33,102)
---------- ------------ ---------- ------------ ------------ ------------
INCREASE (DECREASE) IN CASH AND CASH
EQUIVALENTS............................ (4,298) (23,621) (11,979) 3,720 -- (36,178)
CASH AND CASH EQUIVALENTS AT BEGINNING OF
YEAR................................... 4,384 46,002 16,485 1,948 -- 68,819
---------- ------------ ---------- ------------ ------------ ------------
CASH AND CASH EQUIVALENTS AT END OF
YEAR................................... $ 86 $ 22,381 $ 4,506 $ 5,668 $ -- $ 32,641
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
</TABLE>
F-63
<PAGE> 113
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
FOR THE YEAR ENDED SEPTEMBER 30, 1991
(DOLLARS IN THOUSANDS)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
<TABLE>
<CAPTION>
EPIC
EPIC HEALTHCARE
HEALTHCARE OTHER GROUP, INC.
GROUP, GUARANTOR EPIC NONGUARANTOR AND
INC. SUBSIDIARIES PROPERTIES SUBSIDIARIES ELIMINATIONS SUBSIDIARIES
---------- ------------ ---------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C> <C>
Net cash provided by (used in) operating
activities............................. $ (3,274) $ 68,299 $ 6,128 $ 7,807 $ -- $ 78,960
INVESTING ACTIVITIES
Investments in marketable securities,
net.................................. -- (12,091) -- -- -- (12,091)
Additions to property and equipment.... -- (23,002) (198,868 ) (2,644) 198,868 (25,646)
Proceeds from sales of assets.......... -- 199,190 -- 39 (198,868) 361
Principal collected on note receivable
from EPIC ESOP....................... 12,717 -- 10,357 -- (23,074) --
Principal collected on intercompany
note receivable...................... 41,041 -- -- -- (41,041) --
Other.................................. (48) -- -- -- -- (48)
---------- ------------ ---------- ------------ ------------ ------------
Net cash provided by (used in)
investing activities................. 53,710 164,097 (188,511 ) (2,605) (64,115) (37,424)
FINANCING ACTIVITIES
Payments on debt obligations........... (244,761) (4,550) -- (1,336) -- (250,647)
Principal payments on intercompany
notes payable........................ -- (41,041) -- -- 41,041 --
Proceeds from long-term borrowings..... 29,000 -- 198,868 -- -- 227,868
Contribution to EPIC ESOP.............. -- (23,074) -- -- 23,074 --
Intercompany dividends................. 153,308 (153,308) -- -- -- --
Contributions from minority
interests............................ -- -- -- 556 -- 556
Distributions and dividends to minority
interests............................ -- -- -- (4,122) -- (4,122)
Payment of debt issue costs and other,
net.................................. (10,473) -- -- (1,290) -- (11,763)
---------- ------------ ---------- ------------ ------------ ------------
Net cash provided by (used in)
financing activities................. (72,926) (221,973) 198,868 (6,192) 64,115 (38,108)
---------- ------------ ---------- ------------ ------------ ------------
INCREASE (DECREASE) IN CASH AND CASH
EQUIVALENTS............................ (22,490) 10,423 16,485 (990) -- 3,428
CASH AND CASH EQUIVALENTS AT BEGINNING OF
YEAR................................... 26,874 35,579 -- 2,938 -- 65,391
---------- ------------ ---------- ------------ ------------ ------------
CASH AND CASH EQUIVALENTS AT END OF
YEAR................................... $ 4,384 $ 46,002 $ 16,485 $ 1,948 $ -- $ 68,819
---------- ------------ ---------- ------------ ------------ ------------
---------- ------------ ---------- ------------ ------------ ------------
</TABLE>
F-64
<PAGE> 114
EPIC HEALTHCARE GROUP, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
The subsidiaries comprising the Guarantor Subsidiaries change from year to
year due to new and/or revised agreements relating to the various subsidiaries
of the Company. As a result, the investment in subsidiaries is presented on the
cost basis.
Intercompany receivables/payables relate to cash transfers between entities
on collection of accounts receivable and payment of accounts payable and are
included in cash flows provided by (used in) operating activities. Cash flows
from operating, financing, and investing activities for each subsidiary are
presented in the consolidating statement of cash flows based on that
subsidiary's designation as a guarantor or nonguarantor subsidiary at the end of
the period.
Deferred income taxes and deferred income tax benefit are recorded in the
accounts of EPIC Healthcare Group, Inc. and are not allocated to the
subsidiaries. SFAS No. 109, "Accounting for Income Taxes," requires that the
consolidated amount of current and deferred tax expense for a group that files a
consolidated tax return shall be allocated among the members of the group when
those members issue separate financial statements on a basis consistent with
SFAS No. 109. The Company will adopt SFAS No. 109, including allocation of taxes
within the consolidating financial statements, effective October 1, 1993.
Certain prior period amounts have been reclassified or restated for
intercompany transactions to conform with the fiscal 1993 presentation. In
addition, certain amounts have been reclassified for a change made in the fourth
quarter of 1992 in the method of allocating interest income from the EPIC ESOP
for intercompany purposes.
F-65
<PAGE> 115
- ---------------------------------------------------------
- ---------------------------------------------------------
NO PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR MAKE ANY
REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS PROSPECTUS, AND, IF GIVEN OR
MADE, SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON AS HAVING BEEN
AUTHORIZED BY HEALTHTRUST, INC. - THE HOSPITAL COMPANY OR ANY UNDERWRITER,
DEALER OR AGENT. THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFER TO SELL OR THE
SOLICITATION OF AN OFFER TO BUY ANY SECURITIES OTHER THAN THE SECURITIES TO
WHICH IT RELATES OR ANY OFFER TO SELL OR THE SOLICITATION OF ANY OFFER TO BUY
SUCH SECURITIES IN ANY CIRCUMSTANCES IN WHICH SUCH OFFER OR SOLICITATION IS
UNLAWFUL. NEITHER THE DELIVERY OF THIS PROSPECTUS NOR ANY SALE MADE HEREUNDER
SHALL, UNDER ANY CIRCUMSTANCES, CREATE ANY IMPLICATION THAT THERE HAS BEEN NO
CHANGE IN THE AFFAIRS OF HEALTHTRUST, INC. - THE HOSPITAL COMPANY SINCE THE DATE
HEREOF OR THAT THE INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME
SUBSEQUENT TO ITS DATE.
---------------------
TABLE OF CONTENTS
PROSPECTUS
<TABLE>
<CAPTION>
PAGE
----
<S> <C>
The Company.............................. 3
The Offering............................. 5
Investment Considerations................ 6
The Acquisition and the Financing Plan... 13
Use of Proceeds.......................... 15
Capitalization........................... 16
Selected Historical Financial
Information............................ 17
Selected Pro Forma Financial
Information............................ 20
Selected Operating Statistics............ 21
Description of EPIC...................... 22
Properties............................... 22
Description of the Securities............ 27
Underwriting............................. 40
Legal Matters............................ 40
Experts.................................. 40
Available Information.................... 41
Information Incorporated by Reference.... 41
Index to Financial Statements............ 42
</TABLE>
- ---------------------------------------------------------
- ---------------------------------------------------------
- ---------------------------------------------------------
- ---------------------------------------------------------
$200,000,000
HEALTHTRUST INC.
The Hospital Company
% SUBORDINATED
NOTES DUE 2004
-------------------------
PROSPECTUS
-------------------------
DONALDSON, LUFKIN & JENRETTE
SECURITIES CORPORATION
MERRILL LYNCH & CO.
, 1994
- ---------------------------------------------------------
- ---------------------------------------------------------
<PAGE> 116
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.
<TABLE>
<S> <C>
Securities and Exchange Commission registration fee............................... $ 68,966
National Association of Securities Dealers fee....................................
Printing and engraving............................................................
Accounting services...............................................................
Legal services....................................................................
Fees and expenses of Trustee......................................................
Expenses of qualification under state blue sky laws...............................
Miscellaneous.....................................................................
---------
Total...................................................................
---------
---------
</TABLE>
- ---------------
* Estimated
ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Section 145 of the Delaware General Corporation Law (the "DGCL") provides
for the indemnification of officers and directors under certain circumstances
against expenses (including attorneys' fees, judgments, fines and amounts paid
in settlement) actually and reasonably incurred in connection with the defense
or settlement of any threatened, pending or completed legal proceedings in which
he is involved by reason of the fact that he is or was a director or officer of
the Company if he acted in good faith and in a manner that he reasonably
believed to be in or not opposed to the best interests of the Company, and, in
respect to the criminal actions or proceedings, if he had no reasonable cause to
believe that his conduct was unlawful. Pursuant to Section 102(b)(7) of the
DGCL, the Company's Certificate of Incorporation (the "Certificate") provides
that the directors of the Company, individually or collectively, shall not be
held personally liable to the Company or its stockholders for monetary damages
for breaches of fiduciary duty as directors, except that any director shall
remain liable (i) for any breach of the director's fiduciary duty of loyalty to
the Company or its stockholders, (ii) for acts or omissions not in good faith or
involving intentional misconduct or a knowing violation of law, (iii) for
liability under Section 174 of the DGCL or (iv) for any transaction from which
the director derived an improper personal benefit. The Certificate and By-laws
of the Company provide for indemnification of its officers and directors to the
full extent authorized by law.
The Company maintains officers' and directors' liability insurance which
insures against liabilities that the officers and directors of the Company may
incur in such capacities.
ITEM 16. LIST OF EXHIBITS.
<TABLE>
<C> <S> <C>
**1.1 -- Form of Purchase Agreement.
2.1 -- Agreement and Plan of Merger, dated as of January 9, 1994, among the Registrant,
Odyssey Acquisition Corp. and EPIC Holdings, Inc. Incorporated by reference to
Exhibit 2.1 to the Registrant's Current Report on Form 8-K dated January 10, 1994.
*2.2 -- ESOP Agreement, dated as of January 9, 1994, among the Registrant, Odyssey
Acquisition Corp., EPIC Holdings, Inc., EPIC Healthcare Group, Inc., U.S. Trust
Company of California, N.A. and the ESOP Committee.
**2.3 -- Form of U.S. Purchase Agreement among the Registrant, certain selling stockholders
named therein and Merrill Lynch & Co. and Donaldson, Lufkin & Jenrette Securities
Corporation, as representatives of the U.S. underwriters.
</TABLE>
II-1
<PAGE> 117
<TABLE>
<C> <S> <C>
**2.4 -- Form of International Purchase Agreement among the Registrant, certain selling
stockholders named therein and Merrill Lynch International Limited and Donaldson,
Lufkin & Jenrette Securities Corporation, as representatives of the international
underwriters.
4.1 -- Indenture, dated as of March 30, 1993, between the Registrant and The First
National Bank of Boston, as Trustee. Incorporated by reference to Exhibit 2 to the
Registrant's Registration Statement on Form 8-A dated April 22, 1993.
**5.1 -- Opinion of Dewey Ballantine as to legality of the securities being registered,
including consent.
*12.1 -- Computation of Ratio of Earnings to Fixed Charges.
*12.2 -- Computation of Pro Forma Ratio of Earnings to Fixed Charges.
*23.1 -- Consent of Ernst & Young with respect to the financial statements of the
Registrant.
*23.2 -- Consent of Ernst & Young with respect to the financial statements of EPIC Holdings,
Inc. and EPIC Healthcare Group, Inc.
*24.1 -- Powers of Attorney.
**26.1 -- Form T-1 Statement of Eligibility and Qualification of Trustee under the Trust
Indenture Act of 1939 (bound separately).
</TABLE>
- ---------------
* Filed herewith.
** To be filed by amendment.
ITEM 17. UNDERTAKINGS.
Insofar as indemnification for liabilities arising under the Act may be
permitted to directors, officers and controlling persons of the registrant
pursuant to the foregoing provisions or otherwise, the registrant has been
advised that in the opinion of the Securities and Exchange Commission such
indemnification is against public policy as expressed in the Act and is,
therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the registrant in the
successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.
The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each filing of the
registrant's annual report pursuant to section 13(a) or section 15(d) of the
Securities Exchange Act of 1934 (and, where applicable, each filing of an
employee benefit plan's annual report pursuant to section 15(d) of the
Securities Exchange Act of 1934) that is incorporated by reference in the
registration statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
The undersigned registrant hereby undertakes that:
(1) For purposes of determining any liability under the Securities Act
of 1933, the information omitted from the form of prospectus filed as part
of this registration statement in reliance upon Rule 430A and contained in
a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or
(4) or 497(h) under the Securities Act shall be deemed to be part of this
registration statement as of the time it was declared effective.
(2) For the purpose of determining any liability under the Securities
Act of 1933, each post-effective amendment that contains a form of
prospectus shall be deemed to be a new registration statement relating to
the securities offered therein, and the offering of such securities at that
time shall be deemed to be the initial bona fide offering thereof.
II-2
<PAGE> 118
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES ACT OF 1933, THE REGISTRANT
CERTIFIES THAT IT HAS REASONABLE GROUNDS TO BELIEVE THAT IT MEETS ALL OF THE
REQUIREMENTS FOR FILING ON FORM S-3 AND HAS DULY CAUSED THIS REGISTRATION
STATEMENT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED, THEREUNTO DULY
AUTHORIZED, IN THE CITY OF NASHVILLE, STATE OF TENNESSEE, ON FEBRUARY 24, 1994.
HEALTHTRUST, INC. - THE HOSPITAL
COMPANY
By: /s/ MICHAEL A. KOBAN, JR.
------------------------------------
Michael A. Koban, Jr.
Senior Vice President
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES ACT OF 1933, THIS
REGISTRATION STATEMENT HAS BEEN SIGNED BY THE FOLLOWING PERSONS IN THE
CAPACITIES AND ON THE DATES INDICATED.
<TABLE>
<CAPTION>
SIGNATURE TITLE DATE
- ------------------------------------------ ------------------------------- ------------------
<C> <S> <C>
* Chairman of the Board, Chief February 24, 1994
- ------------------------------------------ Executive Officer and
R. Clayton McWhorter President; Director
(Principal Executive Officer)
* Senior Vice President and Chief February 24, 1994
- ------------------------------------------ Operating Officer; Director
W. Hudson Connery, Jr.
/s/ MICHAEL A. KOBAN, JR. Senior Vice President; Director February 24, 1994
- ------------------------------------------ (Principal Financial Officer)
Michael A. Koban, Jr.
* Director February 24, 1994
- ------------------------------------------
Donald S. MacNaughton
* Director February 24, 1994
- ------------------------------------------
Richard W. Hanselman
* Director February 24, 1994
- ------------------------------------------
Robert F. Dee
* Director February 24, 1994
- ------------------------------------------
Alethea O. Caldwell
* Director February 24, 1994
- ------------------------------------------
William T. Hjorth
* Director February 24, 1994
- ------------------------------------------
Harry N. Beaty, M.D.
* Senior Vice President and February 24, 1994
- ------------------------------------------ Controller (Principal
Kenneth C. Donahey Accounting
Officer)
*By: /s/ MICHAEL A. KOBAN, JR.
- ------------------------------------------
Michael A. Koban, Jr.
(Attorney-in-Fact)
</TABLE>
II-3
<PAGE> 1
ESOP AGREEMENT
This ESOP Agreement (the "Agreement") is made this 9th day of
January, 1994, by and among U.S. Trust Company of California, N.A., as trustee
(the "Trustee") for the trust (the "Trust") established pursuant to the EPIC
Healthcare Group, Inc. Employee Stock Ownership Plan (the "ESOP") of Epic
Healthcare Group, Inc., ("Group"), the Committee (as defined in the ESOP)
administering the ESOP, Epic Holdings, Inc. ("Company"), HealthTrust, Inc. -
The Hospital Company ("Parent") and Odyssey Acquisition Corp. ("Sub").
Capitalized terms used herein but not defined herein shall have the definitions
assigned to them in that certain Agreement and Plan of Merger, dated as of the
date hereof, among Parent, Sub and Company (the "Merger Agreement"), a copy of
which is attached hereto as Exhibit "A".
RECITALS
A. Effective as of September 30, 1988, Group established the ESOP;
B. Group and the Trustee, in its capacity as trustee, entered
into the Trust Agreement dated as of September 30, 1988 (the "Trust
Agreement"), establishing the Trust pursuant to which Group makes contributions
to the ESOP, to be invested primarily in shares of Company common stock and
held by the Trustee on behalf of ESOP participants;
C. The Trustee purchased 24,500,000 shares of Group common stock,
par value $.001 per share, from Group pursuant to the terms of the Agreement,
dated as of September 30, 1988, between Group and the Trustee (the
"Subscription Agreement"), which shares were
<PAGE> 2
subsequently exchanged for an equal number of shares of Company common stock
(such Company common stock is referred to herein as "Company Common Stock");
D. The Trustee financed the purchase of such stock by borrowing
an aggregate of $245,000,000 from Group (the "ESOP Loans") pursuant to the
terms of certain loan agreements between Group and the Trustee dated September
30, 1988, which were subsequently refinanced (such loan agreements are referred
to herein as the "ESOP Loan Agreements");
E. As security for the portion of the ESOP Loans that remains
outstanding, the Trustee pledged to Group the shares of Company Common Stock
that have not been released from pledge as a result of payments of the ESOP
Loans and allocated to the accounts of ESOP participants pursuant to the terms
of the ESOP Pledge Agreement, dated as of September 30, 1988, between Group and
the Trustee (the "Pledge Agreement");
F. Concurrently with the execution of this Agreement, Company,
Parent and Sub are entering into the Merger Agreement, pursuant to which
Company will become a wholly-owned subsidiary of Parent;
G. In connection with the Merger Agreement, Company has agreed to
amend the ESOP to convert the ESOP to a profit sharing or stock bonus plan
following consummation of the transactions contemplated hereunder;
H. The Trustee has received preliminary confirmation from its
financial advisors that the consideration to be received by the
- 2 -
<PAGE> 3
ESOP pursuant to this Agreement will result in the receipt of fair market value
for Company Common Stock transferred by the ESOP pursuant to this Agreement;
and
I. The parties hereto desire to set forth their understanding and
agreement with respect to the ESOP and the actions that each shall take in
connection therewith;
NOW, THEREFORE, the parties hereto agree as follows:
1. Stock Transfer; Satisfaction of Indebtedness. As of the
Closing Date of the Merger Agreement and after giving effect to the
transactions contemplated under Section 2, the Trustee shall release all right,
title and interest of the Trustee in the shares of Company Common Stock that
have not been allocated to the accounts of ESOP participants (the "Unallocated
Shares") (after giving effect to any such allocations required as a result of
contributions previously made), free and clear of any Trustee claims, liens,
pledges, options, charges, security interests, mortgages, deeds of trust,
encumbrances or other rights of the Trustee of any nature whatsoever, and
Company and Group shall accept the Unallocated Shares from the Trustee in full
satisfaction of the ESOP Loans.
2. Certain Covenants and Agreements.
(a) ESOP Provisions. Prior to the conversion of the ESOP
to a stock bonus or profit sharing plan, Company and/or Group shall contribute
cash to the ESOP, or shall forgive ESOP Loans (which forgiveness of
indebtedness shall be treated as a contribution to the ESOP), to the extent
necessary to cause there
- 3 -
<PAGE> 4
to be on the Closing Date a total of 17,571,429 shares of the Company Common
Stock that have been allocated or will be allocable to the accounts of ESOP
participants (excluding the shares allocated pursuant to clause (b) below);
provided, however, that the contribution shall not exceed the amount reasonably
determined in good faith by Parent (i) to be deductible pursuant to Code
Section 404 for the ESOP plan years beginning January 1, 1993, and/or January
1, 1994, and (ii) to be permissibly allocable, for purposes of Code Section
415, during the "limitation year" (as defined in Code Section 415 and
hereinafter referred to as the "Limitation Year") applicable to the ESOP plan
years beginning January 1, 1993, and/or January 1, 1994, subject to Section
2(f) below. The Company and Group shall amend the ESOP and the Trust Agreement
(i) effective as of the Closing Date, to convert the ESOP to a profit sharing
or stock bonus plan, to preclude participation in the ESOP by persons not
employed by the Company or a Subsidiary of the Company as of the Closing Date,
to eliminate the requirement of the ESOP that participants be employed on the
last date of the plan year to receive an allocation of previously Unallocated
Shares for the plan year, to vest full fiduciary authority in the Trustee with
respect to any right of the Trustee or the ESOP under the Merger Agreement and
this Agreement and the actions contemplated thereby and hereby and to eliminate
any directions or limitations as to the discretion the Trustee may exercise in
exercising that authority, and (ii) effective as of December 31, 1994, to
permanently discontinue contributions to the ESOP.
- 4 -
<PAGE> 5
(b) Additional Allocation. Prior to the Closing Date, Parent
shall compute, or cause to be computed, an aggregate dollar amount (the
"Interim Amount") equal to 4% of the "compensation" (as defined in Parent's
401(k) Plan) of the ESOP participants employed by Company or any of its
Subsidiaries immediately prior to the Closing Date (the "ESOP Participants")
earned for each month or portion thereof included in the period beginning March
1, 1994, and ending on the Closing Date. For purposes of determining the
Interim Amount described in the immediately preceding sentence, a portion of a
month shall be taken into account and result in an increase in such
contribution or forgiveness of indebtedness if the Merger Date occurs on or
after the fifteenth day of such month. Immediately prior to the Closing Date,
Company shall contribute cash to the ESOP, or shall forgive ESOP Loans (which
forgiveness of indebtedness shall be treated as a contribution to the ESOP), in
an amount which shall result in the allocation of the number of shares of
Company Common Stock to the accounts of ESOP Participants as is equal to the
Interim Amount, divided by the Merger Consideration per share; provided,
however, that the contribution shall not exceed the amount reasonably
determined in good faith by Parent to be (i) deductible pursuant to Code
Section 404 for the ESOP plan year beginning January 1, 1994, and, (ii) the
amount permissibly allocable, for purposes of Code Section 415, during the
Limitation Year applicable to the ESOP plan year beginning January 1, 1994,
subject to Section 2(f). To the extent that the contribution obligations set
forth in clauses (a), (b) or (d) cannot be met due
- 5 -
<PAGE> 6
to operation of Code Section 404 or 415, as determined in good faith by Parent,
in a subsequent plan year or plan years Parent shall make or shall cause Sub to
make contributions to a plan established pursuant to clause (d)(iii) below in
an amount equal to the contribution that cannot be made in an earlier plan
year, plus earnings at a rate equal to the greater of (i) 300 basis points in
excess of the 3 month United States Treasury Bill Rate, adjusted and compounded
quarterly, or (ii) the percentage change in the fair market value of the assets
of the ESOP (or, if the ESOP is merged into another plan, the plan into which
the ESOP is merged, or, in the event the ESOP is terminated, the qualified plan
or plans in which the employees of the Company are eligible to participate)
over the "measuring period" described below (determined by including changes in
value attributable to realized and unrealized income, gains and losses) for the
period from the Closing Date to the date of contribution (the "measuring
period"); provided, however, that the contribution to be made for any given
plan year shall not exceed the amount reasonably determined in good faith by
Parent, (i) to be deductible for such plan year pursuant to Code Section 404
and (ii) to be permissibly allocable for purposes of Code Section 415, during
the Limitation Year applicable to such plan year. For purposes of this
provision, the "3 month United States Treasury Bill Rate" shall be the rate
published in the Wall Street Journal for thirteen week short-term U.S.
government bills as of the last day of each calendar quarter. The ESOP
Committee
- 6 -
<PAGE> 7
shall make the allocations necessary to comply with this Section 2(b).
(c) Termination of Agreements. Effective as of the
Closing Date, each of the Subscription Agreement, the ESOP Loan Agreements and
the Pledge Agreement is terminated and cancelled and shall be of no further
force or effect, and the Trustee, Company, Group, and the ESOP Committee shall
take all steps necessary to comply with this covenant.
(d) Plan Provisions Post-Closing. Following the
consummation of the transactions contemplated hereby, (i) the Trust and the
Trust Agreement shall continue in full force and effect, as amended pursuant to
Section 2(a) hereinabove, until such time as all distributions have been made
in accordance with the terms of the ESOP as amended pursuant to Section 2(a)
hereinabove; (ii) the interests of each ESOP Participant in any amount, if any,
credited to his ESOP account (including any amount credited or to be credited
as a result of the transactions contemplated hereby) shall become
nonforfeitable from and after the Closing Date in accordance with Code Section
411 and the Treasury Regulations thereunder; and (iii) the ESOP Participants
who continue to be employed by Parent or Sub shall be entitled to participate
in Parent's 401(k) plan or a similar plan to be established by Parent. Such
plan shall provide (A) a profit sharing contribution (the "Profit Sharing
Contribution") on behalf of the ESOP Participants of 4% of the "compensation"
of the ESOP Participants (as defined in such plan for participants generally)
for the period beginning on the day
- 7 -
<PAGE> 8
following the Closing Date and ending December 31, 1994, and (B) a matching
contribution (the "Matching Contribution") by Parent of 100% of each ESOP
Participant's deferrals under such plan, not in excess of 3% of "compensation"
(as defined in such plan for participants generally) made with respect to the
period beginning on the Closing Date and ending December 31, 1998. In
addition, it is the present intention of Parent to provide the Profit Sharing
Contribution described in clause (A) above to ESOP Participants during the plan
years beginning in the calendar years ending December 31, 1995, through
December 31, 1998; provided, however, that the parties hereto acknowledge and
agree that Parent is under no obligation to the Trustee or ESOP Participants
under this Agreement to provide any such Profit Sharing Contribution for years
after 1994. The parties hereto further acknowledge and agree that the
contributions of Parent referred to in this Section 2(d) are (i) conditioned
upon qualification of Parent's plan under Code Section 401(a), and shall be
returned to Parent if the Internal Revenue Service does not issue a
determination letter reasonably acceptable to Parent with respect to such plan,
(ii) that such contribution for any plan year, after having taken into account
the contribution obligation set forth in Section 2(b) above, shall not exceed
the amount reasonably determined in good faith by Parent (a) to be deductible
pursuant to Code Section 404 for the applicable plan year, and (b) not to
exceed the amount permissibly allocable for purposes of Code Section 415 for
the applicable Limitation Year, subject to Section 2(f) below. Parent shall
act
- 8 -
<PAGE> 9
in good faith and use its best efforts to secure such determination letter,
including the adoption of changes reasonably requested by the Internal Revenue
Service.
(e) Contribution and Allocation Restructuring. The
parties expect that the obligations of Parent to make and allocate
contributions to plans pursuant to this Agreement may be fulfilled without loss
of qualification of the ESOP or of any plan established or continued by Parent
for the benefit of employees of Parent and/or its subsidiaries. If in the
opinion of counsel to Parent, the qualification of any such plan could be
jeopardized by Parent's contributions and/or allocations in compliance with
this Agreement, the Trustee shall in good faith enter into an agreement with
Parent to accept the consideration contemplated by this Agreement in another
form or manner, as the Trustee shall determine, in its sole and absolute
discretion, is permitted under ERISA and as mutually agreed to by Parent and
the Trustee. No such agreement shall result in any reduction of the then net
present value of the contribution and allocation obligations of Parent under
this Agreement. If counsel to the Trustee does not concur with counsel to
Parent that the qualification of any such plan could be jeopardized by Parent's
contributions and/or allocations in compliance with this Agreement, Parent and
the Trustee shall select nationally recognized counsel experienced in ERISA and
the Code, especially with respect to ESOPs, mutually agreeable to them to
review the issue and make an independent determination whether the
qualification of the ESOP or any Parent plan could be
- 9 -
<PAGE> 10
jeopardized. If deemed necessary by the independent counsel, a financial
adviser mutually agreeable to Parent and the Trustee shall be selected. Parent
shall pay all reasonable fees and costs of the Trustee, the Trustee's counsel
and financial advisor, the independent counsel and the independent counsel's
financial advisor. The determination of the Interim Amount described in
Section 2(b) and the application of the limitations of Code Sections 404 and
415 to be determined by Parent pursuant to Sections 2(b) and (d) shall be
provided by Parent to the Trustee and the ESOP Committee for the purposes of
allowing either or both to provide comment with respect thereto.
(f) Code Section 415 Priorities. In calculating the Code
Section 415(c) limitation for the ESOP Limitation Year applicable to the ESOP
plan year beginning January 1, 1994, and the Limitation Years applicable to the
plan years beginning or on after January 1, 1994, of the plan described in
Section 2(d) hereinabove in which ESOP Participants will participate after the
Closing Date, contributions (and forgiveness of indebtedness treated as
contributions) described in this Section 2 shall be charged against such
limitation in the following order:
(i) First, the Matching Contribution in Section
2(d) hereof;
(ii) Second, the contribution or forgiveness
of indebtedness described in Section 2(a) hereof;
(iii) Third, the contribution or forgiveness of
indebtedness described in Section 2(b) hereof; and
- 10 -
<PAGE> 11
(iv) Fourth, the Profit Sharing Contribution
described in Section 2(d) hereof.
(g) Contributions by Parent or Sub. Any contribution to
be made by Parent or Sub pursuant to clauses (b) or (d) hereunder may be made,
at Parent or Sub's election, in cash or in stock of Parent that is publicly
traded, freely transferable (not subject to a securities or trading limitation)
and equal in fair market value to the amount of the contribution obligation.
(h) Indemnification. For a period of six years from and
after the Effective Time (as defined in the Merger Agreement), Parent and Sub
shall indemnify U.S. Trust Company of California, N.A., as the Trustee and its
financial advisors, Duff & Phelps Financial Consulting Company ("Duff &
Phelps"), to the extent Group or Company would have been so required under the
Trust Agreement and/or under any engagement letters with the Trustee and Duff &
Phelps to which Company and/or any of its Subsidiaries is a signatory, without
regard to termination of the ESOP or removal of U.S. Trust Company of
California, N.A., as the Trustee. Such indemnification shall be made only to
the extent that such indemnification would be required had Company survived the
Merger as an independent entity and the indemnification obligation had also
survived the Merger, and only in accordance with the terms of the Trust
Agreement and/or such engagement letters.
3. Conditions to Closing. The respective obligations of the
parties to consummate the transactions contemplated by Sections 1 and 2 shall
be conditioned upon (i) the prior or simultaneous
- 11 -
<PAGE> 12
consummation of the Merger in accordance with the terms of the Merger
Agreement, and (ii) the Trustee having been duly authorized by all necessary
corporate action on the part of the Trustee to consummate the transactions
contemplated hereunder, and no other corporate proceedings on the part of the
Trustee being necessary to consummate the transactions contemplated hereby.
4. Delivery of Documents at the Closing.
(a) Documents Delivered by the Trustee. At the Closing,
the Trustee shall deliver to Company the following documents:
(i) A written waiver of all right, title and
interest of the Trustee in the Unallocated Shares, in accordance
with Section 1 hereinabove; and
(ii) a certificate of the Trustee setting
forth the resolutions of the Trustee authorizing and approving this
Agreement and the transactions contemplated hereby, and certifying
that such resolutions were duly adopted and remain in full force and
effect, not having been altered, amended or repealed.
(b) Documents Delivered by Company and Group. At the
Closing, Company or Group shall deliver to the Trustee the following documents:
(i) the cancelled promissory notes evidencing
the ESOP Loans;
(ii) a certificate of the Secretaries of Company
and Group setting forth the resolutions of the board of directors of
each, respectively, authorizing the execution and delivery
- 12 -
<PAGE> 13
of this Agreement and the consummation of the transactions
contemplated hereby, and certifying that such resolutions were duly
adopted and remain in full force and effect, not having been altered,
amended or repealed;
(iii) duly executed amendments to the ESOP and the
Trust Agreement, as required hereinabove; and
(iv) the opinion of Johnson & Gibbs, P.C., counsel
to Company, to the effect that none of (i) the discharge of the
portion of the principal amount of the ESOP Loans that exceeds the
fair market value of the shares of Company Common Stock transferred by
the ESOP Trustee to Company pursuant to Section 1, or (ii), the
transfer by the ESOP Trustee to Company of shares of Company Common
Stock unallocated under the ESOP in satisfaction of the ESOP Loans,
each as contemplated by this Agreement, will result in a violation of
the requirements of the prohibited transaction exemption of Section
4975(d)(3) of the Code and Section 408(b)(3) of ERISA, as expressed in
Treas. Reg. Section 54.4975-7(b)(4), (5) and (6), and DOL Reg.
Section 2550.408b-3(d), (e) and (f), assuming in each case that the
fiduciaries undertaking such transactions are complying with the
applicable fiduciary responsibility requirements of ERISA and that the
ESOP has received no less than adequate consideration.
(c) Documents Delivered by Parent. At the Closing,
Parent shall deliver to the Trustee a certificate of the Secretary of Parent
setting forth the resolutions of Parent authorizing the
- 13 -
<PAGE> 14
execution and delivery of this Agreement and the consummation of the
transactions contemplated hereby, and certifying that such resolutions were
duly adopted and remain in full force and effect, not having been altered,
amended or repealed.
(d) Opinion of Trustee's Counsel. The Trustee agrees
that prior to the Closing Date it will obtain from its counsel, Gardere &
Wynne, L.L.P., an opinion that Gardere & Wynne, L.L.P. concurs in the opinion
of Johnson & Gibbs, P.C., provided pursuant to the provisions of section
4(b)(iv) hereinabove. A copy of such opinion shall be provided to the Company
prior to Closing Date; provided, however, that the parties hereto agree that
the opinion rendered by Gardere & Wynne, L.L.P., may only be relied upon by the
Trustee and may not be relied upon by any other party to this Agreement.
5. Voting Agreement. At such time as Company conducts any
meeting of or otherwise seeks a vote of its stockholders for the purpose of
approving the Merger, the Trustee shall vote the Unallocated Shares and shares
of Company Common Stock allocated to the accounts of ESOP Participants with
respect to which no voting instructions are received from the applicable ESOP
participants, in favor of the Merger and the consummation of the transactions
contemplated by the Merger Agreement, unless the Trustee, in its sole
discretion, reasonably determines in good faith that such vote would violate
the applicable requirements of ERISA.
- 14 -
<PAGE> 15
6. Company, Group, Trustee and Parent Representations and
Warranties.
(a) Company, Group and Related Company Organization.
Company represents and warrants that each of Company and its Subsidiaries is,
if a corporation, a corporation duly organized, validly existing and in good
standing under the laws of the jurisdiction of its incorporation (or, if a
partnership or other legal entity, is duly organized, is validly existing under
the laws of the jurisdiction of its organization and has completed the filing
of any certificates required and by such jurisdiction for the organization and
continued existence thereof) and has all requisite power and authority to own,
lease and operate its properties and to carry on its business as now being
conducted, except when the failure to be so organized, existing and in good
standing or to make such filings or to have such power and authority would not,
individually or in the aggregate, have a material adverse effect on the
business, operations, properties, assets, liabilities, condition (financial or
otherwise) or results of operations of Company and its Subsidiaries, taken as a
whole (a "Material Adverse Effect"). Each of Company and its Subsidiaries is
duly qualified or licensed to do business and in good standing in each
jurisdiction in which the property owned, leased or operated by it or the
nature of the business conducted by it makes such qualification or licensing
necessary, except where the failure to be so duly qualified or licensed and in
good standing would not, individually or in the aggregate, have a Material
Adverse Effect.
- 15 -
<PAGE> 16
(b) Company and Group Authority. Company and Group
represent and warrant that Company and Group have the requisite corporate power
and authority to execute and deliver this Agreement and to carry out their
obligations hereunder. The execution, delivery and performance of this
Agreement and the consummation of the Merger and of the other transactions
contemplated hereunder have been duly authorized by all necessary corporation
action on the part of Company and Group and no other corporate proceedings on
the part of Company and Group are necessary to authorize this Agreement or to
consummate the transactions contemplated hereby. This Agreement has been duly
executed and delivered by Company and Group and constitutes the valid and
binding obligation of Company and Group enforceable against Company and Group
in accordance with its terms, except as may be limited by or subject to any
bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium or
other laws affecting the enforcement of creditors' rights generally, and
subject to general principles of equity.
(c) Parent Organization. Parent represents and warrants
that Parent is a corporation duly organized, validly existing and in good
standing under the laws of Delaware and has all requisite power and authority
to own, lease and operate its properties and to carry on its business as now
being conducted, except when the failure to be so organized, existing and in
good standing or to have such power and authority would not, individually or in
the aggregate, prevent or delay in any material respect the consummation of the
transactions contemplated by this Agreement.
- 16 -
<PAGE> 17
(d) Parent Authority. Parent represents and warrants
that Parent has the requisite corporate power and authority to execute and
deliver this Agreement and to carry out its obligations hereunder. The
execution, delivery and performance of this Agreement and the consummation of
the Merger and the consummation of the transactions contemplated hereby have
been duly authorized by all necessary corporate action on the part of Parent
and no other corporate proceedings on the part of Parent are necessary to
authorize this Agreement or to consummate the transactions contemplated hereby.
This Agreement has been duly executed and delivered by Parent and constitute
the valid and binding obligation of Parent, enforceable against Parent in
accordance with its terms, except as may be limited by or subject to any
bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium or
other similar laws affecting the enforcement of creditors' rights generally,
and subject to general principles of equity.
(e) Trustee Organization. The Trustee represents and
warrants the Trustee is a national association duly organized, validly existing
and in good standing under the jurisdiction of its incorporation and has all
requisite power and authority to own, lease and operate its properties and to
carry on its business now being conducted, except where the failure to be so
organized, existing and in good standing or to have such power and authority
would not, individually or in the aggregate, prevent or delay in any material
respect the consummation of the transactions contemplated by this Agreement.
- 17 -
<PAGE> 18
(f) Trustee Authority. The Trustee represents and
warrants that the Trustee has the requisite power and authority to execute and
deliver this Agreement and to carry out its obligations hereunder. The
execution of this Agreement has been duly authorized by all necessary corporate
action on the part of the Trustee and no other corporate proceedings on the
part of the Trustee are necessary to authorize this Agreement. This Agreement
has been duly executed and delivered by the Trustee and constitutes the valid
and binding obligation of the Trustee, enforceable against the Trustee in
accordance with its terms, except as may be limited by or subject to any
bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium or
other similar laws affecting the enforcement of creditors' rights generally,
and subject to general principles of equity. All authority exercised hereunder
by the Trustee is solely in its fiduciary capacity as the Trustee under the
Trust Agreement, and in no other capacity.
(g) ESOP Committee Organization. The ESOP Committee
represents and warrants that the ESOP Committee has been validly appointed
under the ESOP, and has all requisite power and authority to exercise its
duties under the ESOP.
(h) ESOP Committee Authority. The ESOP Committee
represents and warrants that the ESOP Committee has the requisite power and
authority to execute and deliver this Agreement and to carry out its
obligations hereunder. The execution of this Agreement has been duly
authorized by all necessary action on the part of the ESOP Committee and no
other proceedings on the part of
- 18 -
<PAGE> 19
the ESOP Committee are necessary to authorize this Agreement. This Agreement
has been duly executed and delivered by the ESOP Committee and constitutes the
valid and binding obligation of the ESOP Committee, enforceable against the
ESOP Committee in accordance with its terms, except as may be limited by or
subject to any bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium or other similar laws affecting the enforcement of creditors rights
generally and subject to general principles of equity.
(i) Nonsurvival of Representations and Warranties. None
of the representations and warranties in this Section 6 shall survive the
Closing Date or termination of the Merger Agreement.
7. Amendments. This Agreement contains the entire understanding
of the parties with respect to the ESOP and may be amended only by an agreement
in writing signed by each party hereto.
8. Descriptive Headings. Descriptive headings are for
convenience only and shall not control or affect the meaning or construction of
any provision of this Agreement.
9. Counterparts. For the convenience of the parties, any number
of counterparts of this Agreement may be executed by one or more parties hereto
and each such executed counterpart shall be, and shall be deemed to be, an
original instrument.
10. Notices. All notices, consents, requests, instructions,
approvals and other communications provided for herein and all legal process in
regard hereto shall be validly given, made or
- 19 -
<PAGE> 20
served, if in writing and delivery personally, or sent by facsimile or
registered mail, postage prepaid, if:
TO THE TRUSTEE:
U.S. Trust Company of California, N.A.
555 South Flower Street, Suite 2700
Los Angeles, California 90071-2429
Attention: Charles E. Wert, Sr.
With a copy to: Gardere & Wynne, L.L.P.
1601 Elm Street
Suite 2800
Dallas, Texas 75201
Attention: William W. McClure, Jr., Esq.
TO COMPANY, GROUP OR ESOP COMMITTEE:
EPIC Holdings, Inc.
EPIC Center
3333 Lee Parkway, Suite 900
Dallas, Texas 75219
Attention: Stanley Baldwin, Esq.
With a copy to: Johnson & Gibbs, P.C.
900 Jackson Street
Dallas, Texas 75202
Attention: Jim A. Watson, Esq.
TO PARENT OR SUB:
Healthtrust, Inc. - The Hospital Company
4525 Harding Road
Nashville, Tennessee 37205
Attention: Philip D. Wheeler, Esq.
With a copy to: Dewey Ballantine
1301 Avenue of the Americas
New York, New York 10019-6092
Attention: Morton A. Pierce, Esq.
or to such other address as any party hereto may, from time to time, designate
in a written notice given in a like manner. Notice delivered personally shall
be deemed delivered on the date of delivery. Notice given by facsimile shall
be deemed delivered on
- 20 -
<PAGE> 21
the date on which receipt is acknowledged. Notice given by mail as set out
above shall be deemed delivered three days after the date the same is
postmarked.
11. Law Application. This Agreement shall be governed by and
construed and enforced in accordance with the laws of the State of Delaware
without regard to principles of conflict of laws; provided, however, that the
law governing any fiduciary duties of each party hereto and, in the case of
Company, Parent and Sub, their respective boards of directors and the law
governing any other matters of internal corporate governance of Company, Parent
or Sub shall be the law of their respective jurisdictions of incorporation (in
the case of Company, Parent and Sub, Delaware) or the law specifically
applicable to them (in the case of the Trustee, the laws of the State of
California, ERISA or other applicable federal or state law).
- 21 -
<PAGE> 22
12. Successor and Assigns. This Agreement shall be binding upon
and inure to the benefit of and be enforceable by the successor and assigns of
the parties hereto.
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to
be duly executed and delivered as of the day and year first above written.
HEALTHTRUST, INC. - U.S. TRUST COMPANY OF
THE HOSPITAL COMPANY CALIFORNIA, N.A.
By: /s/ Micheal A. Koban, Jr. By: /s/ Charles E. Wert
---------------------------- ----------------------------
Name: Micheal A. Koban, Jr. Name: Charles E. Wert
-------------------------- --------------------------
Title: Senior Vice President Title: Executive Vice President and
------------------------- -------------------------
Senior Trust Officer
ODYSSEY ACQUISITION CORP. ESOP COMMITTEE
(acting solely in the capacity
as members of the ESOP
Committee)
By: /s/ Micheal A. Koban, Jr. /s/ Kenn S. George
---------------------------- --------------------------------
Name: Micheal A. Koban, Jr. /s/ Stanley F. Baldwin
-------------------------- --------------------------------
Title: Vice President /s/ Thomas T. Schleck
------------------------- --------------------------------
/s/ Gary E. Griffith
--------------------------------
EPIC HOLDINGS, INC. EPIC HEALTHCARE GROUP, INC.
By: /s/ Kenn S. George By: /s/ Kenn S. George
---------------------------- ----------------------------
Name: Kenn S. George Name: Kenn S. George
-------------------------- --------------------------
Title: Chairman, President Title: Chairman, President
------------------------- -------------------------
and CEO and CEO
- 22 -
<PAGE> 1
EXHIBIT 12.1 TO FORM S-3 REGISTRATION STATEMENT
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
<TABLE>
<CAPTION>
THREE MONTHS
ENDED YEAR ENDED AUGUST 31
NOVEMBER 30, -----------------------------------------------------
1993 1993 1992 1991 1990 1989
------------ -------- -------- -------- -------- ---------
<S> <C> <C> <C> <C> <C> <C>
Net income (loss)............. $ 38,852 $135,191 $ 93,242 $ 6,640 $(53,150) $(101,272)
Income tax charge (credit).... 26,559 90,675 71,432 15,439 (21,855) (53,148)
------------ -------- -------- -------- -------- ---------
Pre-tax income (loss)......... $ 65,411 $225,866 $164,674 $ 22,079 $(75,005) $(154,420)
------------ -------- -------- -------- -------- ---------
Fixed Charges:
Interest (expensed or
capitalized)................ $ 23,314 $106,244 $117,592 $150,572 $154,801 $ 170,150
Amortization of debt expense,
discount or premium......... 541 1,978 6,989 4,477 8,111 20,998
Estimated interest factor on
operating lease payments.... 3,791 13,977 12,269 9,573 8,032 7,260
------------ -------- -------- -------- -------- ---------
Total fixed charges.... $ 27,646 $122,199 $136,850 $164,622 $170,944 $ 198,408
------------ -------- -------- -------- -------- ---------
Earnings:
Pre-tax income (loss)......... $ 65,411 $225,866 $164,674 $ 22,079 $(75,005) $(154,420)
Fixed charges................. 27,646 122,199 136,850 164,622 170,944 198,408
Interest capitalized.......... (2,300) (8,435) (5,025) (2,400) (1,850) (1,349)
Amortization of interest
capitalized................. 500 1,709 1,568 1,400 1,332 1,259
------------ -------- -------- -------- -------- ---------
Total earnings......... $ 91,257 $341,339 $298,067 $185,701 $ 95,421 $ 43,898
------------ -------- -------- -------- -------- ---------
Ratio of earnings to fixed
charges..................... 3.3X 2.8X 2.2X 1.1X (A) (A)
------------ -------- -------- -------- -------- ---------
------------ -------- -------- -------- -------- ---------
</TABLE>
- ---------------
(A) The Company's earnings were inadequate to cover fixed charges for the years
ended August 31, 1990 and 1989 by $75,523 and $154,510 respectively.
<PAGE> 1
EXHIBIT 12.2 TO FORM S-3 REGISTRATION STATEMENT
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
COMPUTATION OF PRO FORMA RATIO OF EARNINGS TO FIXED CHARGES
<TABLE>
<CAPTION>
THREE MONTHS YEAR
ENDED ENDED
NOVEMBER 30, AUGUST 31,
1993 1993
------------ ----------
<S> <C> <C>
Pro forma net income................................................. $ 36.1 $129.5
Pro forma income tax charge.......................................... 26.3 95.4
------------ ----------
Pro forma pre-tax income............................................. $ 62.4 $225.2
------------ ----------
Pro Forma Fixed Charges:
Interest (expensed or capitalized)................................. $ 36.9 $157.2
Amortization of debt expense, discount or premium.................. 1.1 4.4
Estimated interest factor on operating lease payments.............. 5.3 19.8
------------ ----------
Total pro forma fixed charges.............................. $ 43.3 $181.4
------------ ----------
Pro Forma Earnings:
Pre-tax income..................................................... $ 62.4 $224.9
Fixed charges...................................................... 43.3 181.4
Interest capitalized............................................... (2.8) (10.4)
Amortization of interest capitalized............................... 0.6 2.2
------------ ----------
Total pro forma earnings................................... $103.5 $398.1
------------ ----------
Pro forma ratio of earnings to fixed charges......................... 2.4X 2.2X
------------ ----------
------------ ----------
</TABLE>
<PAGE> 1
EXHIBIT 23.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the reference to our firm under the captions "Selected
Historical Financial Information" and "Experts" in the Registration Statement
(Form S-3) and related Prospectus of Healthtrust, Inc. -- The Hospital Company
for the registration of $200,000,000 Subordinated Notes and to the incorporation
by reference therein of our report dated October 15, 1993, with respect to the
consolidated financial statements and schedules of Healthtrust, Inc. -- The
Hospital Company included in its Annual Report (Form 10-K) for the year ended
August 31, 1993, filed with the Securities and Exchange Commission.
Ernst & Young
Nashville, Tennessee
February 23, 1994
<PAGE> 1
EXHIBIT 23.2
CONSENT OF INDEPENDENT AUDITORS
We consent to the reference to our firm under the captions "Selected
Historical Financial Information" and "Experts" and to the use of our reports
dated December 3, 1993, with respect to the consolidated financial statements of
EPIC Holdings, Inc. and subsidiaries and EPIC Healthcare Group, Inc. and
subsidiaries included in the Registration Statement (Form S-3) and related
Prospectus of Healthtrust, Inc. -- The Hospital Company for the registration of
$200,000,000 Subordinated Notes.
Ernst & Young
Dallas, Texas
February 23, 1994
<PAGE> 1
POWER OF ATTORNEY
S-3 REGISTRATION STATEMENT
FOR
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
KNOW ALL MEN BY THESE PRESENTS, that the person whose
signature appears below constitutes and appoints R. Clayton McWhorter, Chairman
and Chief Executive Officer of Healthtrust, Inc. - The Hospital Company
(hereinafter referred to as the "Company") Michael A. Koban, Jr., Senior
Vice-President of the Company, and Philip D. Wheeler, Senior Vice-President,
Secretary and General Counsel of the Company, and each of them, jointly and
severally, his true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to execute and file, or cause to be filed, with the
Securities and Exchange Commission (hereinafter referred to as the
"Commission") the Company's S-3 Registration Statement in connection with the
offering of Debt Securities, and all amendments thereto, and all matters
required by the Commission in connection with such report under The Securities
Exchange Act of 1933, as amended, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done as fully to all intents
and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, and each of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
<TABLE>
<S> <C>
/s/ W. Hudson Connery, Jr. 2/11/94
- ------------------------------------------- --------------------------
W. Hudson Connery, Jr. Date
Senior Vice-President, Chief
Operating Officer and Director
</TABLE>
<PAGE> 2
POWER OF ATTORNEY
S-3 REGISTRATION STATEMENT
FOR
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
KNOW ALL MEN BY THESE PRESENTS, that the person whose
signature appears below constitutes and appoints R. Clayton McWhorter, Chairman
and Chief Executive Officer of Healthtrust, Inc. - The Hospital Company
(hereinafter referred to as the "Company"), and Philip D. Wheeler, Senior
Vice-President, Secretary and General Counsel of the Company, and each of them,
jointly and severally, his true and lawful attorney-in-fact and agent, with
full power of substitution and resubstitution, for him and in his name, place
and stead, in any and all capacities, to execute and file, or cause to be
filed, with the Securities and Exchange Commission (hereinafter referred to as
the "Commission") the Company's S-3 Registration Statement in connection with
the offering of Debt Securities, and all amendments thereto, and all matters
required by the Commission in connection with such report under The Securities
Exchange Act of 1933, as amended, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done as fully to all intents
and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, and each of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
<TABLE>
<S> <C>
/s/ Michael A. Koban, Jr. 2/3/94
- ------------------------------------------- --------------------------
Michael A. Koban, Jr. Date
Senior Vice-President and Director
(Principal Financial Officer)
</TABLE>
<PAGE> 3
POWER OF ATTORNEY
S-3 REGISTRATION STATEMENT
FOR
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
KNOW ALL MEN BY THESE PRESENTS, that the person whose
signature appears below constitutes and appoints R. Clayton McWhorter, Chairman
and Chief Executive Officer of Healthtrust, Inc. - The Hospital Company
(hereinafter referred to as the "Company"), Michael A. Koban, Jr., Senior
Vice-President of the Company, and Philip D. Wheeler, Senior Vice-President,
Secretary and General Counsel of the Company, and each of them, jointly and
severally, his true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to execute and file, or cause to be filed, with the
Securities and Exchange Commission (hereinafter referred to as the
"Commission") the Company's S-3 Registration Statement in connection with the
offering of Debt Securities, and all amendments thereto, and all matters
required by the Commission in connection with such report under The Securities
Exchange Act of 1933, as amended, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done as fully to all intents
and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, and each of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
<TABLE>
<S> <C>
/s/ William T. Hjorth 2/3/94
- ------------------------------------------- --------------------------
William T. Hjorth Date
Director
</TABLE>
<PAGE> 4
POWER OF ATTORNEY
S-3 REGISTRATION STATEMENT
FOR
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
KNOW ALL MEN BY THESE PRESENTS, that the person whose
signature appears below constitutes and appoints R. Clayton McWhorter, Chairman
and Chief Executive Officer of Healthtrust, Inc. - The Hospital Company
(hereinafter referred to as the "Company") Michael A. Koban, Jr., Senior
Vice-President of the Company, and Philip D. Wheeler, Senior Vice-President,
Secretary and General Counsel of the Company, and each of them, jointly and
severally, his true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to execute and file, or cause to be filed, with the
Securities and Exchange Commission (hereinafter referred to as the
"Commission") the Company's S-3 Registration Statement in connection with the
offering of Debt Securities, and all amendments thereto, and all matters
required by the Commission in connection with such report under The Securities
Exchange Act of 1933, as amended, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done as fully to all intents
and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, and each of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
<TABLE>
<S> <C>
/s/ Donald S. MacNaughton 2/11/94
- ------------------------------------------- --------------------------
Donald S. MacNaughton Date
Director
</TABLE>
<PAGE> 5
POWER OF ATTORNEY
S-3 REGISTRATION STATEMENT
FOR
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
KNOW ALL MEN BY THESE PRESENTS, that the person whose
signature appears below constitutes and appoints R. Clayton McWhorter, Chairman
and Chief Executive Officer of Healthtrust, Inc. - The Hospital Company
(hereinafter referred to as the "Company"), Michael A. Koban, Jr., Senior
Vice-President of the Company, and Philip D. Wheeler, Senior Vice-President,
Secretary and General Counsel of the Company, and each of them, jointly and
severally, his true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to execute and file, or cause to be filed, with the
Securities and Exchange Commission (hereinafter referred to as the
"Commission") the Company's S-3 Registration Statement in connection with the
offering of Debt Securities, and all amendments thereto, and all matters
required by the Commission in connection with such report under The Securities
Exchange Act of 1933, as amended, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done as fully to all intents
and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, and each of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
<TABLE>
<S> <C>
/s/ Alethea O. Caldwell 2/8/94
- ------------------------------------------- --------------------------
Alethea O. Caldwell Date
Director
</TABLE>
<PAGE> 6
POWER OF ATTORNEY
S-3 REGISTRATION STATEMENT
FOR
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
KNOW ALL MEN BY THESE PRESENTS, that the person whose
signature appears below constitutes and appoints R. Clayton McWhorter, Chairman
and Chief Executive Officer of Healthtrust, Inc. - The Hospital Company
(hereinafter referred to as the "Company"), Michael A. Koban, Jr., Senior
Vice-President of the Company, and Philip D. Wheeler, Senior Vice-President,
Secretary and General Counsel of the Company, and each of them, jointly and
severally, his true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to execute and file, or cause to be filed, with the
Securities and Exchange Commission (hereinafter referred to as the
"Commission") the Company's S-3 Registration Statement in connection with the
offering of Debt Securities, and all amendments thereto, and all matters
required by the Commission in connection with such report under The Securities
Exchange Act of 1933, as amended, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done as fully to all intents
and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, and each of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
<TABLE>
<S> <C>
/s/ Richard W. Hanselman 2/6/94
- ------------------------------------------- --------------------------
Richard W. Hanselman Date
Director
</TABLE>
<PAGE> 7
POWER OF ATTORNEY
S-3 REGISTRATION STATEMENT
FOR
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
KNOW ALL MEN BY THESE PRESENTS, that the person whose
signature appears below constitutes and appoints R. Clayton McWhorter, Chairman
and Chief Executive Officer of Healthtrust, Inc. - The Hospital Company
(hereinafter referred to as the "Company"), Michael A. Koban, Jr., Senior
Vice-President of the Company, and Philip D. Wheeler, Senior Vice-President,
Secretary and General Counsel of the Company, and each of them, jointly and
severally, his true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to execute and file, or cause to be filed, with the
Securities and Exchange Commission (hereinafter referred to as the
"Commission") the Company's S-3 Registration Statement in connection with the
offering of Debt Securities, and all amendments thereto, and all matters
required by the Commission in connection with such report under The Securities
Exchange Act of 1933, as amended, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done as fully to all intents
and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, and each of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
<TABLE>
<S> <C>
/s/ Harry N. Beaty, M.D. 2/10/94
- ------------------------------------------- --------------------------
Harry N. Beaty, M.D. Date
Director
</TABLE>
<PAGE> 8
POWER OF ATTORNEY
S-3 REGISTRATION STATEMENT
FOR
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
KNOW ALL MEN BY THESE PRESENTS, that the person whose
signature appears below constitutes and appoints R. Clayton McWhorter, Chairman
and Chief Executive Officer of Healthtrust, Inc. - The Hospital Company
(hereinafter referred to as the "Company"), Michael A. Koban, Jr., Senior
Vice-President of the Company, and Philip D. Wheeler, Senior Vice-President,
Secretary and General Counsel of the Company, and each of them, jointly and
severally, his true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to execute and file, or cause to be filed, with the
Securities and Exchange Commission (hereinafter referred to as the
"Commission") the Company's S-3 Registration Statement in connection with the
offering of Debt Securities, and all amendments thereto, and all matters
required by the Commission in connection with such report under The Securities
Exchange Act of 1933, as amended, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done as fully to all intents
and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, and each of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
<TABLE>
<S> <C>
/s/ Robert F. Dee 2/8/94
- --------------------------------------------------- -------------------------
Robert F. Dee Date
Director
</TABLE>
<PAGE> 9
POWER OF ATTORNEY
S-3 REGISTRATION STATEMENT
FOR
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
KNOW ALL MEN BY THESE PRESENTS, that the person whose
signature appears below constitutes and appoints Michael A. Koban, Jr., Senior
Vice-President of Healthtrust, Inc. - The Hospital Company (hereinafter
referred to as the "Company") and Philip D. Wheeler, Senior Vice-President,
Secretary and General Counsel of the Company, and each of them, jointly and
severally, his true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to execute and file, or cause to be filed, with the
Securities and Exchange Commission (hereinafter referred to as the
"Commission" the Company's S-3 Registration Statement in connection with
the offering of Debt Securities, and all amendments thereto, and all matters
required by the Commission in connection with such report under The Securities
Exchange Act of 1933, as amended, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done as fully to all intents
and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, and each of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
<TABLE>
<S> <C>
/s/ R. Clayton McWhorter 2/10/94
- ------------------------------------------- --------------------------
R. Clayton McWhorter Date
Chairman of the Board, President,
Chief Executive Officer and Director
(Principal Executive Officer)
</TABLE>
<PAGE> 10
POWER OF ATTORNEY
S-3 REGISTRATION STATEMENT
FOR
HEALTHTRUST, INC. - THE HOSPITAL COMPANY
KNOW ALL MEN BY THESE PRESENTS, that the person whose
signature appears below constitutes and appoints R. Clayton McWhorter, Chairman
and Chief Executive Officer of Healthtrust, Inc. - The Hospital Company
(hereinafter referred to as the "Company"), Michael A. Koban, Jr., Senior
Vice-President of the Company, and Philip D. Wheeler, Senior Vice-President,
Secretary and General Counsel of the Company, and each of them, jointly and
severally, his true and lawful attorney-in-fact and agent, with full power of
substitution and resubstitution, for him and in his name, place and stead, in
any and all capacities, to execute and file, or cause to be filed, with the
Securities and Exchange Commission (hereinafter referred to as the
"Commission") the Company's S-3 Registration Statement in connection with the
offering of Debt Securities, and all amendments thereto, and all matters
required by the Commission in connection with such report under The Securities
Exchange Act of 1933, as amended, granting unto said attorneys-in-fact and
agents, and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done as fully to all intents
and purposes as he might or could do in person, hereby ratifying and confirming
all that said attorneys-in-fact and agents, and each of them, or their or his
substitute or substitutes, may lawfully do or cause to be done by virtue
hereof.
<TABLE>
<S> <C>
/s/ Kenneth C. Donahey 2/17/94
- ------------------------------------------- --------------------------
Kenneth C. Donahey Date
Senior Vice-President (Principal
Accounting Officer)
</TABLE>
